Canadian Cancer Registry System Guide – 2009 Edition

Part ICCR Data Dictionary

Introduction
0.1 Canadian Cancer Registry overview
0.2 CCR system guide document organization
0.3 Part I document organization: CCR Data Dictionary
0.4 Changes to the CCR Data Dictionary for the 2007 and 2008 reference years
0.5 Statistics Canada contacts

Chapter 1 – Reporting Data
1.1 What data should be reported
1.2 How data should be reported
1.3 Typical use cases

Chapter 2 – Data Dictionary
2.0 Introduction
2.1 Input patient variables
2.2 Derived patient variables
2.3 Input tumour variables
2.4 Derived tumour variables

Introduction

  • Canadian Cancer Registry overview
  • CCR system guide document organization
  • Part I document organization – CCR Data Dictionary
  • Changes to the Data Dictionary for the 2007 and 2008 reference years
  • Statistics Canada contacts

0.1 Canadian Cancer Registry overview

The patient–oriented Canadian Cancer Registry (CCR) evolved from the event–oriented National Cancer Incidence Reporting System (NCIRS). Beginning with cases diagnosed in 1992, incidence figures collected by Provincial and Territorial Cancer Registries (PTCRs) have been reported to the CCR, which is maintained by Statistics Canada. Established as a person–oriented database, the CCR includes mechanisms for updating and clearing death records and is linked to provincial and territorial databases to help track patients across Canada who have been diagnosed with tumours.

0.2 CCR system guide document organization

The CCR System Guide has been separated into three parts to improve access and navigation. Although the three parts are separate, the three documents should be used in conjunction with each other. The different sections of the three–part CCR System Guide often refer to each other. The CCR System Guide is now composed of:

Part I: CCR Data Dictionary provides explanation on the reporting of data, including the scope and detailed information on the input and derived variables.

Part II: CCR Data Loading and Tabulation Master Files provides information on the data loading process, including in–depth descriptions of the various edits performed on the data. Part II also provides information on the Tabulation Master Files, including the scope, content and layout. Part II is followed by several appendices that contain supporting information such as explicit code set tables, guidelines to assist coders and other supportive information.

Part III: CCR Core Reference Tables provides detailed information on the CCR Core Reference Tables such as descriptions of the tables, their usage and any revisions made. Part III is an accompanying document to the "CCR Reference Tables 2009.xls".

0.3 Part I document organization: CCR Data Dictionary

Chapter 1 – Reporting data describes what data that should be reported and how it should be reported to CCR. It also gives some examples of the most common operations for reporting data to CCR.

Chapter 2 – Data dictionary describes all data managed by the system including system–derived variables. For every datum, it also includes a list of related edits that describes the constraints on the datum and the relationship it has with other data.

0.4 Changes to the CCR Data Dictionary for the 2007 and 2008 reference years

Changes to the CCR Data Dictionary for the 2007 and 2008 reference years
Section Item(s) Description of change Effective (reference year) 
0 Organization of document The document has been broken into 3 parts 2008
1.1.2.1 CCRCore Scope Additional codes to CCR core scope and CCRscope exceptions 2007
1.2 Table 5 Input tumour record file layout New variables added: T52 – T57 2008
1.2.2 CCR fundamentals Statements have been updated for clarity: no concept changes 2008
1.2.3.1 Reporting collaborative
staging data – typical cases
T52 added to case examples for CCR cooaborative staging scope 2007
1.2.4.1 TNM staging overview Recurrent tumour prefix 'r' not to be staged or submitted to the CCR 2007
2.1 P6 – Current Surname
P7 – First given name
P8 – Second given name
P9 – Third given name
P13 – Birth Surname
Format: Acceptable characters have been specified 2007
2.1 P17 – Underlying cause of death Description now refers to PD7 – Death clearance underlying cause of death 2007
2.1 P18 – Autopsy confirming cause of death Description: Reference to an appendix has been added 2007
2.2 PD7 – Death clearance underlying cause of death Acronym – Acronym has changed 2007
2.2 PD2 – Vital status The derived variable is now being written only at the Tabulation Master File process 2007
2.2 PD3 – Number of tumours Description: CCR has adopted seer rules as of 2007 2007
2.2 PD4 – Death clearance cut–off date Description – Update to description 2007
2.2 PD7 – Death clearance underlying cause of death Acronym – Acronym has changed 2007
2.3 T5 – Tumour record type New related edits
TVAL53
TVAL54
TVAL55
TVAL56
TVAL57
TCOR26
TCOR27
TCOR29
TCOR30
TCOR31
TCOR32
TCOR33
TCOR34
TCOR35
2008
New related edits
TVAL52
TCOR13
2007
2.3 T6 – Name of place of residence Format: Acceptable characters have been specified  2007
2.3 T8 – Standard geographic code Eligible Standard Geographic Codes from 2006 to 2010 now available 2006
2.3 T9 – Census tract T9 will no longer be loaded onto the CCR. For cases diagnosed in 2006 and onwards, the field should be left blank 2006
2.3 T12 – Date of Diagnosis New related edits
TCOR26
TCOR27
2008
New references to appendices I and H New related edits
TVAL52
TCOR13
2007
2.3 T19 – Laterality Change to specific values & meaning: Adoption of NAACCR (SEER) laterality codes. Previously loaded data on the CCR database has also been converted to the NAACCR (SEER) laterality code. 2007(AND conversion of previously loaded data 1992–2006)
2.3 T23 – Grade, differentiation or cell indicator Revision: Application of new guidelines for reporting grade, differentiation, or cell indicator 2006
2.3 T24 – Method used to establish the date of diagnosis New related edit
TCOR13
2006
2.3 T25 – Diagnostic confirmation New related edit
TCOR13
2006
2.3 T27 – CS Tumour Size
T28 – CS Extension
T29 – CS Tumour size/ext eval
T30 – CS lymph nodes
T31 – CS reg nodes eval
T32 − Regional nodes examined
T33 – Regional nodes positive
T34 – CS mets at Dx
T35 – CS mets eval
T36 − CS site specific factor 1
T37 – CS site–specific factor 2
T38 – CS site–specific factor 3
T39 – CS site–specific factor 4
T40 – CS site–specific factor 5
T41 – CS site–specific factor 6
Specific values & meaning: change to meaning of 8 filled and 9–filled fields
New related edits
(See corresponding sections for additional information)
2007
2.3 T52 – CS Version 1st New field added 2007
2.3 T53 – Ambiguous Terminology Diagnosis New field added 2008
2.3 T54 − Date of conclusive diagnosis New field added 2008
2.3 T55 – Type of multiple tumours reported as one primary New field added 2008
2.3 T56 – Date of multiple tumours New field added 2008
2.3 T57 – Multiplicity Counter New field added 2008
2.4 TD2 – Sequence number Description: note that CCR has adopted SEER rules as of 2007 2007
2.4 TD5 – Survival interval Specific values and meanings: The survival interval for DCO records cannot be computed and is recorded as '99998' 2007
2.4 TD19 – CS version latest CS version latest (formerly TD20) becomes TD19 2007
2.4 TD20 – Filler TD20 (formerly CS Version latest) becomes a filler 2007
  • Please note that changes effective in the 2008 reference year are subject to change.
     
  • Additional updates have been made, however only the changes that require action on the part of the PTCRs have been included in this table.
     
  • Note that changes effective in the 2006 reference year have also been included here.

0.5 Statistics Canada contacts

PTCRs employees are encouraged to bring forward any questions by contacting one of the following:

For additional information regarding the processing of CCR data, please contact:

Colette Brassard
Section Chief
Operations and Integration Division
Statistics Canada
Tel: (613) 951-7282
Fax: (613) 951-0709
For any subject matter related questions/queries, please contact:

Kim Boyuk
Chief, Cancer Statistics
Health Statistics Division
Statistics Canada
Tel: (613) 951-2510
Fax: (613) 951-0792

Hollie Anderson
Manager, Canadian Cancer Registry
Health Statistics Division
Statistics Canada
Tel: (613) 951-0757
Fax: (613) 951-0792

Chapter 1 – Reporting data

  • What data should be reported
  • How data should be reported
  • Typical use cases

1.1 What data should be reported

1.1.1 Reported variables

The Canadian Cancer Registry (CCR) system is a patient–oriented database. The following lists of data items must be reported for every patient and every tumour:

Table 1 Reportable data items
Patient Tumour
Patient reporting province/territory
Patient identification number
CCR identification number
Type of current surname
Current surname
First given name
Second given name
Third given name
Sex
Date of birth
Province/territory or country of birth
Birth surname
Date of death
Province/territory or country of death
Death registration number
Underlying cause of death
Autopsy confirming cause of death
Tumour reporting province/territory
Tumour patient identification number
Tumour reference number
CCR identification number
Name of place of residence
Postal code
Standard geographic code
Census tract
Health insurance number
Method of diagnosis
Date of diagnosis
ICD–9 Cancer code
Source Classification flag
ICD–O–2/3 Topography
ICD–O–2 Histology
ICD–O–2 Behaviour
Laterality
ICD–O–3 Histology
ICD–O–3 Behaviour
Grade, differentiation or cell indicator
Method used to establish the date of diagnosis
Diagnostic confirmation
Date of transmission
CS tumour size
CS extension
CS tumour size/ext eval
CS lymph nodes
CS reg nodes eval
Regional nodes examined
Regional nodes positive
CS mets at Dx
CS mets eval
CS site–specific factor 1
CS site–specific factor 2
CS site–specific factor 3
CS site–specific factor 4
CS site–specific factor 5
CS site–specific factor 6
AJCC clinical T
AJCC clinical N
AJCC clinical M
AJCC pathologic T
AJCC pathologic N
AJCC pathologic M
AJCC clinical TNM stage group
AJCC pathologic TNM stage group
AJCC TNM stage group
AJCC TNM edition number
CS Version 1st
Ambiguous Terminology Diagnosis
Date of conclusive diagnosis
Type of multiple tumours reported as one primary
Date of multiple tumours
Multiplicity counter

For more detail about each variable, see the corresponding section in Chapter 2 – Data dictionary.

1.1.2 Reporting scope

1.1.2.1 CCR core scope

The Canadian Council of Cancer Registries (CCCR) recommends that the following tumours diagnosed in 1992 and onwards be reported to the CCR:

Table 2 CCR core scope
Date of diagnosis ICD–O–3 Behaviour code ICD–O–3 Topography codes ICD–O–3 Histology codes
1992/01/01 to 2006/12/31 1, 2, 3 C00 – C80 except C44 (Skin), 8000 to 9989
0 C70 – C72 (Meninges, brain and spinal cord, cranial nerves and other parts of central nervous system) 8000 to 9989
2007/01/01
and onwards
0 C70 – C72 (Meninges, brain and spinal cord, cranial nerves and other parts of central nervous system)
C75.1, C75.2, C75.3 (pituitary, craniopharyngeal duct and pineal gland)
8000 to 9989
1 and 3 C00 – C80 except C44 (Skin), 8000 to 9989
2 C00 – C80 except C44 (Skin), C53 (cervix)C61.9 (Prostate) 8000 to 9989
Table 2.1 CCR Scope Exceptions (not to be reported)
Date of diagnosis ICD–O–3 Behaviour code ICD–O–3 Topography codes ICD–O–3 Histology codes
1992/01/01
and onwards
1, 2, 3 C44 (skin) 8000 to 8005 (NOS) or
8010 to 8046 (epithelial neoplasm) or
8050 to 8084 (squamous cell neoplasm) or
8090 to 8110 (basal cell neoplasm)
2007/01/01
and onwards
2 C53 (cervix), C61.9 (prostate) All histologies

Notes:

  • Tumours with ICD–O–3 Behaviour Codes '6' and '9' must not be reported to the CCR.
  • For cases diagnosed in 2007 and onwards, duplicate tumours based on the SEER multiple primary/histology rules must not be reported to CCR.
  • For cases diagnosed prior to 2007, duplicate tumours based on the CCR multiple primary rules must not be reported to the CCR. See Appendix D (Part II – CCR Sytem Guide) – multiple primary tumours rules for CCR for more detail.
  • Tumours occurring in patients residing outside of Canada must not be reported to CCR. See Appendix T (Part II – CCR Sytem Guide) – Residency guidelines in Canada for more detail.

1.1.2.2 CCR collaborative staging scopeAll tumours within the CCR core scope and diagnosed in 2004 and onwards should be staged according to the Collaborative Staging Manual and Coding Instructions version 01.04.01 (March 25, 2008) available from the Collaborative Staging Task Force of the American Joint Committee on Cancer.

See next section for more details on how to report collaborative staging data.

1.1.2.3 CCR AJCC TNM staging scope

Colorectal, breast and prostate primary tumours diagnosed in 2003 and onwards can be staged according to their corresponding AJCC TNM 6th Edition staging schema. Reportable tumours are selected based on International Classification of Diseases for Oncology – 3rd Edition (ICD–O–3) as shown in the following table.

Table 3 CCR AJCC TNM staging scope
Date of diagnosis Site ICD–O–3 Topography codes ICD–O–3 Histology codes ICD–O–3 Behaviour codes
2003/01/01
and onwards
Colorectal C18.0 to C18.9; C19.9; C20.9 8000 to 8576; 8935 to 8936; 8940 to 8950; 8980 to 8981 2, 3
Breast C50.0 to C50.9 8000 to 8576; 8940 to 8950; 8980 to 8981; 9020 2, 3
Prostate C61.9 8000 to 8110; 8120; 8131to 8576; 8940 to 8950; 8980 to 8981 3

See next section for details on how to report AJCC TNM staging data.

1.2 How data should be reported

1.2.1 Input record files

Data must be reported to the Canadian Cancer Registry (CCR) system using flat files encoded with an ISO 8859–1 (Latin 1) compatible character set. Patient data must be reported using the input patient record file and the tumour data must reported using the input tumour record file. See corresponding input record layouts in Table 4 and Table 5 below.

In addition to the specific data items, every input record has a record type and a date of transmission. The record type indicates which action should be conducted by the CCR system (adding, updating or deleting a record in the CCR) while the date of transmission is needed for tracking purposes. For details on a given data item, see its corresponding section in Chapter 2.

Although a data submission (also called a cycle) is normally composed of two files (one input patient record file and one input tumour record file), it may also be composed of only one file for specific needs (for example, updating tumour information only).

Table 4 Input patient record layout
Field Length Position Description Acronym
P1 2 1 to 2 Patient reporting province/territory PREPPROV
P2 12 3 to 14 Patient identification number PPIN
P3 9 15 to 23 CCR identification number CCR_ID
P4 1 24 Patient record type PRECTYPE
P5 1 25 Type of current surname PTYP_CUR
P6 25 26 to 50 Current surname PCURSNAM
P7 15 51 to 65 First given name PGNAME_1
P8 15 66 to 80 Second given name PGNAME_2
P9 7 81 to 87 Third given name PGNAME_3
P10 1 88 Sex PSEX
P11 8 89 to 96 Date of birth PDATBIR
P12 3 97 to 99 Province/territory or country of birth PPROVBIR
P13 25 100 to 124 Birth surname PBIRNAM
P14 8 125 to 132 Date of death PDATDEA
P15 3 133 to 135 Province/territory or country of death PPROVDEA
P16 6 136 to 141 Death registration number PDEAREG
P17 4 142 to 145 Underlying cause of death PCAUSDEA
P18 1 146 Autopsy confirming cause of death PAUTOPSY
P19 8 147 to 154 Patient date of transmission PDATTRAN
Table 5 Input tumour record file layout
Field Length Position Description Acronym
T1 2 1 to 2 Tumour reporting province/territory TREPPROV
T2 12 3 to 14 Tumour patient identification number TPIN
T3 9 15 to 23 Tumour reference number TTRN
T4 9 24 to 32 CCR identification number CCR_ID
T5 1 33 Tumour record type TRECTYPE
T6 25 34 to 58 Name of place of residence TPLACRES
T7 6 59 to 64 Postal code TPOSTCOD
T8 7 65 to 71 Standard geographic code TCODPLAC
T9 9 72 to 80 Census tract TCENTRAC
T10 15 81 to 95 Health insurance number THIN
T11 1 96 Method of diagnosis TMETHDIAG
T12 8 97 to 104 Date of diagnosis TDATDIAG
T13 4 105 to 108 ICD–9 Cancer code TICD_9
T14 1 109 Source classification flag TSCF
T15 4 110 to 113 ICD–O–2/3 Topography TICD_O2T
T16 4 114 to 117 ICD–O–2 Histology TICD_O2H
T17 1 118 ICD–O–2 Behaviour TICD_O2B
T18 4 119 to 122 Filler Not applicable
T19 1 123 Laterality TLATERAL
T20 1 124 Filler Not applicable
T21 4 125 to 128 ICD–O–3 Histology TICD_O3H
T22 1 129 ICD–O–3 Behaviour TICD_03B
T23 1 130 Grade, differentiation or cell indicator TGRADE
T24 1 131 Method used to establish the date of diagnosis TMETHUSED
T25 1 132 Diagnostic confirmation TMETHCONF
T26 8 133 to 140 Tumour date of transmission TDATTRAN
T27 3 141 to 143 CS tumour size TCSTSIZE
T28 2 144 to 145 CS extension TCSEXTN
T29 1 146 CS tumour size/ext eval TCSEVAL
T30 2 147 to 148 CS lymph nodes TCSLNODE
T31 1 149 CS reg nodes eval TCSRNEVAL
T32 2 150 to 151 Regional nodes examined TCSRNEXAM
T33 2 152 to 153 Regional nodes positive TCSRNPOS
T34 2 154 to 155 CS mets at diagnosis TCSMDIAG
T35 1 156 CS mets evaluation TCSMEVAL
T36 3 157 to 159 CS site–specific factor 1 TCSSSF1
T37 3 160 to 162 CS site–specific factor 2 TCSSSF2
T38 3 163 to 165 CS site–specific factor 3 TCSSSF3
T39 3 166 to 168 CS site–specific factor 4 TCSSSF4
T40 3 169 to 171 CS site–specific factor 5 TCSSSF5
T41 3 172 to 174 CS site–specific factor 6 TCSSSF6
T42 9 175 to 183 AJCCclinical T TAJCCCLINT
T43 3 184 to 186 AJCC clinical N TAJCCCLINN
T44 3 187 to 189 AJCC clinical M TAJCCCLINM
T45 9 190 to 198 AJCC pathologic T TAJCCPATHT
T46 6 199 to 204 AJCC pathologic N TAJCCPATHN
T47 3 205 to 207 AJCC pathologic M TAJCCPATHM
T48 4 208 to 211 AJCC clinical TNM stage group TAJCCCLINSG
T49 4 212 to 215 AJCC pathologic TNM stage group TAJCCPATHSG
T50 4 216 to 219 AJCC TNM stage group TAJCCSG
T51 2 220 to 221 AJCC TNM edition number TAJCCEDNUM
T52 6 222 to 227 CS Version 1st TCSFVER
T53 1 228 to 228 Ambiguous terminology diagnosis TAMBIGTERM
T54 8 229 to 236 Date of conclusive diagnosis TDATCONCLUSDIAG
T55 2 237 to 238 Type of multiple tumours reported as one primary TMULTTUMONEPRIM
T56 8 239 to 246 Date of multiple tumours TDATMULT
T57 2 247 to 248 Multiplicity counter TMULTCOUNT

1.2.2 CCR fundamentals

Following is a list of fundamental rules and concepts that may help the Cancer Registries understand the constraints related to data submission to the CCR.

Submission

  • Input record files must indicate coherent operations for related patient and tumour records.
  • A PTCR can only report data for its jurisdiction.

Ownership

  • A Patient record is initially owned by its reporting province/territory. Its ownership may change through the internal record linkage process; if it is found that the same patient is owned by two provinces/territories, sole ownership of the Patient record will be assigned to the province/territory which reported the latest tumour record.
  • A Tumour record is always owned by its reporting province/territory. The ownership of a tumour record never changes.
  • A PTCR must own a patient or tumour record in order to update or delete it.

Integrity

  • Every patient record must be associated with at least one tumour record from the same province/territory.
  • Every tumour record must be associated with one patient record.
  • The CCR contains only valid and coherent patient and tumour records. Consequently, invalid or incoherent records are rejected by the data editing process. As a temporary measure, invalid staging data (Collaborative Staging and/or AJCC TNM Staging) will not prevent valid core tumour fields from being loaded in the CCR database. In this case, invalid staging data will not be loaded but will be marked as being rejected in the CCR database.

Keys

  • The Patient identification number (PIN) must be unique for each patient record from a given province/territory.
  • Tumour reference number (TTRN) must be unique for a patient's tumour record from a given province/territory.
  • CCR identification number (CCR_ID) connects patient record to its related tumour records from any province/territory.

Scope

  • Tumours outside the CCR core scope are not loaded.
  • For a given patient record, duplicate tumours based on the CCR multiple primary tumour rules are not loaded.
  • Collaborative staging data for tumours outside the CCR collaborative staging scope are not loaded.
  • AJCC TNM staging data for tumours outside the CCR AJCC TNM staging scope are not loaded.

1.2.3 Reporting collaborative staging data

1.2.3.1 Typical cases

Case 1: Tumours outside the CCR collaborative staging scope (see section 1.1.2.2)

All corresponding variables (T27 to T41 and T52) must be left blank.

Case 2: Tumours within the CCR collaborative staging scope (see section 1.1.2.2)

  • If the tumour has been staged using the collaborative staging schema, then all corresponding variables (T27 to T41 and T52) must be reported according to the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) available from the Collaborative Staging Task Force of the American Joint Committee on Cancer. Unknown variables must be coded using the proper CS schema specific 'Unknown' code.
  • If the tumour has not been staged using the collaborative staging schema, then all corresponding variables (T27 to T41 and T52) must be coded using the proper CCR Specific 'Not Staged' code. Variables must not be left blank.
Table 6 CCR Specific 'Not Staged' codes
T27 T28 T29 T30 T31 T32 T33 T34 T35 T36 T37 T38 T39 T40 T41 T52
999 99 9 99 9 99 99 99 9 999 999 999 999 999 999 999999

1.2.4 Reporting AJCC TNM staging data

1.2.4.1 TNM staging overview

The AJCC TNM system is based on the assessment of the T, N, and M components and the assignment of a stage grouping. The structure of TNM varies from site to site. Recurrent tumours (prefix 'r') are not to be staged or submitted to the CCR.

T component

The T element designates the extent of the primary tumour (size or depth of invasion). The numerical subset increases with the progressive extent of the malignant disease. For example:

  • Small lesion confined to the organ of origin would be coded as T1;
  • Larger tumour size or deeper extension into adjacent structures, tissues, capsules, or ligaments as T2;
  • Larger tumour size or extension beyond the organ of origin but confined to the region, T3;
  • Massive lesion or one that directly invades another organ or viscera, major nerves, arteries, or bone as T4.

N component

The N component designates the presence or absence and extent of metastasis in the regional lymph nodes.

  • In some sites, there is an increasing numerical value based on size, fixation, or capsular invasion.
  • In other sites, the numerical value is based on multiple nodal involvement or number and location of the regional lymph nodes.

M component

The M component identifies the presence or absence of distant metastases, including lymph nodes that are not regional.

Stage group

The stage group is assigned using the table listed in the corresponding chapter of the AJCC Cancer staging manual. Stage 0 reflects minimal involvement, usually carcinoma in–situ, whereas Stage IV indicates either greatest tumour involvement or distant metastasis. Histologic grade and age may impact staging in certain sites.

Please refer to the breast, colorectal and prostate chapter specific guidelines in the AJCC Cancer staging manual, sixth edition, as these take precedence over the general guidelines.

1.2.4.2 Typical cases

Case 1: Tumours outside the CCR AJCC TNM staging scope (see section 1.1.2.3).

All corresponding variables (T42 to T51) must be left blank.

Case 2: Tumours within the CCR AJCC TNM staging scope (see section 1.1.2.3).

  • If the tumour has been staged using the AJCC TNM system then all corresponding variables (T42 to T51) must be reported according to the CCR data dictionary corresponding sections. Variables must not be left blank. Unknown variables must be coded using the proper 'Unknown' code.
  • If the tumour has not been staged using the AJCC TNM staging system, then all corresponding variables (T42 to T51) must be coded using the proper CCR Specific 'Unknown'/'Not Staged' code (see table below). Variables must not be left blank.
Table 7 CCR Specific 'Unknown' or 'Not Staged' codes
T42 T43 T44 T45 T46 T47 T48 T49 T50 T51
99 99 99 99 99 99 99 99 99 00

1.2.4.3 Data quality

Stage group is "required" for all histology codes listed at the end of the applicable AJCC chapters, including the published (posted) AJCC errata. Cases meeting those requirements must have a clinical stage group (T47) and/or a pathological stage group (T48) and/or TNM stage group (T50) with a valid stage group as defined in the appropriate chapter of the AJCC Cancer staging manual, sixth edition. Unknown stage group will not prevent AJCC TNM staging data from being loaded in the CCR but will be reported through data quality reports.

The following table depicts which ICD–O–3 topography and histology codes require a stage group. All sites included in the following table are also included in the CCR AJCC TNM staging scope.

Table 8 ICD–O–3 Topography and histology codes that require at least one stage group
Site ICD–O–3 Topography codes ICD–O–3 Histology codes ICD–O–3 Behaviour codes
Colorectal C18.0 to C18.9; C19.9; C20.9 8000 to 8002; 8004 to 8005; 8010; 8012 to 8013; 8020 to 8021; 8032; 8041 to 8045; 8050; 8070; 8140 to 8141; 8210; 8211; 8214 to 8215; 8220 to 8221; 8230; 8261 to 8263; 8480 to 8481; 8490; 8510; 8560; 8570 to 8571; 8935 to 8936 2, 3
Breast C50.0 to C50.6, C50.8, C50.9 8010, 8020, 8070, 8140, 8200 to 8201, 8211, 8480, 8500 to 8503, 8510, 8520, 8522, 8530, 8540 to 8541, 8543, 8980, 9020 2, 3
Prostate C61.9 8010, 8041, 8070, 8074, 8082, 8098, 8120, 8140, 8148, 8200, 8260, 8480, 8490, 8500, 8550, 8560 3

Tumours within the CCR AJCC TNM staging scope but not listed in the above table may have unknown stage groups. These cases will not be reported through data quality reports.

1.2.4.4 Technical notes

Extra descriptors
As described on pages 7 and 8 of the AJCC Cancer staging manual, sixth edition, 2 prefixes and 1 suffix are used to identify special cases of TNM or TNM classifications.

Table 9 Descriptors used in AJCC Cancer staging manual, sixth edition
Prefixes Suffixe
Staging is performed during or after treatment (ycTNM or ypTNM) m Multiple primary tumours in a single site: pT(m)NM
Stage determined at autopsy  

These prefixes and suffixes do not affect the stage grouping but they identify pieces of information that require these cases to be analyzed separately. The staging implementation working group decided that the additional descriptors would not be collected in the CCR, as they could not be collected consistently across the country. Therefore, if a registry collects descriptors for an eligible staging record, corresponding variables must be reported without them.

Assigning X
Values Meaning Example
TX Primary Tumour cannot be assessed When the tumour is identified, but there is not enough information from clinical observation, imaging or microscopic depth of invasion, size, etc. to assign a value. This could also mean that the patient did not return for further workup or treatment.
NX Regional Lymph nodes have not been or cannot be evaluated When initial resection takes place, but further workup or treatment is refused, the status of the regional lymph nodes is not available.
MX Distant metastasis cannot be assessed When studies have not been performed to adequately assess the presence of metastases.
Clinical or Pathological stage group X May mean that the case cannot be stage grouped When there is at least one T, N or M component listed as 'X' but T, N, M components combination does not lead to a stage group.

Prostate cases

If initial diagnosis is through biopsy, and then the patient is put on "watchful waiting" for a period of time, followed by a prostatectomy, then the date of diagnosis should be the date of the biopsy. If the intent of waiting is considered treatment, then the case can only be clinically staged, based on the biopsy information. This initial information can be used for clinical staging information, but there would not be a pathological stage available. This would then be listed with pathologic TNM values of 'X', since the information is not available.

If the intent of the waiting is for surgery, then the information from the prostatectomy can be used for pathologic staging, according to page 5 of the AJCC Cancer staging manual, sixth edition.

1.3 Typical use cases

Adding a new patient and new tumours

  • Submit one add patient record and one or more add tumour records.
  • Use the same reporting province/territory and patient identification number on both input patient and tumour record to create the relationship.
  • Do not provide any CCR identification number.

Adding new tumour(s) to existing patient

  • Submit one or more add tumour records.
  • Use the reporting province/territory, patient identification number and CCR identification number of the existing patient record in the CCR.

Updating an existing patient

  • Submit one update patient record.
  • Use the reporting province/territory, patient identification number and CCR identification number of the existing patient record to be updated.

Updating an existing tumour

  • Submit one update tumour record.
  • Use the reporting province/territory, patient identification number, tumour reference number and CCR identification number of the existing tumour record to be updated.

Deleting an existing patient

  • Submit one delete patient record.
  • Submit as many delete tumour records as there are tumour records with the same CCR identification number and reporting province/territory in the CCR.
  • Use the reporting province/territory, patient identification number and CCR identification number of the existing patient record to be deleted on both delete patient and delete tumour records.
  • All remaining fields must be left blank.

Deleting an existing tumour

  • Submit one delete tumour record.
  • Use the reporting province/territory, patient identification number, tumour reference number and CCR identification number of the existing tumour record to be deleted.
  • All remaining fields must be left blank.

Chapter 2 – Data dictionary

  • Input patient variables
  • Derived patient variables
  • Input tumour variables
  • Derived tumour variables

2.0 Introduction

2.0.1 Input and derived variable fields

The following describes the various fields in the data dictionary for input patient, derived patient, input tumour and derived tumour variables:

Acronym for a variable name – Input patient variables begin with P and derived patient variables begin with PD. Input tumour variables begin with T and derived tumour variables begin with TD.

Description – A general description of the variable content. Provides additional information such as specific coding instructions; use of the variable; links to other variables; and coding sources.

Effective – Determines the reference years (for example, based on date of diagnosis, not collection date) when the variables are in effect and collected.

Length – The length of the variable in the record layout. Format – Provides formatting details such as data positions and character specifications.

Used by – Field for derived patient and tumour variables only. Provides details about which process reads and/or writes the derived variable.

Specific values & meanings – Lists acceptable values and defines their meanings.

Related edits – Lists edits related to the variable. See Chapter 3 (Part II – CCR System Guide) for more details on the edits.

Revision – Provides historical detail on revisions performed on the variable. The year refers to the reference year (for example, based on date of diagnosis, not collection date).

2.1 Input patient variables

The input patient variables are variables related to the patient and reported by the PTCR. Table 10 lists all the input patient variables and the following pages describe these variables in more detail.

For convenience, variables are presented in order by variable number. The reader can easily find the page corresponding to any variable by looking for the variable number in the title. For example, CCR identification number is described on page P3 – CCR identification number.

Table 10 List of input patient variables
Variable N° Variable Acronym
P1 Patient reporting province/territory PREPPROV
P2 Patient identification number PPIN
P3 CCR identification number CCR_ID
P4 Patient record type PRECTYPE
P5 Type of current surname PTYP_CUR
P6 Current surname PCURSNAM
P7 First given name PGNAME_1
P8 Second given name PGNAME_2
P9 Third given name PGNAME_3
P10 Sex PSEX
P11 Date of birth PDATBIR
P12 Province/territory or country of birth PPROVBIR
P13 Birth surname PBIRNAM
P14 Date of death PDATDEA
P15 Province/territory or country of death PPROVDEA
P16 Death registration number PDEAREG
P17 Underlying cause of death PCAUSDEA
P18 Autopsy confirming cause of death PAUTOPSY
P19 Patient date of transmission PDATTRAN

P1 – Patient reporting province/territory

Acronym: PREPPROV

Description: The Standard Geographic Code (SGC) of the PTCR submitting the patient record to the Canadian Cancer Registry (CCR).

Refer to Appendix T (Part II – CCR System Guide)– Residency guidelines in Canada for more details.

Effective: Reference year 1992 and onwards.

Length: 2

Specific values and meaning (P1)
Value Meaning
10 Newfoundland and Labrador
11 Prince Edward Island
12 Nova Scotia
13 New Brunswick
24 Quebec
35 Ontario
46 Manitoba
47 Saskatchewan
48 Alberta
59 British Columbia
60 Yukon
61  Northwest Territories
62 Nunavut

Related edits: PVAL1, PCOR1, KIM1, KIM3, KIM4, KIM5, KBM1, KBM2, KBM4, DIM1, DIM2, DIM3, DIM4, DIM5, PPM1, PPM2.

Revision (P1)
Year Description
2004 Related edits changed: See KIM4 and KBM4.
1999 Specific values & meaning: Addition of Nunavut code (62).

P2 – Patient identification number

Acronym: PPIN

Description: The unique identification number assigned by the provincial/territorial registry to each new patient registered.

This field is part of Statistics Canada patient record key. It cannot be updated or reused.

Effective: Reference year 1992 and onwards.

Length: 12

Related edits: PVAL2, PCOR1, KIM1, KIM3, KIM4, KIM5, KBM1, KBM2, KBM4, DIM1, DIM2, DIM3, DIM4, DIM5, PPM1, PPM2.

Revision (P2)
Year Description
2004 Acronym changed: Formerly known as PIN.
Related edits changed: See PVAL2, KIM4 and KBM4.

P3 – CCR identification number

Acronym: CCR_ID

Description: The unique number assigned by Statistics Canada to each new patient at the time of the initial registration in the CCR

Effective: Reference year 1992 and onwards.

Length: 9

Format: It is composed of 3 parts:

Position 1–2: Last 2 digits of the year of CCR Processing Date
Position 3–8: Sequential number from 000001–999999.
Position 9: A check digit (See Appendix X (Part II - CCR System Guide) - CCR_ID check digit routine)

Related edits: PVAL3, PCOR1, KBM2, KBM4, DIM1, DIM2, DIM3, DIM4, DIM5, PPM1, PPM2.

Revision (P3)
Year Description
2004 Related edits changed: See KBM4.

P4 – Patient record type

Acronym: PRECTYPE

Description: The code which identifies the type of record submitted to the CCR.

This field will not be stored or returned by the CCR System.

Effective: Reference year 1992 and onwards.

Length: 1

Specific values & meaning (P4)
Value Meaning
1 New record
2 Update record
3 Delete record

Related edits: PVAL3, PVAL4, PVAL5, PVAL6, PVAL7, PVAL8, PVAL9, PVAL10, PVAL11, PVAL12, PVAL13, PVAL14, PVAL15, PVAL16, PVAL17, PVAL18, PCOR1, PCOR2, PCOR3, PCOR4, PCOR5, PCOR6, PCOR7, PCOR8, PCOR9, PCOR10, PCOR11, KIM3, KIM4, KIM5, KBM1, KBM2, DIM1, DIM2, DIM3, DIM4, DIM5, PPM1, PPM2.

Revision (P4)
Year Description
2004 Specific values & meaning: Change of ownership record has been removed.
Related edits changed: See PVAL6, PVAL12, PVAL14, PVAL15, PVAL17, PCOR2, PCOR7, PCOR9, PCOR10, PCOR11, KIM4 and KBM4.

P5 – Type of current surname

Acronym: PTYP_CUR

Description: The code describing the type of surname currently used by the patient in field P6 – Current Surname.

Effective: Reference year 1992 and onwards.

Length: 1

Specific values & meaning (P5)
Value Meaning
0 Current Surname unknown
1 Birth Surname
2 Other type of surname (for example, married name, legal change–of–name)
9 Type of surname unknown

Related edits: PVAL5, PCOR1, PCOR4, PCOR5.

Revision (P6)
Year Description
Not applicable Not applicable

P6 – Current surname

Acronym: PCURSNAM

Description: The legal surname currently used by the patient as reported by PTCR.

Effective: Reference year 1992 and onwards.

Length: 25

Format: Acceptable characters are limited to:

  • Uppercase letters from ACSII–7 bit character set ([A–Z]);
  • Lowercase letters from ACSII–7 bit character set ([a–z]);
  • Accented characters (Â À Ç É Ê Ë È Î Ï Ô Û Ü â à ç é ê ë è î ï ô û ü);
  • Special characters:
    • Spaces ( );
    • Periods (.);
    • Apostrophes (');
    • Hyphens (–).

Related edits: PVAL6, PCOR1, PCOR4, PCOR5, PCOR6.

Revision (P6)
Year Description
2007 Format: Acceptable characters are specified.
2004 Description: Current surname contains the value as reported by the PTCR. Standardized current surname is not kept in the CCR anymore.

P7 – First given name

Acronym: PGNAME_1

Description: The first given name (or initial) currently used by the patient as reported by PTCR.

Effective: Reference year 1992 and onwards.

Length: 15

Format: Acceptable characters are limited to:

  • Uppercase letters from ACSII–7 bit character set ([A–Z]);
  • Lowercase letters from ACSII–7 bit character set ([a–z]);
  • Accented characters (Â À Ç É Ê Ë È Î Ï Ô Û Ü â à ç é ê ë è î ï ô û ü)
  • Special characters:
    • Spaces ( );
    • Periods (.);
    • Apostrophes (');
    • Hyphens (–).

Related edits: PVAL7, PCOR1, PCOR2, PCOR3.

Revision (P7)
Year Description
2007 Format: Acceptable characters are specified.
2004 Description: First given name contains the value as reported by the PTCR. Standardized first given name is not kept in the CCR anymore.

P8 – Second given name

Acronym: PGNAME_2

Description: The second given name (or initial) currently used by the patient as reported by PTCR.

Effective: Reference year 1992 and onwards.

Length: 15

Format: Acceptable characters are limited to:

  • Uppercase letters from ACSII–7 bit character set ([A–Z]);
  • Lowercase letters from ACSII–7 bit character set ([a–z]);
  • Accented characters (Â À Ç É Ê Ë È Î Ï Ô Û Ü â à ç é ê ë è î ï ô û ü)
  • Special characters:
    • Spaces ( );
    • Periods (.);
    • Apostrophes (');
    • Hyphens (–).

Related edits: PVAL8, PCOR1, PCOR2, PCOR3.

Revision (P8)
Year Description
2007 Format: Acceptable characters are specified.
2004 Description: Second given name contains the value as reported by the PTCR. Standardized second given name is not kept in the CCR anymore.

P9 – Third given name

Acronym: PGNAME_3

Description: The third given name (or initial) currently used by the patient as reported by PTCR.

Effective: Reference year 1992 and onwards.

Length: 7

Format: Acceptable characters are limited to:

  • Uppercase letters from ACSII–7 bit character set ([A–Z]);
  • Lowercase letters from ACSII–7 bit character set ([a–z]);
  • Accented characters (Â À Ç É Ê Ë È Î Ï Ô Û Ü â à ç é ê ë è î ï ô û ü)
  • Special characters:
    • Spaces ( );
    • Periods (.);
    • Apostrophes (');
    • Hyphens (–).

Related edits: PVAL9, PCOR1, PCOR2, PCOR3

Revision (P9)
Year Description
2007 Format: Acceptable characters are specified.
2004 Description: Third given name contains the value as reported by the PTCR. Standardized third given name is not kept in the CCR anymore.

P10 – Sex

Acronym: PSEX

Description: The code that represents the sex of the patient.

Effective: Reference year 1992 and onwards.

Length: 1

Specific values & meaning (P10)
Value Meaning
1 Male
2 Female
9 Sex unknown

Related edits: PVAL10, PCOR1, PCOR2, DIM5.

Revision (P10)
Year Description
2004 Related edits changed: see PCOR2.

P11 – Date of birth

Acronym: PDATBIR

Description: The patient's date of birth represented by the year, month and day.

Effective: Reference year 1992 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Specific values & meaning
YYYY (P11)
Value Meaning
[0000–9998] Year of birth
9999 Year of birth unknown
MM (P11)
Value Meaning
[01–12] Month of birth (January – December)
99 Month of birth unknown
DD (P11)
Value Meaning
[01–31] Day of birth
99 Day of birth unknown

Related edits: PVAL11, PVAL12, PCOR1, PCOR7, DIM1.

Revision (P11)
Year Description
2004 Related edits changed: see PVAL12 and PCOR7.

P12 – Province/territory or country of birth

Acronym: PPROVBIR

Description: The code created by the International Standards Organization1 (ISO) used to represent the patient's province/territory (if in Canada) or country (if outside Canada) of birth.

The location is coded according to geo–political boundaries at time of birth.

Effective: Reference year 1992 and onwards.

Length: 3

Specific values & meaning (P12)
Value Meaning
999 Province/territory or country of birth unknown.
[Others] For Date of birth prior to year 1996, see Appendix A (Part III – CCR System Guide) – Core reference tables – Eligible province/territory or country codes prior to 1996.
For Date of birth in 1996 and onwards, see Appendix A (Part III – CCR System Guide) – Core reference tables – Eligible province/territory or country codes in 1996 and after.

Related edits: PVAL12, PCOR1.

Revision (P12)
Year Description
2004 Related edits changed: see PVAL12.
1996 Specific values & meaning: new province/territory and country codes list added for date of birth in 1996 and onwards.

P13 – Birth surname

Acronym: PBIRNAM

Description: The legal surname or family/last name under which the patient was registered at birth as reported by PTCR.

Effective: Reference year 1992 and onwards.

Length: 25

Format: Acceptable characters are limited to:

  • Uppercase letters from ACSII–7 bit character set ([A–Z]);
  • Lowercase letters from ACSII–7 bit character set ([a–z]);
  • Accented characters (Â À Ç É Ê Ë È Î Ï Ô Û Ü â à ç é ê ë è î ï ô û ü)
  • Special characters:
    • Spaces ( );
    • Periods (.);
    • Apostrophes (');
    • Hyphens (–).

Related edits: PVAL13, PCOR1, PCOR5, PCOR6

Revision (P13)
Year Description
2007 Format: Acceptable characters are specified.
2004 Description: Birth surname contains the value as reported by the PTCR. Standardized birth surname is not kept in the CCR anymore.

P14 – Date of death

Acronym: PDATDEA

Description: The patient's date of death represented by the year, month and day.

Effective: Reference year 1992 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Specific values & meaning
YYYY (P14)
Value Meaning
0000 Patient is not known to have died
[0001–9998] Year of death
9999 Year of death unknown
MM (P14)
Value Meaning
00 Patient is not known to have died
[01–12] Month of death (January – December)
99 Month of death unknown
DD (P14)
Value Meaning
00 Patient is not known to have died
[01–31] Day of death
99 Day of death unknown

Related edits: PVAL14, PVAL15, PVAL17, PCOR1, PCOR7, PCOR8, PCOR10, DIM2, DIM3, DIM4.

Revision (P14)
Year Description
2004 Related edits changed: See PVAL15, PVAL17 and PCOR7.

P15 – Province/territory or country of death

Acronym: PPROVDEA

Description: The code created by the International Standards Organization2 (ISO) used to represent the patient's province/territory (if in Canada) or country (if outside Canada) of death.

The location is coded according to geo–political boundaries at time of death.

Effective: Reference year 1992 and onwards.

Length: 3

Specific values & meaning (P15)
Value Meaning
000 Patient is not known to have died
999 Province/territory or country of death unknown
[Others] For Date of death prior to year 1996, see Appendix A (Part III – CCR System Guide) – Core reference tables – Eligible province/territory or country codes before 1996.
For Date of death in 1996 and onwards, see Appendix A (Part III – CCR System Guide) – Core reference tables – Eligible province/territory or country codes in 1996 and after.

Related edits: PVAL15, PCOR1, PCOR8, PCOR9.

Revision (P15)
Year Description
2004 Related edits changed: See PVAL15 and PCOR9. 
1996 Specific values & meaning: new province/territory and country codes list added for Date of death in 1996 and onwards.

P16 – Death registration number

Acronym: PDEAREG

Description: The registration number found on the official death certificate issued by the Canadian province/territory in which the patient died (see P15 – Province/territory or country of de

Specific values & meaning (P16)
Value Meaning
000000 Patient is not known to have died
999998 Patient died outside of Canada
999999 Patient died: death registration number is unknown
[Others] Valid registration numbers

Effective: Reference year 1992 and onwards.

Length: 6

Related edits: PVAL16, PCOR1, PCOR8, PCOR9, PCOR10, PCOR11

Revision (P16)
Year Description
2004 Related edits changed: See PCOR9, PCOR10 and PCOR11.

P17 – Underlying cause of death

Acronym: PCAUSDEA

Description: The code that represents the patient's underlying cause of death, as determined by the Vital Statistics office from the official death certificate and reported to the CCR by the provincial/territorial Cancer Registry (PTCR).

The underlying cause of death is defined as: 'the disease or injury which initiated the train of morbid events leading directly to death, or the circumstances of the accident or violence which produced the fatal injury'. It is coded using the International Classification of Diseases, 9th Revision (ICD–9) or International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10), depending on the Date of death.

See also PD7 – Death clearance underlying cause of death.

Effective: Reference year 1992 and onwards.

Length: 4

Format: The code must not contain any periods (.).

Specific values & meaning (P17)
Value Meaning
0000 Patient is not known to have died
0009 Unknown/unavailable underlying cause of death
[Others] For Date of death prior to year 2000, refer to Appendix A (Part III – CCR System Guide) – Core reference tables - Eligible ICD-9 underlying cause of death codes for exact meaning.
For Date of death between 2000 and 2002, refer to Appendix A (Part III – CCR System Guide) – Core reference tables - Eligible ICD-10 underlying cause of death codes from 2000 to 2002 for exact meaning.
For Date of death in 2003 and onwards, refer to Appendix A (Part III – CCR System Guide) – Core reference tables - Eligible ICD-10 underlying cause of death codes in 2003 and after for exact meaning.

Related edits: PVAL17, PCOR1, PCOR8, PCOR11.

Revision (P17)
Year Description
2004 Related edits changed: See PVAL17 and PCOR11.
2000 Specific values & meaning: ICD-10 Cause of death codes added.

P18 – Autopsy confirming cause of death

Acronym: PAUTOPSY

Description: The code indicating whether the cause of death from the official death certificate takes account of autopsy findings.

See Appendix I (Part II – CCR System Guide) – Guidelines for abstracting and determining DCO cases for PTCRs in Canada for more details.

Effective: Reference year 1992 and onwards.

Length: 1

Specific values & meaning (P18)
Value Meaning
0 Patient is not known to have died
1 Autopsy held - results taken into account by the stated cause of death
2 Autopsy held - results not taken into account by the stated cause of death
9 No autopsy/unknown autopsy/do not know if autopsy results have been taken into account by the stated cause of death

Related edits: PVAL18, PCOR1, PCOR8.

Revision (P18)
Year Description
Not applicable Not applicable

P19 – Patient date of transmission

Acronym: PDATTRAN

Description: The date on which a copy of the patient record was extracted from the provincial/territorial registry for submission to the CCR.

Effective: Reference year 1992 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Specific values & meaning
YYYY (P19)
Value Meaning
[0000-9999] Year of transmission
MM (P19)
Value Meaning
[01-12] Month of transmission (January – December)
DD(P19)
Value Meaning
[01-31] Day of transmission

Related edits: PVAL14, PVAL19, PCOR7

Revision (P19)
Year Description
2004 Acronym changed: Formerly known as PDATTRA2.
Related edits changed: See PVAL14 and PCOR7.

2.2 Derived patient variables

The derived patient variables are variables related to the patient and copied/derived/calculated by the CCR system through various processes such as data loading, record linkage, death clearance and tabulation master file creation. Table 11 lists all the derived patient variables; the following pages describe these variables in more detail.

For convenience, variables are presented in order by variable number. The reader can easily find the page corresponding to any variable by looking for the variable number in the title. For example, Vital status is described on page PD2 – Vital status.

Table 11 List of Derived patient variables
Variable N° Variable Acronym
PD1 Processing Date – patient record PDCCRDATPROC
PD2 Vital status PDCCRVITALST
PD3 Number of tumours PDCCRNBRTMRS
PD4 Death clearance cut off date PDDCDATCO
PD5 Death clearance status PDDCSTAT
PD6 Death clearance method PDDCMETH
PD7 Death clearance underlying cause of death PDDCUCD
PD8 Date of death (Un) confirmation PDDCDATCN

PD1 – Processing date – patient record

Acronym: PDCCRDATPROC

Description: The date of the last action taken against the patient record by Statistics Canada.

Effective: Reference year 1992 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Used by (PD1)
Process Read Write
Data loading – posting No Yes*
Internal record linkage No Yes*
Death clearance No Yes*
Tabulation master file Yes No

* See corresponding section for calculation details.

Specific values & meaning
YYYY (PD1)
Value Meaning
[0000-9999] Year of the last action
MM (PD1)
Value Meaning
[01-12] Month of the last action (January – December)
DD (PD1)
Value Meaning
[01-31] Day of the last action
Revision (PD1)
Year Description
2004 Acronym changed: Formerly known as PDATPROC.

PD2 – Vital status

Acronym: PDCCRVITALST

Description: The code indicating whether the patient is alive or deceased.

Effective: Reference year 1992 and onwards.

Length: 1

Used by (PD2)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

* See corresponding section for calculation details.

Specific values & meaning (PD2)
Value Meaning
1 The patient is not known to have died
2 The patient is deceased
Revision (PD2)
Year Description
2007 Used by: PD2 is now being written at the Tabulation master file process
2004 Acronym changed: Formerly known as PVITALST

PD3 – Number of tumours

Acronym: PDCCRNBRTMRS

Description: The number of tumour records belonging to the patient record.

Note: The number of tumours may change depending on the Multiple primary rules used (CCR or IARC). As of 2007 the CCR has adopted SEER rules.

Effective: Reference year 1992 and onwards.

Length: 2

Used by (PD3)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

* See corresponding section for calculation details.

Specific values & meaning (PD3)
Value Meaning
[1-99] The number of tumours the patient has at the time of the TMF creation.
** The Patient has more than 99 tumours at the time of the TMF creation.
Revision (PD3)
Year Description
2004 Acronym changed: Formerly known as PNBRTMRS.

PD4 – Death clearance cut-off date

Acronym: PDDCDATCO

Description: The date of the latest death event (based on the Canadian Vital Statistics) considered during the death clearance process.

Effective: Reference year 1992 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Used by (PD4)
Process Read Write
Data loading – posting No Yes*
Internal record linkage No No
Death clearance No Yes*
Tabulation master file Yes No

* See corresponding section for calculation details.

Specific values & meaning
YYYY (PD4)
Value Meaning
0000 Patient never underwent Death clearance.
[0001-9999] Latest registration year for which the record was matched against the Canadian mortality database.
MM (PD4)
Value Meaning
00 Patient never underwent Death clearance.
[01-12] The month of the date described above (January – December).
DD (PD4)
Value Meaning
00 Patient never underwent Death clearance.
[01-31] The day of the date described above.
Revision (PD4)
Year Description
2007 Description: Updated.
2004 Acronym changed: Formerly known as PDCDATCO.

PD5 – Death clearance status

Acronym: PDDCSTAT

Description: The code indicating whether the record has ever participated in Death clearance and its current status with respect to provincial/territorial actions.

Effective: Reference year 1992 and onwards.

Length: 1

Used by (PD5)
Process Read Write
Data loading – posting No Yes*
Internal record linkage No No
Death clearance No Yes*
Tabulation master file Yes No

* See corresponding section for calculation details.

Specific values & meaning (PD5)
Value Meaning
0 Patient record never underwent Death clearance
1 Patient record underwent Death clearance - not confirmed as dead
2 Patient record underwent Death clearance - confirmed as dead
3 Patient record no longer confirmed as dead - PTCR has changed the Date of death, province/territory or country of death or Death registration number
4 Patient record no longer confirmed as dead - decision rejected by PTCR
Revision (PD5)
Year Description
2004 Acronym changed: Formerly known as PDCSTAT

PD6 – Death clearance method

Acronym: PDDCMETH

Description: The code indicating the method used during the Death clearance process to confirm the patient death.

Effective: Reference year 1992 and onwards.

Length: 1

Used by (PD6)
Process Read Write
Data loading – posting No Yes*
Internal record linkage No No
Death clearance No Yes*
Tabulation master file Yes No

* See corresponding section for calculation details.

Specific values & meaning (PD6)
Value Meaning
0 Patient never underwent Death clearance or patient not confirmed as dead
1 Match: Identical information on Date of death, province/territory or country of death, Death registration number, sex and date of Birth (year and month only)
2 Probabilistic linkage
3 Inactive default: province/territory reported death information, with no confirmation - record has been inactive for 5 years
4 Age Default: Age > 117 years
Revision (PD6)
Year Description
2004 Acronym changed: Formerly known as PDCMETHD

PD7 – Death clearance underlying cause of death

Acronym: PDDCUCD

Description: The code reported to Statistics Canada that represents the patient's underlying cause of death, as determined by the Vital Statistics office from the official death certificate.

The underlying cause of death is defined as: 'the disease or injury which initiated the train of morbid events leading directly to death, or the circumstances of the accident or violence which produced the fatal injury'. It is coded using the International Classification of Diseases, 9th Revision (ICD–9) or International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD–10), depending on the Date of death.

Effective: Reference year 1992 and onwards.

Length: 4

Used by (PD7)
Process Read Write
Data loading – posting No Yes*
Internal record linkage No No
Death clearance No Yes*
Tabulation master file Yes No

* See corresponding section for calculation details.

Specific values & meaning (PD7)
Value Meaning
0000 Patient record never underwent Death clearance or not confirmed as deceased. (Default value)
[Others] For Date of death prior to year 2000, refer to Appendix A (Part III– CCR System Guide) – Core reference tables - Eligible ICD-9 underlying cause of death codes for exact meaning.
For Date of death between 2000 and 2002, refer to Appendix A (Part III– CCR System Guide) – Core reference tables - Eligible ICD-10 underlying cause of death codes from 2000 to 2002 for exact meaning.
For Date of death in 2003 and onwards, refer to Appendix A (Part III– CCR System Guide) – Core reference tables - Eligible ICD-10 underlying cause of death codes in 2003 and after for exact meaning.
Revision (PD7)
Year Description
2008 Acronym changed: Formerly known as PDDCCMDBUCD.
2004 Acronym changed: Formerly known as PMDBUCOD.

PD8 – Date of death (Un) confirmation

Acronym: PDDCDATCN

Description: The date on which:

A patient was confirmed as being deceased during Death clearance processing, or
A PTCR revoked the Death clearance of a record: the CCR decision was rejected, or
A PTCR changed some death information: Date of death, province/territory or country of death or Death registration number.

Effective: Reference year 1992 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Used by (PD8)
Process Read Write
Data loading – posting No Yes*
Internal record linkage No No
Death clearance No Yes*
Tabulation master file Yes No

* See corresponding section for calculation details.

Specific values & meaning
YYYY (PD8)
Value Meaning
0000 Patient record never underwent Death clearance or not confirmed as deceased.
[0001-9999] The year of date described above.
MM (PD8)
Value Meaning
00 Patient record never underwent Death clearance or not confirmed as deceased.
[01-12] The month of the date described above (January – December).
DD (PD8)
Value Meaning
00 Patient record never underwent Death clearance or not confirmed as deceased.
[01-31] The day of the date described above.
Revision (PD8)
Year Description
2004 Acronym changed: Formerly known as PDCDATCN.

2.3 Input tumour variables

The input tumour variables are variables related to the tumour and reported by the PTCR. Table 12 lists all the input tumour variables; the following pages describe these variables in more details.

For convenience, variables are presented in order by variable number. The reader can easily find the page corresponding to any variable by looking for the variable number in the title. For example, CCR identification number is described on page T4 – CCR identification number.

Table 12 List of Input tumour variables
Variable N° Variable Acronym
T1 Tumour reporting province/territory TREPPROV
T2 Tumour patient identification number TPIN
T3 Tumour reference number TTRN
T4 CCR identification number CCR_ID
T5 Tumour record type TRECTYPE
T6 Name of place of residence TPLACRES
T7 Postal code TPOSTCOD
T8 Standard geographic code TCODPLAC
T9 Census tract TCENTRAC
T10 Health insurance number THIN
T11 Method of diagnosis TMETHDIAG
T12 Date of diagnosis TDATDIAG
T13 ICD–9 cancer code TICD_9
T14 Source classification flag TSCF
T15 ICD–O–2/3 Topography TICD_O2T
T16 ICD–O–2 Histology TICD_O2H
T17 ICD–O–2 Behaviour TICD_O2B
T18 Not used Not applicable
T19 Laterality TLATERAL
T20 Not used Not applicable
T21 ICD–O–3 Histology TICD_O3H
T22 ICD–O–3 Behaviour TICD_O3B
T23 Grade, differentiation or cell indicator TGRADE
T24 Method used to establish the date of diagnosis TMETHUSED
T25 Diagnostic confirmation TMETHCONF
T26 Tumour date of transmission TDATTRAN
T27 CS tumour size TCSTSIZE
T28 CS extension TCSEXTN
T29 CS tumour size/ext eval TCSEVAL
T30 CS lymph nodes TCSLNODE
T31 CS reg nodes eval TCSRNEVAL
T32 Regional nodes examined TCSRNEXAM
T33 Regional nodes positive TCSRNPOS
T34 CS mets at Dx TCSMDIAG
T35 CS mets eval TCSMEVAL
T36 CS site-specific factor 1 TCSSSF1
T37 CS site-specific factor 2 TCSSSF2
T38 CS site-specific factor 3 TCSSSF3
T39 CS site-specific factor 4 TCSSSF4
T40 CS site-specific factor 5 TCSSSF5
T41 CS site-specific factor 6 TCSSSF6
T42 AJCC clinical T TAJCCCLINT
T43 AJCC clinical N TAJCCCLINN
T44 AJCC clinical M TAJCCCLINM
T45 AJCC pathologic T TAJCCPATHT
T46 AJCC pathologic N TAJCCPATHN
T47 AJCC pathologic M TAJCCPATHM
T48 AJCC clinical TNM stage group TAJCCCLINSG
T49 AJCC pathologic TNM stage group TAJCCPATHSG
T50 AJCC TNM stage group TAJCCSG
T51 AJCC TNM edition number TAJCCEDNUM
T52 CS Version 1st TCSFVER
T53 Ambiguous Terminology Diagnosis TAMBIGTERM
T54 Date of Conclusive Diagnosis TDATCONCLUSDIAG
T55 Type of Multiple Tumours Reported as One Primary TMULTTUMONEPRIM
T56 Date of Multiple Tumours TDATMULT
T57 Multiplicity Counter TMULTCOUNT

T1 – Tumour reporting province/territory

Acronym: TREPPROV

Description: The Standard geographic code (SGC) of the province/territory submitting the Tumour record to the CCR at time of diagnosis.

Refer to Appendix T (Part II – CCR System Guide) – Residency guidelines in Canada for more details.

Effective: Reference year 1992 and onwards.

Length: 2

Specific values & meaning (T1)
Value Meaning
10 Newfoundland and Labrador
11 Prince Edward Island
12 Nova Scotia
13 New Brunswick
24 Quebec
35 Ontario
46 Manitoba
47 Saskatchewan
48 Alberta
59 British Columbia
60 Yukon
61 Northwest Territories
62 Nunavut

Related edits: TVAL1, TCOR1, TCOR4, KIM2, KIM3, KIM4, KIM5, KBM3, KBM4, KBM5, DIM1, DIM2, DIM3, DIM4, DIM5, DIM6, PPM1, PPM2.

Revision (T1)
Year Description
2004 Related edits changed: See KIM4, KBM4 and DIM6.
1999 Specific values & meaning: Addition of Nunavut code (62).

T2 – Tumour patient identification number

Acronym: TPIN

Description: The unique identification number assigned by the provincial/territorial registry to each new patient registered.

This field is part of Statistics Canada Tumour record key. It cannot be updated or reused.

Effective: Reference year 1992 and onwards.

Length: 12

Related edits: TVAL2, TCOR1, KIM2, KIM3, KIM4, KIM5, KBM3, KBM4, KBM5, DIM1, DIM2, DIM3, DIM4, DIM5, DIM6, PPM1, PPM2.

Revision (T2)
Year Description
2004 Acronym changed: Formerly known as PIN.
Related edits changed: See TVAL2, KIM4, KBM4 and DIM6.

T3 – Tumour reference number

Acronym: TTRN

Description: The unique identification number assigned by the provincial/territorial cancer registry, as a reference, to each new tumour reported to the CCR.

It cannot be updated or reused.

Effective: Reference year 1992 and onwards.

Length: 9

Related edits: TVAL3, TCOR1, KIM2, KBM3, KBM5, DIM1, DIM2, DIM3, DIM4, DIM5, DIM6.

Revision (T3)
Year Description
2004 Related edits changed: See TVAL3 and DIM6.

T4 – CCR identification number

Acronym: CCR_ID

Description:The unique number assigned by Statistics Canada to each new patient at the time of the initial registration in the CCR

It is used to link tumours with the corresponding patient. (P3 – CCR identification number)

Effective: Reference year 1992 and onwards.

Length: 9

Format:

It is composed of three parts:

  1. Position 1–2: Last two digits of the year of the CCR Processing Date
  2. Position 3–8: Sequential number from 000001–999999
  3. Position 9: A check digit (See Appendix X (Part II– CCR System Guide) – CCR ID check digit routine)

Related edits: TVAL4, TCOR1, KIM3, KIM5, KBM4, KBM5, DIM1, DIM2, DIM3, DIM4, DIM5, DIM6, PPM1, PPM2.

Revision (T4)
Year Description
2007 Format: Format of variable specified.
2004 Related edits changed: See KBM4 and DIM6.

T5 – Tumour record type

Acronym: TRECTYPE

Description: The code which identifies the type of record submitted to the CCR.

This field will not be stored or returned by the CCR System.

Effective: Reference year 1992 and onwards.

Length: 1

Specific values & meaning (T5)
Value Meaning
1 New record
2 Update record
3 Delete record

Related edits:TVAL5, TVAL6, TVAL7, TVAL8, TVAL9, TVAL10, TVAL11, TVAL12, TVAL13, TVAL14, TVAL15, TVAL16, TVAL17, TVAL19, TVAL21, TVAL22, TVAL23, TVAL24, TVAL25, TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL42, TVAL43, TVAL44, TVAL45, TVAL46, TVAL47, TVAL48, TVAL49, TVAL50, TVAL51, TVAL52, TVAL53, TVAL54, TVAL55, TVAL56, TVAL57, TCOR1, TCOR2, TCOR3, TCOR4, TCOR5, TCOR6, TCOR7, TCOR9, TCOR10, TCOR11, TCOR12, TCOR13, TCOR14, TCOR15, TCOR16, TCOR17, TCOR18, TCOR19, TCOR20, TCOR21, TCOR22, TCOR23, TCOR24, TCOR26, TCOR27, TCOR29, TCOR30, TCOR31, TCOR32, TCOR33, TCOR34, TCOR35, KIM3, KIM4, KIM5, KBM3, KBM4, KBM5, DIM1, DIM2, DIM3, DIM4, DIM5, DIM6, PPM1, PPM2.

Revision (T5)
Year Description
2008 Related edits changed: See TVAL53, TVAL54, TVAL55, TVAL56, TVAL57, TCOR26, TCOR27, TCOR29, TCOR30, TCOR31, TCOR32, TCOR33, TCOR34, TCOR35
2007 Related edits changed: See TVAL52 and TCOR13
2004 Related edits changed: See TVAL18, TVAL20, TVAL23, TVAL27, TCOR1, TCOR5, TCOR6, TCOR7, TCOR9, TCOR10, TCOR11, TCOR12, TCOR14, TCOR15, TCOR16, TCOR17, KIM4, KBM1, KBM4 and DIM6.

T6 – Name of place of residence

Acronym: TPLACRES

Description: The name of the city, town, village, reserve, etc. of the patient's usual permanent place of residence at time of diagnosis.

Refer to Appendix T (Part II– CCR System Guide) – Residency guidelines in Canada for more details.

Effective: Reference year 1992 and onwards.

Length: 25

Format: Acceptable characters are limited to:

  • Uppercase letters from ACSII-7 bit character set ([A-Z]);
  • Lowercase letters from ACSII-7 bit character set ([a-z]);
  • Accented characters (Â À Ç É Ê Ë È Î Ï Ô Û Ü â à ç é ê ë è î ï ô û ü)
  • Special characters:
    • Spaces ( );
    • Periods (.);
    • Apostrophes (');
    • Hyphens (-);
    • Exclamation mark (!);
    • Ampersand (&);
    • Forward slash (/);
    • Parentheses ("and");
    • Number sign (#);
    • Comma (,).

Related edits: TVAL6 and TCOR1.

Revision (T6)
Year Description
2007 Format: Acceptable characters are specified.

T7 – Postal code

Acronym: TPOSTCOD

Description: The Canadian postal code of the patient's usual permanent place of residence at time of diagnosis.

Effective: Reference year 1992 and onwards.

Length: 6

Specific values & meaning (T7)
Value Meaning
999999 Postal code unknown
[Others] Postal code

Related edits: TVAL7, TCOR1 and TCOR2

Revision (T7)
Year Description
Not applicable Not applicable

T8 – Standard geographic code

Acronym: TCODPLAC

Description: The Standard geographic code of the patient's usual permanent place of residence at time of diagnosis.

It is coded using Standard geographic classification (SGC) - 1991, 1996, 2001 or 2006 depending on the Date of diagnosis.

Effective: Reference year 1992 and onwards.

Length: 7

Format: PRCDCSD where PR (2 first digits) is the Province code, CD (3rd and 4th digits) is the Census division code and CSD (3 last digits) is the Census subdivision code.

Specific values & meaning (T8)
Value Meaning
10 Newfoundland and Labrador
11 Prince Edward Island
12 Nova Scotia
13 New Brunswick
24 Quebec
35 Ontario
46 Manitoba
47 Saskatchewan
48 Alberta
59 British Columbia
60 Yukon
61 Northwest Territories
62 Nunavut
CD (T8)
Value Meaning
00 Unknown Census division
[Others] For Date of diagnosis between 1992 and 1995, refer to Appendix A (Part III– CCR System Guide )– Core reference tables – Eligible standard geographic classification codes from 1992 to 1995 for meaning.
For Date of diagnosis between 1996 and 2000, refer to Appendix A (Part III– CCR System Guide)– Core reference tables – Eligible standard geographic classification codes from 1996 to 2000 for meaning.
For Date of diagnosis between 2001 and 2005, refer to Appendix A (Part III– CCR System Guide) – Core reference tables – Eligible standard geographic classification codes from 2001 to 2005 for meaning.
For Date of Diagnosis between 2006 and 2010, refer to Appendix A (Part III– CCR System Guide) – Core Reference Tables – Eligible Standard Geographic Classification Codes from 2006 to 2010 for meaning.
CSD (T8)
Value Meaning
999 Unknown Census subdivision
[Others] For Date of diagnosis between 1992 and 1995, refer to Appendix A (Part III– CCR System Guide ) – Core reference tables – Eligible standard geographic classification codes from 1992 to 1995 for meaning.
For Date of diagnosis between 1996 and 2000, refer to Appendix A (Part III– CCR System Guide) – Core reference tables – Eligible standard geographic classification codes from 1996 to 2000 for meaning.
For Date of diagnosis between 2001 and 2005, refer to Appendix A (Part III– CCR System Guide) – Core reference tables – Eligible standard geographic classification codes from 2001 to 2005 for meaning.
For Date of Diagnosis between 2006 and 2010, refer to Appendix A (Part III– CCR System Guide) – Core Reference Tables – Eligible Standard Geographic Classification Codes from 2006 to 2010 for meaning.


Related edits: TVAL8, TCOR1, TCOR2, TCOR3, TCOR4.

Revision (T8)
Year Description
2006 Specific values & meaning: SGC – 2006 added.
2001 Specific values & meaning: SGC – 2001 added.
1996 Specific values & meaning: SGC – 1996 added.

T9 – Census tract

Acronym: TCENTRAC

Description: The geostatistical area of the patient's usual permanent place of residence at time of diagnosis.

Census tracts are found only in large urban communities and contain populations ranging from 2500 to 8000, with an average of 4000. They are designed as being as homogeneous as possible in terms of economic status and social conditions. All Census metropolitan areas (CMA) and Census agglomerations (CA), containing a Census subdivision (that is, a city) having a population of at least 50000, are eligible to have Census tracts.

It is coded using Census tract dictionary – 1991, 1996 or 2001 depending on the Date of diagnosis.

Effective: Reference year 1992 to 2005.

Length: 9

Format: For cases diagnosed in 2006 and onwards, leave the field blank.

For cases diagnosed between 1992 and 2005, enter a value using the CMACCC.TT format where CMA (3 first digits) is the Census metropolitan area/Census agglomeration and CCC.TT (6 last digits) is the Census tract.

Specific values & meaning (T9)
Value Meaning
[Blank] For cases outside the effective date range (for example, cases diagnosed in 2006 and onwards)
000000.00 Place of residence not in a Census tract
999999.99 Census tract unknown/incomplete address
[Others] For Date of diagnosis between 1992 and 1995, refer to Census tract dictionary – 1991³ for meaning.
For Date of diagnosis between 1996 and 2000, refer to Census tract dictionary – 1996³ for meaning.
For Date of diagnosis between 2001 and 2005, refer to Census tract dictionary – 2001³ for meaning.

Related edits: TVAL9, TCOR1, TCOR3.

Revision (T9)
Year Description
2006 Effective dates: Field is only effective for reference years 1992 to 2005. For 2006 cases and onwards, this field will be reported as blank (null). Census tract was removed for all cases diagnosed in 2006.
Specific values & meaning: Null (blank) value added.
2001 Specific values & meaning: Census tract dictionary – 2001 added.
1996 Specific values & meaning: Census tract dictionary – 1996 added.

T10 – Health insurance number

Acronym: THIN

Description: The patient's provincial/territorial health insurance number at time of diagnosis.

Effective: Reference year 1992 and onwards.

Length: 15

Specific values & meaning (T10)
Value Meaning
999999999999999 Unknown
[Others] Health insurance number

Related edits: TVAL10, TCOR1.

Revision (T10)
Year Description
Not applicable Not applicable

T11 – Method of diagnosis

Acronym: TMETHDIAG

Description: The code that represents the most definitive procedure by which the tumour was diagnosed.

In general, the method of diagnosis should be based on the method by which the earliest microscopic date of diagnosis was determined. The method should be based on the status before any treatment other than surgery is given.

It is not linked to the Date of diagnosis.

Effective: Reference year 1992 to 2003.

Length: 1

Specific values & meaning (T11)
Value Meaning
0 For Date of diagnosis in 2004 and onward.
Method of diagnosis reported in Input tumour variables:
  • T24 – Method used to establish the date of diagnosis and;
  • T25 – diagnostic confirmation.
1 Histology
2 Autopsy
3 Cytology
4 Radiology or laboratory diagnosis other than specified above
5 Surgery (without histology), or clinical diagnosis
6 Death certificate only4
9 Method of diagnosis unknown

Related edits: TVAL11, TCOR1, TCOR14, DIM3.

Revision (T11)
Year Description
2004 Acronym changed: Formerly known as TMETDIAG.
Specific values & meaning: Code added (0) to handle Date of Diagnosis in 2004 and onwards.
Related edits changed: See TCOR14.

T12 – Date of diagnosis

Acronym: TDATDIAG

Description: The date of diagnosis of the tumour. It is determined using the following sequence order (effective since 2004 for all data):

  1. Date of cytological diagnosis

    If suspicious cytology is confirmed by subsequent histological diagnosis (including autopsy) or clinical impression of cancer supports the cytology findings, then the cytological diagnosis date will be used.
     
  2. Date of histological diagnosis, including cases diagnosed only on autopsy
     
  3. Date of non microscopically confirmed diagnosis. including:
     

    a)Positive laboratory test/marker study;
    b)Direct visualization without microscopic confirmation (surgery without histology);
    c)Radiography and other imaging techniques without microscopic confirmation;
    d)Clinical diagnosis, including: physical findings (without histology); 
    e)Method of Diagnosis unknown.

  4. Date of death, if not reported at any other time.Includes:
     

    a) Death certificate only;
    b) Autopsy only.

Exceptions
1. If applicable, the date associated with the method that prompts treatment takes precedence over the above choices and should be chosen.
2. If autopsy only case, follow back as per the Guidelines for abstracting and determining DCO cases for PTCRs in Canada (see Appendix I (Part II – CCR System Guide)). If previous information is available for this tumour, the initial date takes precedence, including if it is non microscopic information. For example, if an x-ray result is available prior to the autopsy; the date associated with this initial diagnostic information takes precedence over the autopsy (histological) date.

Refer to the CCR guidelines for ambiguous terms (See Appendix H (Part II – CCR System Guide)) when determining the date of diagnosis.

Date of diagnosis is linked to the Input tumour variable T24 - Method used to establish the date of diagnosis.

Effective: Reference year 1992 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Specific values & meaning
YYYY (T12)
Value Meaning
[0000-9999] Year of diagnosis (1992 to current reference year)
MM (T12)
Value Meaning
[01-12] Month of diagnosis (January – December)
99 Month of diagnosis unknown
DD (T12)
Value Meaning
[01-31] Day of diagnosis
99 Day of diagnosis unknown

Related edits: TVAL8, TVAL9, TVAL12, TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL42, TVAL43, TVAL44, TVAL45, TVAL46, TVAL47, TVAL48, TVAL49, TVAL50, TVAL51, TVAL52, TCOR1, TCOR3, TCOR9, TCOR10, TCOR11, TCOR12, TCOR13, TCOR14, TCOR15, TCOR16, TCOR17, TCOR18, TCOR19, TCOR20, TCOR21, TCOR22, TCOR23, TCOR24, TCOR26, TCOR27, TCOR30, DIM1, DIM2, DIM3, DIM4, DIM6

Revision (T12)
Year Description
2008 Related edits changed: See TCOR26, TCOR27 and TCOR30.
2007 Related edits changed: See TVAL52 and TCOR13.
2004 Description: New sequence order.
Related edits changed: See TVAL27, TCOR9, TCOR12, TCOR14, TCOR15, TCOR16, TCOR17, TCOR18, TCOR19, TCOR20, TCOR21, TCOR22, TCOR23 and TCOR24.

T13 – ICD–9 cancer code

Acronym: TICD_9

Description:The diagnosis of the neoplasm coded according to the International Classification of Diseases, 9th revision.

ICD-9 Cancer code is used to describe the site of the tumour, and must be supplemented with an ICD–O–2 Histology (field T16) and an ICD–O–2 Behaviour (field T17).

Effective: Reference year 1992 and onwards.

Length: 4

Format:

  • The value does not contain a period between the 3rd and 4th digits
  • 3 digit long values are followed by a blank space in the 4th digit
Specific values & meaning (T13)
Value Meaning
0000 Topography not reported using ICD-9.
[Others] Refer to Appendix A (Part III – CCR System Guide) – Core reference tables - Eligible ICD-9 Cancer codes for meaning.

Related edits:TVAL13, TCOR1, TCOR5, TCOR6.

Revision (T13)
Year Description
2004 Name: Formerly known as T13 – ICD-9.
Related edits changed: TCOR5 and TCOR6.

T14 – Source classification flag

Acronym: TSCF

Description: The code that indicates the classification system in which the topography, histology and behaviour of the tumour were originally coded.

It is assumed that other reported topography, histology and behaviour are the result of a conversion from the original source code.

Effective: Reference year 1992 and onwards.

Length: 1

Specific values & meaning (T14)
Value Meaning
1 Topography originally coded in ICD–9,
Histology and behaviour originally coded in ICD–O–2
2 Topography, histology and behaviour originally coded in ICD–O–2
4 Topography, histology and Behaviour originally coded in ICD–O–3

Related edits: TVAL14, TCOR1, TCOR5, TCOR6, TCOR7.

Revision (T14)
Year Description
2004 Specific values & meaning: Code 3 (ICD-10) removed from the eligible codes.
Related edits changed: See TCOR5, TCOR6 and TCOR7.

T15 – ICD–O–2/3 Topography

Acronym: TICD_O2T

Description: The site of origin of the neoplasm coded according to the International Classification of diseases for oncology (2nd or 3rd edition) topography section.

Effective: Reference year 1992 and onwards.

Length: 4

Format: The value does not contain a period (.) between the 3rd and 4th digits.

Specific values & meaning (T15)
Value Meaning
0000 Topography not reported using ICD-O-2/3.
If possible, ICD-O-2/3 Topography will automatically be derived from ICD-9 Cancer code by the CCR system.
[Others] Refer to Appendix A (Part III – CCR System Guide) – Core reference tables – Eligible ICD–O–2/3 topography codes for meaning.

Related edits: TVAL15, TVAL16, TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL42, TVAL43, TVAL44, TVAL45, TVAL46, TVAL47, TVAL48, TVAL49, TVAL50, TVAL51, TCOR1, TCOR6, TCOR7, TCOR9, TCOR10, TCOR12, TCOR19, TCOR20, TCOR21, TCOR22, TCOR23, TCOR24, TCOR31, TCOR33, DIM5, DIM6.

Revision (T15)
Year Description
2008 Related edits changed: See TCOR31, TCOR33
2004 Related edits changed: See TVAL42, TVAL43, TVAL44, TVAL45, TVAL46, TVAL47, TVAL48, TVAL49, TVAL50, TVAL51, TCOR6, TCOR7, TCOR9, TCOR10, TCOR12, TCOR19, TCOR20, TCOR21, TCOR22, TCOR23, TCOR24 and DIM6.

T16 – ICD–O–2 Histology

Acronym: TICD_O2H

Description: The histological description of the neoplasm, coded according to the International Classification of Diseases for Oncology 2nd edition - Morphology Section.

Effective: Reference year 1992 and onwards.

Length: 4

Specific values & meaning (T16)
Value Meaning
0000 Histology not reported using ICD-O-2.
[Others] Refer to Appendix A (Part III – CCR System Guide) – Core reference tables – Eligible ICD–O–2 histology codes for meaning.

Related edits: TVAL16, TCOR1, TCOR5, TCOR6, TCOR7.

Revision (T16)
Year Description
2004 Name: Formerly known as T16 – ICD-O-2 Morphology. Renamed according to CCR data and quality management Committee recommendation.
Acronym: Formerly known as TICD_O2M. Changed to reflect new name.
Related edits changed: See TCOR5, TCOR6 and TCOR7.

T17 – ICD–O–2 Behaviour

Acronym: TICD_O2B

Description: The behaviour associated with the histological description of the neoplasm, reported in Field T16.

Effective: Reference year 1992 and onwards.

Length: 1

Specific values & meaning (T17)
Value Meaning
0 Benign if ICD-O-2 Histology is reported
– OR –
Behaviour not reported using ICD–O–2
1 Uncertain whether benign or malignant / borderline malignancy
2 Carcinoma in situ / intraepithelial / non-infiltrating / non-invasive
3 Malignant, primary site

Related edits: TVAL17, TCOR1, TCOR5, TCOR6, TCOR7.

Revision (T17)
Year Description
2004 Name: Formerly known as T17 – ICD-O-2 M Behaviour. Renamed to be consistent with T16 new name.
Related edits changed: See TCOR6 and TCOR7.

T18 – Filler

Acronym: Not applicable

Description: Filler: free space reserved for future requirement implementation.

This field will not be processed or returned by the CCR System.

Effective: Reference year 1992 and onwards.

Length: 4

Format: Enter any values or leave the field blank.

Revision (T18)
Year Description
Not applicable Not applicable

T19 – Laterality

Acronym: TLATERAL

Description: The site-specific localization of the tumour in paired organs or the side of the body on which the tumour originated. It specifies whether the tumour is on the right, left or bilateral, where applicable.

Refer to Appendix A (Part III – CCR System Guide) – Core reference tables – Valid site and laterality combinations for more details.

Effective: Reference year 1992 and onwards.

Length: 1

For date of diagnosis 2007 and onwards:

Specific values & meaning (T19)
Value Meaning
0 Not a paired organ
1 Right: origin of primary
2 Left: origin of primary
3 Only one side involved, right or left origin unspecified
4 Bilateral involvement, lateral origin unknown: stated to be single primary
This code is seldom used EXCEPT for the following diseases:
i.Both ovaries involved simultaneously, single histology
ii. Bilateral retinoblastomas
iii. Bilateral Wilm's tumours
9 Paired site, but no information concerning laterality, midline tumour

For date of diagnosis between 1992 and 2006:

Specific values & meaning (T19)
Value Meaning
0 Not a paired organ
1 Right: origin of primary
2 Left: origin of primary
4 Bilateral involvement, lateral origin unknown: stated to be single primary
This code is seldom used EXCEPT for the following diseases:
i.Both ovaries involved simultaneously, single histology
ii.Bilateral retinoblastomas
iii. Bilateral Wilm's tumours
9 Paired site, but no information concerning laterality, midline tumour

Related edits: TVAL19, TCOR1, TCOR12, DIM6.

Revision (T19)
Year Description
2007 Specific values & meaning: NAACCR (SEER) laterality codes and meaning are now used for this variable. Code'1' now refers to 'Right: origin of primary'. Code '2' now refers to 'Left: origin of primary'. Code '3' added to handle 'Only one side involved, right or left origin unspecified. Data already loaded in the CCR (1992-2006) has been updated to reflect the new code set (note: Code '3' was not implemented for cases diagnosed prior to 2007).
2004 Related edits changed: See TCOR12 and DIM6.

T20 – Filler

Acronym: Not applicable

Description: Filler: free space reserved for future requirement implementation.

This field will not be processed or returned by the CCR System.

Effective: Reference year 1992 and onwards.

Length: 1

Format: Enter any values or leave the field blank.

Revision (T20)
Year Description
Not applicable Not applicable

T21 – ICD–O–3 Histology

Acronym: TICD_O3H

Description: The histological description of the neoplasm, coded according to the International Classification of Diseases for Oncology 3rd edition - Morphology Section.

Effective: Reference year 1992 and onwards.

Although this field was added to the CCR in 2001, historical data back to 1992 has been converted to this classification.

Length: 4

Specific values & meaning (T21)
Value Meaning
0000 Histology not reported using ICD-O-3.
ICD-O-3 Histology will automatically be derived from ICD-O-2 fields (topography, histology and behaviour) by the CCR system.
[Others] Refer to Appendix A (Part III – CCR System Guide) – Core reference tables – Eligible ICD–O–3 histology codes for meaning.

Related edits: TVAL21, TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL42, TVAL43, TVAL44, TVAL45, TVAL46, TVAL47, TVAL48, TVAL49, TVAL50, TVAL51, TCOR1, TCOR7, TCOR9, TCOR10, TCOR11, TCOR19, TCOR20, TCOR21, TCOR22, TCOR23, TCOR24, TCOR33, DIM6.

Revision (T21)
Year Description
2008 Related edits changed: See TCOR33
2004 Name: Formerly known as T21M – ICD-O-3 Morphology. renamed according to CCR data and quality management committee recommendation. Renumbered to fit in sequence.
Acronym: Formerly known as TICD_O3M. Changed to reflect new name.
Related edits changed: See TVAL42, TVAL43, TVAL44, TVAL45, TVAL46, TVAL47, TVAL48, TVAL49, TVAL50, TVAL51, TCOR7, TCOR9, TCOR10, TCOR11, TCOR19, TCOR20, TCOR21, TCOR22, TCOR23, TCOR24 and DIM6.

T22 – ICD–O–3 Behaviour

Acronym: TICD_O3B

Description: The behaviour associated with the histological description of the neoplasm, reported in Field T21.

Effective: Reference year 1992 and onwards.

Although this field was added to the CCR in 2001, historical data back to 1992 has been converted to this classification.

Length: 1

Specific values & meaning T22)
Value Meaning
0 Benign if ICD-O-3 Histology is reported
– OR –
Behaviour not reported using ICD–O–3.
If not reported, ICD-O-3 Behaviour will automatically be derived from ICD-O-2 fields (topography, histology and behaviour) by the CCR system.
1 Uncertain whether benign or malignant / borderline malignancy
2 Carcinoma in situ / intraepithelial / non-infiltrating / non-invasive
3 Malignant, primary site

Related edits: TVAL22, TVAL42, TVAL43, TVAL44, TVAL45, TVAL46, TVAL47, TVAL48, TVAL49, TVAL50, TVAL51, TCOR1, TCOR7, TCOR9, TCOR11, TCOR19, TCOR20, TCOR21, TCOR22, TCOR23, TCOR24, TCOR32.

Revision (T22)
Year Description
2008 Related edits changed: TCOR32
2004 Fields reorganized: Field formerly known as T22 – Date of transmission has been moved to T26 – Date of transmission.
Name: Current field formerly know as T21B – ICD-O-3 M Behaviour. Renamed to be consistent with T21 new name. Renumbered to fit in sequence.
Related edits changed: See TVAL42, TVAL43, TVAL44, TVAL45, TVAL46, TVAL47, TVAL48, TVAL49, TVAL50, TVAL51, TCOR7, TCOR9, TCOR11, TCOR19, TCOR20, TCOR21, TCOR22, TCOR23 and TCOR24.

T23 – Grade, differentiation or cell indicator

Acronym: TGRADE

Description: The code that describes the system used to identify the Type of grade/differentiation/cell indicator.

Grade is used by the CS algorithm to produce CS derived data.

Refer to Appendix G (Part II – CCR System Guide)– Guidelines for reporting grade, differentiation or cell indicator for 2006 data forward.

Effective: Reference year 2004 and onwards.

Length: 1

Specific values & meaning (T23)
Value Meaning
0 For Date of diagnosis prior to 2004.
Not reported
1 Grade I; grade i; grade 1; well differentiated; differentiated, NOS
2 Grade II; grade ii; grade 2; moderately differentiated; moderately well differentiated; intermediate differentiation
3 Grade III; grade iii, grade 3; poorly differentiated; dedifferentiated
4 Grade IV; grade iv; grade 4; undifferentiated; anaplastic
5 T-cell; T-precursor
6 B-Cell; Pre-B; B-precursor
7 Null cell; Non T-non B
8 NK cell (natural killer cell)
9 Grade/differentiations unknown, not stated, or not applicable

Related edits: TVAL23, TCOR1, TCOR17.

Revision (T23)
Year Description
2006 Application of new guidelines for reporting grade, differentiation or cell indicator
2004 Fields reorganized: Field formerly known as T23 – Method used to establish date of diagnosis has been moved to T24 – Method used to establish the date of diagnosis.

T24 – Method used to establish the date of diagnosis

Acronym: TMETHUSED

Description: The code that specifies the method by which the date of diagnosis of this tumour was established.

The SEER Program Code Manual, third edition, diagnostic confirmation descriptions were used as a reference when determining the appropriate codes for the CCR.

This field is linked to T12 – Date of diagnosis.

Effective: Reference year 2004 and onwards.

Length: 1

Categories of diagnostic methods are listed below in order of priority.

Specific values & meaning (T24)
Value Meaning
0 For Date of diagnosis prior to 2004
Not reported. (Refer to T11 – Method of diagnosis.)
1-3 Microscopically confirmed
1 Positive cytology Cytological diagnoses based on microscopic examination of cells as contrasted with tissues. Included are smears from sputum, bronchial brushings, bronchial washings, tracheal washings, prostatic secretions, breast secretions, gastric fluid, spinal fluid, peritoneal fluid, and urinary sediment. Cervical and vaginal smears are common examples. Also included are diagnoses based upon paraffin block specimens from concentrated spinal, pleural and peritoneal fluid. Fine needle aspiration is included here.
2 Positive histology Histological diagnoses based upon tissue specimens from biopsy (including wide core and needle biopsy), frozen section, surgery, autopsy or D and C. Positive hematological findings relative to leukemia, including peripheral blood smears, are also included. Bone marrow specimens (including aspiration biopsies) are coded as '2'.
3 Autopsy only Diagnosis confirmed by autopsy only, (if tissue taken) when no other information available.
4-9 Non-microscopically confirmed
4 Positive laboratory test/marker study Clinical diagnoses of cancer based on certain laboratory tests or marker studies, which are clinically diagnostic for cancer. This includes alpha-fetoprotein for liver cancer and abnormal electrophoretic spike for multiple myeloma. Elevated PSA is non-diagnostic for cancer. If the physician uses the PSA as a basis for diagnosing prostate cancer with no other work-up, it should be recorded as code 4.
5 Direct visualization without microscopic confirmation (surgery without histology) Visualization includes diagnosis made at surgical exploration, including autopsy where no tissue is taken, or by use of the various endoscopes (including colposcope, mediastinoscope, and peritoneoscope). However, use only if such visualization is not supplemented by positive histology or positive cytology reports.
6 Radiography and other imaging techniques without microscopic confirmation Cases with diagnostic radiology for which there is neither a positive histology nor a positive cytology report. 'Other imaging techniques' include procedures such as ultrasound, computerized (axial) tomography (CT or CAT) scans, and magnetic resonance imaging (MRI).
7 Clinical diagnosis, including physical findings (without histology) Cases diagnosed by clinical methods not mentioned above and for which there were no positive microscopic findings.
8 Death certificate only Cases diagnosed by Death certificates only, when no other information available.
9 Method used to establish the date of diagnosis unknown.

Related edits: TVAL24, TCOR1, TCOR13, TCOR15, TCOR33, TCOR35, DIM4.

Revision (T24)
Year Description
2008 Related edits changed: See TCOR33, TCOR35
2006 Related edits changed: See TCOR13.
2004 Fields reorganized: Field formerly known as T24 – Diagnosis confirmation has been moved to T25 – Diagnosis confirmation.
Name: Current field formerly known as T23 – Method used to establish the date of diagnosis. Renumbered to fit in sequence.

T25 – Diagnostic confirmation

Acronym: TMETHCONF

Description: The method of the most accurate diagnostic confirmation. Determine whether this tumour was microscopically confirmed at any time during the patient's medical history.

The SEER Program Code Manual, third edition, diagnostic confirmation descriptions were used as a reference when determining the appropriate codes for the CCR.

This field is not linked with T12 – Date of diagnosis.

Effective: Reference year 2004 and onwards.

Length: 1

Categories of diagnostic methods are listed below in order of priority.

Specific values & meaning (T25)
Value Meaning
0 For Date of diagnosis prior to 2004
Not reported. (Refer to T11 – Method of diagnosis.)
1-3 Microscopically confirmed
1 Positive histology Histological diagnoses based upon tissue specimens from biopsy (including wide core and needle biopsy), frozen section, surgery, autopsy or D and C. Positive hematological findings relative to leukemia, including peripheral blood smears, are also included. Bone marrow specimens (including aspiration biopsies) are coded as '1'.
2 Positive cytology Cytological diagnoses based on microscopic examination of cells as contrasted with tissues. Included are smears from sputum, bronchial brushings, bronchial washings, tracheal washings, prostatic secretions, breast secretions, gastric fluid, spinal fluid, peritoneal fluid, and urinary sediment. Cervical and vaginal smears are common examples. Also included are diagnoses based upon paraffin block specimens from concentrated spinal, pleural and peritoneal fluid. Fine needle aspiration included here.
3 Autopsy only Diagnosis confirmed by autopsy only, (if tissue taken) when no other information available
4-9 Non-microscopically confirmed
4 Positive laboratory test/marker study Clinical diagnoses of cancer based on certain laboratory tests or marker studies, which are clinically diagnostic for cancer. This includes alpha-fetoprotein for liver cancer and abnormal electrophoretic spike for multiple myeloma. Elevated PSA is non-diagnostic for cancer. If the physician uses the PSA as a basis for diagnosing prostate cancer with no other work-up, it should be recorded as code 4.
5 Direct visualization without microscopic confirmation (surgery without histology) Visualization includes diagnosis made at surgical exploration including autopsy where no tissue is taken, or by use of the various endoscopes (including colposcope, mediastinoscope, and peritoneoscope). However, use only if such visualization is not supplemented by positive histology or positive cytology reports.
6 Radiography and other imaging techniques without microscopic confirmation Cases with diagnostic radiology for which there is neither a positive histology nor a positive cytology report. 'Other imaging techniques' include procedures such as ultrasound, computerized (axial) tomography (CT or CAT) scans, and magnetic resonance imaging (MRI).
7 Clinical diagnosis, including physical findings (without histology) Cases diagnosed by clinical methods not mentioned above and for which there were no positive microscopic findings.
8 Death certificate only Cases diagnosed by Death certificates only, when no other information available.
9 Diagnostic confirmation unknown

Related edits: TVAL25, TCOR1, TCOR13, TCOR16

Revision (T25)
Year Description
2006 Related edits changed: See TCOR13.
2004 Name: Formerly known as T24 – Diagnostic confirmation. Renumbered to fit in sequence.

T26 – Date of transmission

Acronym: TDATTRAN

Description: The date on which a copy of the tumour record was extracted from the provincial/territorial registry for submission to the CCR.

Effective: Reference year 1992 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Specific values & meaning
YYYY (T26)
Value Meaning
[0000-9999] Year of transmission
MM (T26)
Value Meaning
[01-12] Month of transmission (January – December)
DD (T26)
Value Meaning
[01-31] Day of the transmission

Related edits: TVAL26.

Revision (T26)
Year Description
2004 Name: Formerly known as T22 – Date of transmission. Renumbered to fit in sequence.
Acronym: Formerly known as TDATTRA2.

T27 – CS tumour size

Acronym: TCSTSIZE

Description: The largest dimension or the diameter of the primary tumour in millimetres (for example: 1 mm = 001, 1 cm = 010). See the CS schemas for site-specific variants.

For many sites, the CS algorithm uses this data item to calculate the Derived T or Derived M according to the AJCC Cancer staging manual, sixth edition.

Effective: Reference year 2004 and onwards.

Length: 3

Specific values & meaning (T27)
Value Meaning
[Blank] Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR Collaborative Scope).
[000-998] See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
Some values in the range may be invalid depending on site.
999 Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning
RRR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18.

Revision (T27)
Year Description
2007 Specific values & meaning: Meaning of value '999' modified
Related edits changed: See TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52

T28 – CS extension

Acronym: TCSEXTN

Description: The primary tumour growth within the organ of origin or its direct extension into neighbouring organs.

This data item is used by the algorithm to derive the AJCC T code according to the AJCC Cancer staging manual, sixth edition.

For certain sites such as ovary, discontinuous metastasis is coded in the CS extension field. 

Effective: Reference year 2004 and onwards.

Length: 2

Specific values & meaning (T28)
Value Meaning
[Blank] Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
[00-98] See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
Some values in the range may be invalid depending on site.
99 Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning
RR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18.

Revision (T28)
Year Description
2007 Specific values & meaning: Meaning of value '99' modified
Related edits changed: See TVAL27, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52

T29 – CS tumour size/ext eval

Acronym: TCSEVAL

Description: CS tumour size/extension evaluation: the code indicating how the 'CS tumour size' and 'CS extension' were determined based on the diagnostic methods employed.

This data item is used in CS to identify whether the T (of AJCC TNM) was clinically or pathologically diagnosed and by what method 'CS tumour size/ext eval' is used to calculate the derived AJCC T descriptor.

Effective: Reference year 2004 and onwards.

Length: 1

Specific values & meaning (T29)
Value Meaning
[Blank] Tumour outside the CCR collaborative staging scope (see section1.1.2.2. CCR collaborative staging scope).
[0-8] See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
Some values in the range may be invalid depending on site.
9 Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning
R Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18.

Revision (T29)
Year Description
2007 Specific values & meaning: Meaning of value '9' modified
Related edits changed: See TVAL27, TVAL28, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52

T30 – CS lymph nodes

Acronym: TCSLNODE

Description: The site-specific code identifying the regional lymph nodes involved with cancer at time of diagnosis.

This data item is used by the algorithm to derive the AJCC N code according to the AJCC Cancer staging manual, sixth edition.

Site-specific codes provide extensive detail describing disease extent. 

Effective: Reference year 2004 and onwards.

Length: 2

Specific values & meaning (T30)
Value Meaning
[Blank] Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
[00-98] See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
Some values in the range may be invalid depending on site.
99 Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
RR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T30)
Year Description
2007 Specific values & meaning: Meaning of value '99' modified
Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52

T31 – CS reg nodes eval

Acronym: TCSRNEVAL

Description: CS regional nodes evaluation: the code indicating how the 'CS Lymph Nodes' code was determined based on the diagnostic methods employed.

This data item is used in CS to identify whether the N (of AJCC TNM) was clinically or pathologically diagnosed and by what method 'CS reg nodes eval' is used to calculate the Derived AJCC nodes descriptor.

Effective: Reference year 2004 and onwards.

Length: 1

Specific values & meaning (T31)
Value Meaning
[Blank] Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
[0-8] See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
Some values in the range may be invalid depending on site.
9 Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
R Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T31)
Year Description
2007 Specific values & meaning: Meaning of value '9' modified
Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52

T32 – Regional nodes examined

Acronym: TCSRNEXAM

Description: The total number of regional lymph nodes that were removed and examined by the pathologist.

Based on pathologic (microscopic) information only.

Effective: Reference year 2004 and onwards.

Length: 2

Specific values & meaning(T32)
Value Meaning
[Blank] Tumour outside the CCR collaborative staging scope (see section 1.1.2.2.CCR collaborative staging scope).
[00-98] See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
Some values in the range may be invalid depending on site.
99 Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
RR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T32)
Year Description
2007 Specific values & meaning: Meaning of value '99' modified
Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52

T33 – Regional nodes positive

Acronym: TCSRNPOS

Description: The exact number of regional lymph nodes examined by the pathologist and found to contain metastases.

Based on pathologic (microscopic) information only.

Effective: Reference year 2004 and onwards.

Length: 2

Specific values & meaning (T33)
Value Meaning
[Blank] Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
[00-98] See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
Some values in the range may be invalid depending on site.
99 Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
RR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T33)
Year Description
2007 Specific values & meaning: Meaning of value '99' modified
Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52

T34 – CS mets at dx

Acronym: TCSMDIAG

Description: CS metastases at diagnosis: the code identifying the distant site(s) of metastatic involvement at time of diagnosis.

This data item is used by the algorithm to derive the AJCC M code according to the AJCC Cancer staging manual, sixth edition.

Effective: Reference year 2004 and onwards.

Length: 2

Specific values & meaning (T34)
Value Meaning
[Blank] Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
[00-98] See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
Some values in the range may be invalid depending on site.
99 Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
RR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T34)
Year Description
2007 Specific values & meaning: Meaning of value '99' modified
Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52

T35 – CS mets eval

Acronym: TCSMEVAL

Description: CS metastases evaluation: the code indicating how 'CS mets at dx' was determined based on the diagnostic methods employed.

This data item is used in CS to identify whether the M (of AJCC TNM) was clinically or pathologically diagnosed and by what methods 'CS mets eval' is used to calculate the Derived AJCC M descriptor.

Effective: Reference year 2004 and onwards.

Length: 1

Specific values & meaning (T35)
Value Meaning
[Blank] Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
[0-8] See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
Some values in the range may be invalid depending on site.
9 Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
R Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T35)
Year Description
2007 Specific values & meaning: Meaning of value '9' modified
Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52

T36 – CS site-specific factor 1

Acronym: TCSSSF1

Description: The code identifying additional site-specific information needed to derive TNM or AJCC stage, or to code prognostic factors that have an effect on stage or survival. 

Many site-specific schemas do not use any of the Site-specific factors; other schemas use from 1 to all 6 of the factors. When the Site-specific factors are not used for a specific schema, the value will be entered as '888' (Not applicable).

Effective: Reference year 2004 and onwards.

Length: 3

Specific values & meaning (T36)
Value Meaning
[Blank] Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope)
888 Not applicable; specific schema does not use CS site-specific factor 1
999 Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
[others] See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
Some values in the range may be invalid depending on site.
RRR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T36)
Year Description
2007 Specific values & meaning: Code 888 specified for schemas that do not use the site-specific factor. Meaning of value '999' has also been modified.
Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52.

T37 – CS site-specific factor 2

Acronym: TCSSSF2

Description: The code identifying additional site-specific information needed to derive TNM or AJCC stage, or to code prognostic factors that have an effect on stage or survival. 

Many site-specific schemas do not use any of the Site-specific factors; other schemas use from 1 to all 6 of the factors. When the Site-specific factors are not used for a specific schema, the value will be entered as '888' (Not applicable).

Effective: Reference year 2004 and onwards.

Length: 3

Specific values & meaning (T37)
Value Meaning
[Blank] Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
888 Not applicable; specific schema does not use CS site-specific factor 2.
999 Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
[others] See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
Some values in the range may be invalid depending on site.
RRR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T37)
Year Description
2007 Specific values & meaning: Code 888 specified for schemas that do not use the site-specific factor. Meaning of value '999' has also been modified.
Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52.

T38 – CS site-specific factor 3

Acronym: TCSSSF3

Description: The code identifying additional site-specific information needed to derive TNM or AJCC stage, or to code prognostic factors that have an effect on stage or survival. 

Many site-specific schemas do not use any of the Site-specific factors; other schemas use from 1 to all 6 of the factors. When the Site-specific factors are not used for a specific schema, the value will be entered as '888' (Not applicable).

Effective: Reference year 2004 and onwards.

Length: 3

Specific values & meaning (T38)
Value Meaning
[Blank] Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
888 Not applicable; specific schema does not use CS site-specific factor 3.
999 Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
[others] See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
Some values in the range may be invalid depending on site.
RRR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T38)
Year Description
2007 Specific values & meaning: Code 888 specified for schemas that do not use the site-specific factor. Meaning of value '999' has also been modified.
Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL39, TVAL40, TVAL41 and TVAL52.

T39 – CS site-specific factor 4

Acronym: TCSSSF4

Description: The code identifying additional site-specific information needed to derive TNM or AJCC stage, or to code prognostic factors that have an effect on stage or survival. 

Many site-specific schemas do not use any of the Site-specific factors; other schemas use from 1 to all 6 of the factors. When the Site-specific factors are not used for a specific schema, the value will be entered as '888' (Not applicable).

Effective: Reference year 2004 and onwards.

Length: 3

Specific values & meaning (T39)
Value Meaning
[Blank] Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
888 Not applicable; specific schema does not use CS site-specific factor 4.
999 Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
[others] See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
Some values in the range may be invalid depending on site.
RRR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T39)
Year Description
2007 Specific values & meaning: Code 888 specified for schemas that do not use the site-specific factor. Meaning of value '999' has also been modified.
Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL40, TVAL41 and TVAL52.

T40 – CS site-specific factor 5

Acronym: TCSSSF5

Description: The code identifying additional site-specific information needed to derive TNM or AJCC stage, or to code prognostic factors that have an effect on stage or survival. 

Many site-specific schemas do not use any of the Site-specific factors; other schemas use from 1 to all 6 of the factors. When the Site-specific factors are not used for a specific schema, the value will be entered as '888' (Not applicable).

Effective: Reference year 2004 and onwards.

Length: 3

Specific values & meaning (T40)
Value Meaning
[Blank] Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope)
888 Not applicable; specific schema does not use CS site-specific factor 5.
999 Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
[others] See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
Some values in the range may be invalid depending on site.
RRR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T40)
Year Description
2007 Specific values & meaning: Code 888 specified for schemas that do not use the site-specific factor. Meaning of value '999' has also been modified.
Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL41 and TVAL52.

T41 – CS site-specific factor 6

Acronym: TCSSSF6

Description: The code identifying additional site-specific information needed to derive TNM or AJCC stage, or to code prognostic factors that have an effect on stage or survival. 

Many site-specific schemas do not use any of the Site-specific factors; other schemas use from 1 to all 6 of the factors. When the Site-specific factors are not used for a specific schema, the value will be entered as '888' (Not applicable).

Effective: Reference year 2004 and onwards.

Length: 3

Specific values & meaning (T41)
Value Meaning
[Blank] Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope.
888 Not applicable; specific schema does not use CS site-specific factor 6.
999 Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
[others] See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
Some values in the range may be invalid depending on site.
RRR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T41)
Year Description
2007 Specific values & meaning: Code 888 specified for schemas that do not use the site-specific factor. Meaning of value '999' has also been modified.
Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52.

T42 – AJCC clinical T

Acronym: TAJCCCLINT

Description: The site-specific code evaluating the primary tumour clinically (T) and reflects the tumour size and/or extension as recorded.

Clinical stage is assigned prior to any cancer-directed treatment and should not be changed based on subsequent information.

Effective: Reference year 2003 and onwards.

Length: 9

Specific values & meaning (T42)
Value Meaning
[Blank] Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope).
TX Primary tumour cannot be assessed (all reasonable clinical manoeuvres have been used).
T0 Site-specific meaning
See AJCC Cancer staging manual, sixth edition for exact meaning.
Tis
TisDCIS
TisLCIS
TisPagets
T1
T1mic
T1a
T1b
T1c
T2
T2a
T2b
T2c
T3
T3a
T3b
T4
T4a
T4b
T4c
T4d
99 AJCC clinical T is unknown.
RRRRRRRRR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL42, TCOR1, TCOR19, TCOR21, TCOR23, TCOR24

Revision (T42)
Year Description
Not applicable Not applicable

T43 – AJCC clinical N

Acronym: TAJCCCLINN

Description: The site-specific code identifying the absence or presence of clinical regional lymph node (N) metastasis and describes the extent of regional lymph node metastasis as recorded. 

Clinical stage is assigned prior to any cancer-directed treatment and should not be changed based on subsequent information.

Effective: Reference year 2003 and onwards.

Length: 3

Specific values & meaning (T43)
Value Meaning
[Blank] Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope).
NX Regional lymph nodes cannot be assessed (all reasonable clinical manoeuvres have been used).
N0 Site-specific meaning
See AJCC Cancer staging manual, sixth edition for exact meaning.
N1
N2
N2a
N2b
N3
N3a
N3b
N3c
99 AJCC clinical N is unknown.
RRR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL43, TCOR1, TCOR19, TCOR21, TCOR23, TCOR24

Revision (T43)
Year Description
Not applicable Not applicable

T44 – AJCC clinical M

Acronym: TAJCCCLINM

Description: The site-specific code identifying the presence or absence of clinical distant metastasis (M) as recorded.

Clinical stage is assigned prior to any cancer-directed treatment and should not be changed based on subsequent information. 

Effective: Reference year 2003 and onwards.

Length: 3

Specific values & meaning (T44)
Value Meaning
[Blank] Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope).
MX Distant metastasis cannot be assessed (all reasonable clinical manoeuvres have been used).
M0 Site-specific meaning
See AJCC Cancer staging manual, sixth edition for exact meaning.
M1
M1a
M1b
M1c
99 AJCC clinical M is unknown.
RRR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL44, TCOR1, TCOR19, TCOR21, TCOR23, TCOR24

Revision (T44)
Year Description
Not applicable Not applicable

T45 – AJCC pathologic T

Acronym: TAJCCPATHT

Description: The site-specific code evaluating the primary tumour pathologically (T) and reflects the tumour size and/or extension as recorded. 

Pathological stage uses all data for clinical staging; the evidence acquired before treatment, supplemented or modified by the additional evidence acquired during and from surgery, particularly from pathologic examination.

Effective: Reference year 2003 and onwards.

Length: 9

Specific values & meaning (T45)
Value Meaning
[Blank] Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope).
TX Primary tumour cannot be assessed (all reasonable pathologic manoeuvres have been used).
T0 Site-specific meaning
See AJCC Cancer staging manual, sixth edition for exact meaning.
Tis
TisDCIS
TisLCIS
TisPagets
T1
T1mic
T1a
T1b
T1c
T2
T2a
T2b
T2c
T3
T3a
T3b
T4
T4a
T4b
T4c
T4d
99 AJCC pathologic T is unknown.
RRRRRRRRR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL45, TCOR1, TCOR19, TCOR22, TCOR23, TCOR24

Revision (T45)
Year Description
Not applicable Not applicable

T46 – AJCC pathologic N

Acronym: TAJCCPATHN

Description: The site-specific code identifying the absence or presence of pathological regional lymph node (N) metastasis and describes the extent of regional lymph node metastasis as recorded. 

Pathological stage uses all data for clinical staging; the evidence acquired before treatment, supplemented or modified by the additional evidence acquired during and from surgery, particularly from pathologic examination.

Effective: Reference year 2003 and onwards.

Length: 6

Specific values & meaning (T46)
Value Meaning
[Blank] Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope).
NX Regional lymph nodes cannot be assessed (all reasonable pathologic manoeuvres have been used).
N0 Site-specific meaning
See AJCC Cancer staging manual, sixth edition for exact meaning.
N0i-
N0i+
N0mol-
N0mol+
N1
N1mi
N1a
N1b
N1c
N2
N2a
N2b
N3
N3a
N3b
N3c
99 AJCC pathologic N is unknown.
RRRRRR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL46, TCOR1, TCOR19, TCOR22, TCOR23, TCOR24

Revision (T46)
Year Description
Not applicable Not applicable

T47 – AJCC pathologic M

Acronym: TAJCCPATHM

Description: The site-specific code identifying the presence or absence of pathological distant metastasis (M) as recorded.

Pathological stage uses all data for clinical staging; the evidence acquired before treatment, supplemented or modified by the additional evidence acquired during and from surgery, particularly from pathologic examination.

Effective: Reference year 2003 and onwards.

Length: 3

Specific values & meaning (T47)
Value Meaning
[Blank] Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope).
MX Distant metastasis cannot be assessed (all reasonable pathologic manoeuvres have been used).
M0 Site-specific meaning
See AJCC Cancer staging manual, sixth edition for exact meaning.
M1
M1a
M1b
M1c
99 AJCC pathologic M is unknown.
RRR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL47, TCOR1, TCOR19, TCOR22, TCOR23, TCOR24

Revision (T47)
Year Description
Not applicable Not applicable

T48 – AJCC clinical TNM stage group

Acronym: TAJCCCLINSG

Description: The site-specific code identifying the anatomic extent of disease based on the clinical T, N and M elements as recorded in TNM Clinical T, N and M fields.

Effective: Reference year 2003 and onwards.

Length: 4

Specific values & meaning (T48)
Value Meaning
[Blank] Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope).
X All reasonable clinical manoeuvres have been used, but Clinical TNM values do not lead to a certain, specific stage group.
0 Site-specific meaning
See AJCC Cancer staging manual, sixth edition for exact meaning.
I
II
IIA
IIB
III
IIIA
IIIB
IIIC
IV
99 AJCC clinical TNM stage group is unknown: no clinical manoeuvres have been used; unknown if clinical manoeuvres have been used.
RRRR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL48, TCOR1, TCOR19, TCOR20, TCOR21, TCOR24

Revision (T48)
Year Description
Not applicable Not applicable

T49 – AJCC pathologic TNM stage group

Acronym: TAJCCPATHSG

Description: The site-specific code identifying the anatomic extent of disease based on the pathologic T, N and M elements as recorded in TNM Pathologic T, N and M fields.

Effective: Reference year 2003 and onwards.

Length: 4

Specific values & meaning (T49)
Value Meaning
[Blank] Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope).
X All reasonable pathologic manoeuvres have been used, but Pathologic TNM values do not lead to a certain, specific stage group.
0 Site-specific meaning
See AJCC Cancer staging manual, sixth edition for exact meaning.
I
II
IIA
IIB
III
IIIA
IIIB
IIIC
IV
99 AJCC pathologic TNM stage group is unknown: no pathologic manoeuvres have been used; unknown if pathologic manoeuvres have been used.
RRRR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL49, TCOR1, TCOR19, TCOR20, TCOR22, TCOR24

Revision (T49)
Year Description
Not applicable Not applicable

T50 – AJCC TNM stage group

Acronym: TAJCCSG

Description: The site-specific code identifying the stage group when Clinical / Pathologic T, N, M values are incomplete and do not lead to a Clinical / Pathologic stage group.

Effective: Reference year 2003 and onwards.

Length: 4

Specific values & meaning (T50)
Value Meaning
[Blank] Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope).
0 Site-specific meaning
See AJCC Cancer staging manual, sixth edition for exact meaning.
I
II
IIA
IIB
III
IIIA
IIIB
IIIC
IV
99 AJCC TNM stage group is unknown.
RRRR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL50, TCOR1, TCOR19, TCOR20, TCOR23, TCOR24

Revision (T50)
Year Description
Not applicable Not applicable

T51 – AJCC edition number

Acronym: TAJCCEDNUM

Description: Identifies the edition of the Cancer Staging Manual used to stage the case. TNM codes have changed over time and conversion is not always possible. Therefore, a case-specific indicator is needed to allow grouping of cases for comparison.

Effective: Reference year 2003 and onwards.

Length: 2

Specific values & meaning (T51)
Value Meaning
[Blank] Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope)
00 Not staged (AJCC/UICC staging scheme applies however site not staged)
01 AJCC sixth edition
02 AJCC seventh edition
11 International union against cancer (UICC) sixth edition
12 International union against cancer (UICC) seventh edition
98 AJCC staged, but the edition is unknown
99 UICC staged, but the edition is unknown
RR Reported data rejected by CCR system (For Statistics Canada use only)

Related edits: TVAL51, TCOR1, TCOR19, TCOR24

Revision (T51)
Year Description
2004 Value '88' (Not applicable: cases that do not have an AJCC/UICC staging scheme) has been removed since every tumour included in CCR AJCC TNM staging scope(see section 1.1.2.3) has an AJCC staging scheme.

T52 – CS Version 1st

Acronym: TCSFVER

Description: Indicates the number of the version used to initially code Collaborative staging fields. The data item should be entered at the time the CS fields are first coded and the algorithm first applied. If the calculation algorithm is not called at the time of the initial abstracting, the CS Version 1st could also be entered manually by the abstractor.

Effective: Reference year 2004 and onwards.

Length: 6

Specific values & meaning (T52)
Value Meaning
[Blank] Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
[others] Refer to Appendix A (Part III – CCR System Guide) – Core reference tables – Eligible CS Version 1st codes for meaning.
999999 Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
RRRRRR Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T52)
Year Description
2007 New field added: Was formerly TD19 – CS Version 1st.

T53– Ambiguous terminology diagnosis

Acronym: TAMBIGTERM

Description: Identifies all cases, including death certificate only and autopsy only, for which an ambiguous term is used to establish a cancer diagnosis (for example, to determine whether or not the case is reportable). Ambiguous terminology may originate from any source document, such as pathology report, radiology report, or from a clinical report. This data item is used only when ambiguous terminology is used to establish diagnosis. It is not used when ambiguous terminology is used to clarify a primary site, specific histology, histologic group, or stage of disease. It is not used if there is any conclusive statement of a cancer diagnosis in the medical record.

This data item will identify specific primary sites where the ambiguous terminology is commonly used to describe or establish a cancer diagnosis.

Refer to the SEER Multiple Primary and Histology Coding Rules Manual (page 335-337) for more details on definitions, time frames, coding instructions and examples.

Refer to the CCR Appendix I (Part II – CCR System Guide): Guidelines for Ambiguous Terms, as referenced in T12 (date of diagnosis).

Effective: Reference year 2008 and onwards.

Length: 1

Specific values & meaning (T53)
Value Meaning
[Blank] For cases diagnosed prior to 2008, leave this file blank
–or–

Conclusive terminology of cancer diagnosis in medical record
0 Conclusive terminology within 60 days of original diagnosis
1 Ambiguous terminology only (includes all diagnostic methods except cytology)
2 Ambiguous terminology followed by conclusive terminology (more than 60 days after initial diagnosis)
9 Unknown terminology (no information about ambiguous terminology)

Related edits: TVAL53, TCOR1, TCOR26, TCOR29

Revision (T53)
Year Description
2008 New variable must be reported

T54– Date of conclusive diagnosis

Acronym: TDATCONCLUSDIAG

Description: The date when a conclusive cancer diagnosis (definite statement of malignancy) is made following an initial diagnosis that was based only on ambiguous terminology. Change the code for data item "Ambiguous terminology diagnosis" from a 1 to a 2 and enter the date that the malignancy was described clearly and definitively in "Date of conclusive diagnosis". The date of the conclusive diagnosis must be greater than 60 days following the initial (ambiguous terminology only) diagnosis.

Refer to the SEER Multiple Primary and Histology Coding Rules Manual (page 338) for more details on definitions, time frames and examples.

Effective: Reference year 2008 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Specific values & meaning
YYYY (T54)
Value Meaning
[Blank] For cases diagnosed prior to 2008, leave this file blank
–or–

Cancer diagnosis based initially on conclusive terminology
[2008-xxxx] Year of conclusive diagnosis (2008 to current reference year)
0000 Accessioned based on ambiguous terminology only (Code 1 in data item Ambiguous terminology diagnosis)
8888 Not applicable, initial diagnosis made by conclusive diagnosis within 60 days of original diagnosis (Code 0 in data item Ambiguous terminology diagnosis)
9999 Year unknown for conclusive diagnosis made after Ambiguous terminology diagnosis
MM (T54)
Value Meaning
[Blank] For cases diagnosed prior to 2008, leave this file blank
–or–

Cancer diagnosis based initially on conclusive terminology
[01-12] Month of conclusive diagnosis (January – December)
00 Accessioned based on Ambiguous terminology diagnosis only (Code 1 in data item Ambiguous terminology diagnosis)
88 Not applicable, initial diagnosis made by conclusive diagnosis within 60 days of original diagnosis (Code 0 in data item Ambiguous terminology diagnosis)
99 Month unknown for conclusive diagnosis made after Ambiguous terminology diagnosis
DD (T54)
Value Meaning
[Blank] For cases diagnosed prior to 2008, leave this file blank
–or–

Cancer diagnosis based initially on conclusive terminology
[01-31] Day of diagnosis
00 Accessioned based on ambiguous terminology diagnosis only (Code 1 in data item Ambiguous terminology diagnosis)
88 Not applicable, initial diagnosis made by conclusive diagnosis within 60 days of original diagnosis (Code 0 in data item Ambiguous terminology diagnosis)
99 Day unknown for conclusive diagnosis made after Ambiguous terminology diagnosis

Related edits: TVAL54, TCOR1, TCOR26, TCOR29, TCOR30.

Revision (T54)
Year Description
2008 New variable must be reported

T55– Type of multiple tumours reported as one primary

Acronym: TMULTTUMONEPRIM

Description: This data item is used to identify the type of multiple tumours in cases with multiple tumours that are abstracted and reported as a single primary using the SEER multiple primary rules.

Multiple tumours may individually exhibit in situ, invasive, or a combination of in situ and invasive behaviours.

Multiple intracranial and central nervous system tumours may individually exhibit benign, borderline, or a combination of these behaviours.

Multiple tumours found in the same organ or in a single primary site may occur at the time of initial diagnosis or later.

Refer to the SEER Multiple Primary and Histology Coding Rules Manual (page 342-343) for more details on definitions, time frames and examples.

Effective: Reference year 2008 and onwards.

Related edits: TVAL55, TCOR1, TCOR31, TCOR32, TCOR33, TCOR34, TCOR35

Revision (T55)
Year Description
2008 New variable must be reported
Specific values & meaning (T55)
Value Meaning
[Blank] For cases diagnosed prior to 2008, leave this file blank
–or–

Variable not used
00 Single tumour
10 Multiple benign (intracranial and CNS sites only)
11 Multiple borderline
12 Benign (intracranial and CNS sites only) and borderline
20 Multiple in situ
30 In situ and invasive
31 Polyp and adenocarcinoma
32 Familial Adenomatous Polyposis (FAP) with carcinoma
40 Multiple invasive or
Two or more invasive tumours plus one or more in situ tumours
80 Unknown in situ or invasive
88 Not Applicable for this site
99 Unknown

T56– Date of multiple tumours

Acronym: TDATMULT

Description: This data item is used to identify the year, month and day the patient is diagnosed with multiple tumours reported as a single primary. Use the SEER multiple primary rules for that specific site to determine whether the tumours are a single primary or multiple primaries.

Refer to the SEER Multiple Primary and Histology Coding Rules Manual (page 341) for more details on definitions, time frames and examples.

Effective: Reference year 2008 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Specific values & meaning
YYYY (T56)
Value Meaning
[Blank] For cases diagnosed prior to 2008, leave this file blank
–or–

Variable not used
[2008-xxxx] Year of Date of multiple tumours (2008 to current reference year)
0000 Single tumour
8888 Information on multiple tumours not applicable for this site
9999 Year of Date of multiple tumours is unknown
MM (T56)
Value Meaning
[Blank] For cases diagnosed prior to 2008, leave this file blank
–or–

Variable not used
[01-12] Month of Date of multiple tumours (January – December)
00 Single tumour
88 Information on multiple tumours not applicable for this site
99 Month of Date of multiple tumours is unknown
DD (T56)
Value Meaning
[Blank] For cases diagnosed prior to 2008, leave this file blank
–or–

Variable not used
[01-31] Day of Date of multiple tumours
00 Single tumour
88 Information on multiple tumours not applicable for this site
99 Day of Date of multiple tumours is unknown

Related edits: TVAL56, TCOR1, TCOR33, TCOR34, TCOR35

Revision (T56)
Year Description
2008 New variable must be reported

T57– Multiplicity counter

Acronym: TMULTCOUNT

Description: This data item is used to count the number of tumours (multiplicity) that are reported as a single primary, when present at the time of diagnosis. Do not count metastatic tumours.

Refer to the SEER Multiple Primary and Histology Coding Rules Manual (page 339-340) for more details on definitions, time frames and examples.

Once a case has documented multiple tumours in the Multiplicity Counter, do not update the counter. Do not continue to add subsequent lesions.

Example:

  • 2 tumours at diagnosis; enter 02
  • If a third tumour is diagnosed later which is considered part of the same primary, do not update Multiplicity Counter to 03

Examples of when to use code "88":

  • Essential Thrombocythemia (ICD-O-3 Histology of 9962/3)
  • All lymphomas, leukemias and immunoproliferative (ICD-O-3 Histology 9590-9989)
  • Multiple myeloma (ICD-O-3 Histology 9732)
  • Myelodysplastic syndromes (ICD-O-3 Histology 9980-9989)
  • EXCEPT ICD-O-3 Histology 9731, 9734, 9740, 9750, 9755, 9756, 9757, 9758, 9930

Effective: Reference year 2008 and onwards.

Length: 2

Refer to coding manual for detailed coding instructions.

Specific values & meaning (T57)
Value Meaning
[Blank] For cases diagnosed prior to 2008, leave this file blank
–or–

Information on multiple tumours not collected
01-87 Number of tumours present
88 Information on multiple tumours not applicable to this site (see examples above)
99 Multiple tumours present, unknown how many; unknown if single or multiple tumours

Related edits: TVAL57, TCOR1, TCOR33, TCOR34, TCOR35

Revision (T57)
Year Description
2008 New variable must be reported

2.4 Derived tumour variables

The derived tumour variables are variables related to the tumour and copied/derived/calculated by the CCR system through various processes such as data loading, record linkage and death clearance. Table 13 lists all the derived tumour variables; the following pages describe these variables in more detail.

For convenience, variables are presented in order by variable number. The reader can easily find the page corresponding to any variable by looking for the variable number in the title. For example, age at diagnosis is described on page TD3 – Age at diagnosis.

Table 13 List of the derived tumour variables
Variable N° Variable Acronym
TD1 Processing date – Tumour record TDCCRDATPROC
TD2 Sequence number TDCCRSEQNUM
TD3 Age at diagnosis TDCCRAGEDIAG
TD4 Age group at diagnosis TDCCRAGEGRP
TD5 Survival interval TDDCSURVINT
TD6 Survival censor TDDCCENSOR
TD7 Derived AJCC T TDCSAJCCT
TD8 Derived AJCC N TDCSAJCCN
TD9 Derived AJCC M TDCSAJCCM
TD10 Derived AJCC T descriptor TDCSAJCCTDESC
TD11 Derived AJCC N descriptor TDCSAJCCNDESC
TD12 Derived AJCC M descriptor TDCSAJCCMDESC
TD13 Derived AJCC stage group TDCSAJCCSG
TD14 Derived AJCC flag TDCSAJCCF
TD15 Derived SS1977 TDCSSS1977
TD16 Derived SS1977 flag TDCSSS1977F
TD17 Derived SS2000 TDCSSS2000
TD18 Derived SS2000 flag TDCSSS2000F
TD19 CS version latest TDCSLVER
TD20 Filler Not applicable

TD1 – Processing date – tumour record

Acronym: TDCCRDATPROC

Description: The date any action was last taken on the tumour record by Statistics Canada.

Effective: Reference year 1992 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Used by (TD1)
Process Read Write
Data Loading – posting No Yes*
Internal Record Linkage No Yes*
Death Clearance No Yes*
Tabulation Master File Yes No

* See corresponding section for calculation details.

Specific values & meaning
YYYY (TD1)
Value Meaning
[0000-9999] Year of the last action
MM (TD1)
Value Meaning
[01-12] Month of the last action (January – December)
DD (TD1)
Value Meaning
[01-31] Day of the last action
Revision (TD1)
Year Description
2004 Acronym changed: Formerly known as TDATPROC

TD2 – Sequence number

Acronym: TDCCRSEQNUM

Description: A chronologic sequence number of multiple primaries for this patient since 1992.

This number does not represent an absolute sequence order of multiple primaries for this patient, as it does not consider any primary cancers that may have been diagnosed for this patient prior to 1992.

Note: The sequence number may change depending on the Multiple primary rules used (CCR or IARC). As of 2007 the CCR has adopted SEER rules.

Effective: Reference year 1992 and onwards.

Length: 2

Used by (TD2)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD2)
Value Meaning
[01-99] Sequence number
** Sequence number higher than 99
Revision (TD2)
Year Description
2004 Acronym changed: Formerly known as TSEQNUM

TD3 – Age at diagnosis

Acronym: TDCCRAGEDIAG

Description: The patient's age in years at the time of diagnosis of the tumour.

Effective: Reference year 1992 and onwards.

Length: 3

Format: NNN (fixed-Length, zero-left-padded)

Used by (TD3)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD3)
Value Meaning
[000-998] Age
999 Age unknown (assigned when Date of birth is unknown)
Revision (TD3)
Year Description
2004 Acronym changed: Formerly known as AGEDIAG

TD4 – Age group at diagnosis

Acronym: TDCCRAGEGRP

Description: A code that represents the range of years in which the Age at diagnosis falls.

Effective: Reference year 1992 and onwards.

Length: 2

Used by (TD4)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

*See corresponding section for calculation details.

Specific values & meaning (TD4)
Value Meaning
1 <1
2 1 to 4
3 5 to 9
4 10 to 14
5 15 to 19
6 20 to 24
7 25 to 29
8 30 to 34
9 35 to 39
10 40 to 44
11 45 to 49
12 50 to 54
13 55 to 59
14 60 to 64
15 65 to 69
16 70 to 74
17 75 to 79
18 80 to 84
19 85 to 998
20 999 (Age unknown)
Revision (TD4)
Year Description
2004 Acronym changed: Formerly known as AGEGRP

TD5 – Survival interval

Acronym: TDDCSURVINT

Description: The number of days between the Date of diagnosis and the first of the following events: Death clearance cut off date or Date of death.

Effective: Reference year 1992 and onwards.

Length: 5

Used by (TD5)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD5)
Value Meaning
[0-99997] Number of days.
99998 Survival interval cannot be computed: Death Certificate Only (DCO) records, corresponding patient record never underwent Death clearance process or Date of diagnosis is after the Death clearance cut-off date.
99999 Survival interval cannot be computed: Corresponding patient Date of death is unknown.
Revision (TD5)
Year Description
2007 Specific values & meaning: The survival interval for DCO cases cannot be computed and is subsequently recorded as '99998'. Text revised for clarification.
2004 Acronym changed: Formerly known as SURVINT.

TD6 – Survival censor

Acronym: TDDCCENSOR

Description: A code indicating whether the Survival interval was computed using the Date of death or the Death clearance cut-off date.

Effective: Reference year 1992 and onwards.

Length: 1

Used by (TD6)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD6)
Value Meaning
0 Survival interval was not computed.
1 Survival interval was computed using Date of death.
2 Survival interval was computed using Death clearance cut-off date.
Revision (TD6)
Year Description
2004 Acronym changed: Formerly known as CENSOR.

TD7 – Derived AJCC T

Acronym: TDCSAJCCT

Description: A code that represents the AJCC 'T' component that is derived from CS coded fields using the CS algorithm. Derived AJCC T can be used to evaluate disease spread at diagnosis, plan and track treatment patterns, and analyze outcomes.

Effective: Reference year 2004 and onwards.

Length: 2

Used by (TD7)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD7)
Value Display string*
99 TX
00 T0
01 Ta
05 Tis
06 Tispu
07 Tispd
10 T1
11 T1mic
12 T1a
13 T1a1
14 T1a2
15 T1b
16 T1b1
17 T1b2
18 T1c
19 T1NOS
20 T2
29 T2NOS
21 T2a
22 T2b
23 T2c
30 T3
39 T3NOS
31 T3a
32 T3b
33 T3c
40 T4
49 T4NOS
41 T4a
42 T4b
43 T4c
44 T4d
88 Not applicable
Blank CS algorithm was not run

* The meaning of the Display strings is explained for each site in the AJCC Cancer staging manual, sixth edition.

Revision (TD7)
Year Description
Not applicable Not applicable

TD8 – Derived AJCC N

Acronym: TDCSAJCCN

Description: A code that represents the AJCC 'N' component that is derived from CS coded fields using the CS algorithm. Derived AJCC N can be used to evaluate disease spread at diagnosis, plan and track treatment patterns, and analyze outcomes.

Effective: Reference year 2004 and onwards.

Length: 2

Used by (TD8)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD8)
Value Display string*
99 NX
00 N0
09 N0NOS
01 N0(i-)
02 N0(i+)
03 N0(mol-)
04 N0(mol+)
10 N1
19 N1NOS
11 N1a
12 N1b
13 N1c
18 N1mi
20 N2
29 N2NOS
21 N2a
22 N2b
23 N2c
30 N3
39 N3NOS
31 N3a
32 N3b
33 N3c
88 Not applicable
Blank CS algorithm was not run

* The meaning of the Display strings is explained for each site in the AJCC Cancer staging manual, sixth edition.

Revision (TD8)
Year Description
Not applicable Not applicable

TD9 – Derived AJCC M

Acronym: TDCSAJCCM

Description: A code that represents the AJCC 'M' component that is derived from CS coded fields using the CS algorithm. Derived AJCC M can be used to evaluate disease spread at diagnosis, plan and track treatment patterns, and analyze outcomes.

Effective: Reference year 2004 and onwards.

Length: 2

Used by (TD9)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD9)
Value Display String*
99 MX
00 M0
10 M1
11 M1a
12 M1b
13 M1c
19 M1NOS
88 Not applicable
Blank CS algorithm was not run

* The meaning of the Display strings is explained for each site in the AJCC Cancer staging manual, sixth edition.

Revision (TD9)
Year Description
Not applicable Not applicable

TD10 – Derived AJCC T descriptor

Acronym: TDCSAJCCTDESC

Description: A code that represents the AJCC 'T descriptor' component that is derived from CS coded fields using the CS algorithm. Derived AJCC T descriptor can be used in analysis to differentiate the timing of staging with respect to the treatment process.

Effective: Reference year 2004 and onwards.

Length: 1

Used by (TD10)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD10)
Value Meaning
c Clinical stage
p Pathologic stage
a Autopsy stage
y Cases in which staging classification is performed during or following initial multimodality therapy. Surgical resection performed after pre-surgical systemic treatment or radiation; tumour size/extension based on pathologic evidence.
N Not applicable
Blank CS algorithm was not run
Revision (TD10)
Year Description
Not applicable Not applicable

TD11 – Derived AJCC N descriptor

Acronym: TDCSAJCCNDESC

Description: A code that represents the AJCC 'N descriptor' component that is derived from CS coded fields using the CS algorithm. Derived AJCC N descriptor can be used in analysis to differentiate the timing of staging with respect to the treatment process.

Effective: Reference year 2004 and onwards.

Length: 1

Used by (TD11)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD11)
Value Meaning
c Clinical stage
p Pathologic stage
a Autopsy stage
y Cases in which staging classification is performed during or following initial multimodality therapy. Lymph nodes removed for examination after pre-surgical systemic treatment or radiation and lymph node evaluation based on pathologic evidence.
N Not applicable
Blank CS algorithm was not run
Revision (TD11)
Year Description
Not applicable Not applicable

TD12 – Derived AJCC M descriptor

Acronym: TDCSAJCCMDESC

Description: A code that represents the AJCC 'M descriptor' component that is derived from coded fields using the CS algorithm. Derived AJCC M descriptor is used in analysis to differentiate the timing of staging with respect to the treatment process.

Effective: Reference year 2004 and onwards.

Length: 1

Used by (TD12)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD12)
Value Meaning
c Clinical stage
p Pathologic stage
a Autopsy stage
y Cases in which staging classification is performed during or following initial multimodality therapy. Pathologic examination of metastatic tissue performed after pre-surgical systemic treatment or radiation and extension based on pathologic evidence.
N Not applicable
Blank CS algorithm was not run
Revision (TD12)
Year Description
Not applicable Not applicable

TD13 – Derived AJCC stage group

Acronym: TDCSAJCCSG

Description: A code that represents the AJCC 'stage group' component that is derived from CS coded fields using the CS algorithm. Derived AJCC stage group can be used to evaluate disease spread at diagnosis, plan and track treatment patterns, and analyze outcomes.

Effective: Reference year 2004 and onwards.

Length: 2

Used by (TD13)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD13)
Value Display string*
00 0
01 0a
02 0is
10 I
11 INOS
12 IA
13 IA1
14 IA2
15 IB
16 IB1
17 IB2
18 IC
19 IS
23 ISA
24 ISB
20 IEA
21 IEB
22 IE
30 II
31 IINOS
32 IIA
33 IIB
34 IIC
35 IIEA
36 IIEB
37 IIE
38 IISA
39 IISB
40 IIS
41 IIESA
42 IIESB
43 IIES
50 III
51 IIINOS
52 IIIA
53 IIIB
54 IIIC
55 IIIEA
56 IIIEB
57 IIIE
58 IIISA
59 IIISB
60 IIIS
61 IIIESA
62 IIIESB
63 IIIES
70 IV
71 IVNOS
72 IVA
73 IVB
74 IVC
88 Not applicable
90 OCCULT
99 UNK
Blank CS algorithm was not run

* The meaning of the Display strings is explained for each site in the AJCC Cancer staging manual, sixth edition.

Revision (TD13)
Year Description
Not applicable Not applicable

TD14 – Derived AJCC flag

Acronym: TDCSAJCCF

Description: A code that indicates whether AJCC stage group was coded directly or derived from collaborative staging.

Effective: Reference year 2004 and onwards.

Length: 1

Used by (TD14)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD14)
Value Meaning
1 AJCC 6th edition derived from Collaborative Staging Manual and Coding Instructions, version 01.04.01
2 Not valid for CCR
Blank CS algorithm was not run
Revision (TD14)
Year Description
Not applicable Not applicable

TD15 – Derived SS1977

Acronym: TDCSSS1977

Description: A code that represents the SEER Summary Stage 1977 component (anatomic extent of disease at diagnosis for cases diagnosed prior to January 1st, 2001) that is derived from CS coded fields using the CS algorithm.

Effective: Reference year 2004 and onwards.

Length: 1

Used by (TD15)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD15)
Value Meaning
0 IS (In Situ)
1 L (Localized)
2 RE (Regional, direct extension)
3 RN (Regional, lymph nodes only)
4 RE+RN (Regional, extension and nodes)
5 RNOS (Regional, NOS)
7 D (Distant)
8 NA (Not applicable)
9 U (Unknown/Unstaged)
Blank CSalgorithm was not run
Revision (TD15)
Year Description
Not applicable Not applicable

TD16 – Derived SS1977 flag

Acronym: TDCSSS1977F

Description: A code that indicates whether Derived SS1977 was derived from collaborative staging.

Effective: Reference year 2004 and onwards.

Length: 1

Used by (TD16)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD16)
Value Meaning
1 SS1977 derived from Collaborative Staging Manual and Coding Instructions, version 01.04.01.
2 Not valid for CCR.
Blank CS algorithm was not run.
Revision (TD16)
Year Description
Not applicable Not applicable

TD17 – Derived SS2000

Acronym: TDCSSS2000

Description: A code that represents the SEER Summary Stage 2000 component (anatomic extent of disease at diagnosis for cases diagnosed on or after January 1st, 2001) that is derived from CS coded fields using the CS algorithm.

Effective: Reference year 2004 and onwards.

Length: 1

Used by (TD17)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD17)
Value Meaning
0 IS (In Situ)
1 L (Localized)
2 RE (Regional, direct extension)
3 RN (Regional, lymph nodes only)
4 RE+RN (Regional, extension and nodes)
5 RNOS (Regional, NOS)
7 D (Distant)
8 NA (Not applicable)
9 U (Unknown/Unstaged)
Blank CS algorithm was not run
Revision (TD17)
Year Description
Not applicable Not applicable

TD18 – Derived SS2000 flag

Acronym: TDCSSS2000F

Description: A code that indicates whether Derived SS2000 was derived from collaborative staging.

Effective: Reference year 2004 and onwards.

Length: 1

Used by (TD18)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD18)
Value Meaning
1 SS2000 derived from Collaborative Staging Manual and Coding Instructions, version 01.04.01.
2 Not valid for CCR.
Blank CS algorithm was not run.
Revision (TD18)
Year Description
Not applicable Not applicable

TD19 – CS version latest

Acronym: TDCSLVER

Description: The version of the collaborative staging used most recently to derive the CS output fields at the CCR. This data item is recorded the first time the CS output fields are derived and should be updated each time the CS derived items are re-computed. The CS version number is returned as part of the output of the CS algorithm. The returned value from the program should be automatically stored as CS Version Latest. This item should not be updated manually.

Effective: Reference year 2004 and onwards.

Length: 6

Used by (TD19)
Process Read Write
Data loading – posting No No
Internal record linkage No No
Death clearance No No
Tabulation master file Yes Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD19)
Value Meaning
[000000-999999] Version number
Blank CS algorithm was not run or field not implemented
Revision (TD19)
Year Description
2007 CS version latest (Formerly known as TD20 – CS version latest) replaces TD19.
Name: Formerly known as TD19 – CS Version 1st
Description: Data concerning CS version 1st is now collected as a tumour input variable as T52 – CS Version 1st.

TD20 –Filler

Acronym: Not applicable

Description: Filler: free space reserved for future requirement implementation.

This field will not be processed or returned by the CCR System.

Effective: Reference year 2006 and onwards.

Length: 6

Used by: Not applicable

Specific values & meaning: Not applicable

Revision (TD20)
Year Description
2007 Name: Formerly known as TD20 – CS version latest.
Description: Field now converted to filler. Data concerning CS version latest is now derived as TD19 – CS version latest.

Canadian Cancer Registry System Guide – 2009 Edition

Part III – Core Reference Tables Appendix

Introduction
0.1 Canadian Cancer Registry Overview
0.2 CCR System Guide: Document Organization
0.3 Part III Document organization: Core Reference Tables
0.4 Changes to the Core Reference Tables for the 2007 and 2008 reference years
0.5 Statistics Canada Contacts

Appendix A – Core Reference Tables
Eligible province/territory or country codes prior to 1996
Eligible province/territory or country codes in 1996 and after
Eligible ICD-9 Cancer codes
Eligible ICD-O-2 & 3 Topography codes
Eligible ICD-O-2 Histology codes
Eligible ICD-O-3 Histology codes
Eligible ICD-9 Underlying Cause of Death Codes (UCOD)
Eligible ICD-10 Underlying Cause of Death Codes (UCOD) from 2000 to 2002
Eligible ICD-10 Underlying Cause of Death Codes (UCOD) in 2003 and after
Eligible Standard Geographic Classification (SGC) Codes from 1992 to 1995
Eligible Standard Geographic Classification (SGC) Codes from 1996 to 2000
Eligible Standard Geographic Classification (SGC) Codes from 2001 to 2005
Eligible Standard Geographic Classification (SGC) Codes from 2006 to 2010
Eligible Census Tracts from 1992 to 1995
Eligible Census Tracts from 1996 to 2000
Eligible Census Tracts from 2001 to 2005
CCR core Scope
ICD-9 to ICD-O-2/3 topography conversion table
ICD-O-2 to ICD-O-3 conversion table
Invalid Site and Histology combinations
Invalid Histology and Behaviour combinations
Valid Site and Laterality combinations
Equivalent Topographies for overlapping and unspecified sites
Equivalent Histologies
Eligible CS Version 1st

Introduction

  • Canadian Cancer Registry overview
  • CCR System Guide: Overall Document Organization
  • Part III document organization: Core Reference Tables
  • Changes to the Core Reference Tables Appendix for the 2007 and 2008 reference years
  • Contacts in Statistics Canada

0.1 Canadian Cancer Registry Overview

The patient–oriented Canadian Cancer Registry (CCR) evolved from the event–oriented National Cancer Incidence Reporting System (NCIRS). Beginning with cases diagnosed in 1992, incidence figures collected by Provincial and Territorial Cancer Registries (PTCRs) have been reported to the CCR, which is maintained by Statistics Canada. Established as a person–oriented database, the CCR includes mechanisms for updating and clearing death records and is linked to provincial and territorial databases to help track patients across Canada who have been diagnosed with tumours.

0.2 CCR System Guide: Document Organization

The CCR System Guide has been separated into three parts to improve access and navigation. Although the three parts are separate, the three documents should be used in conjunction with each other. The different sections of the three–part CCR System Guide often refer to each other. The CCR System Guide is now composed of:

Part I: CCR Data Dictionary provides explanation on the reporting of data, including the scope and detailed information on the input and derived variables.

Part II: CCR Data Loading and Tabulation Master Files provides information on the data loading process, including in–depth descriptions of the various edits performed on the data. Part II also provides information on the Tabulation Master Files, including the scope, content and layout. Part II is followed by several appendices that contain supporting information such as explicit code set tables, guidelines to assist coders and other supportive information.

Part III: CCR Core Reference Tables provides detailed information on the CCR Core Reference Tables such as descriptions of the tables, their usage and any revisions made. Part III is an accompanying document to the CCR Reference Tables 2009.xls.

0.3 Part III Document Organization: Core Reference Tables

Appendix A – Core reference Tables – Describes in detail all CCR Core Reference Tables. An Excel spreadsheet is also included with supporting documentation about the tables.

0.4 Changes to the Core Reference Tables for the 2007 and 2008 reference years

Changes to the Core Reference Tables for the 2007 and 2008 reference years
Item (s) Description of change Effective (reference year)
Core reference tables New core reference table - Invalid Site, Histology and Behaviour Combinations. 2008
Core reference tables Eligible Standard Geographic Classification (SGC) Codes from 2006 to 2010. 2006
CCR core scope Updates to exception in topographies, and additions in topographies. 2007
Invalid Site and Histology combinations Content added: Year of diagnosis (lower and upper bound) specified further.
Combinations added : combinations of site and histology considered invalid following NAACCR guidelines.
Combinations updated: combinations of site and histology updated following NAACCR guidelines.
2007
Invalid histology and behaviour combinations Content added: Year of diagnosis (lower and upper bound) specified further.
Addition of codes – addition of histology/behaviour combinations.
2007
Valid Site and Laterality combinations Laterality codes new CCR meaning (see T19 in Data Dictionary).
Laterality codes removed.
Laterality codes added.
Laterality codes changed.
Content added:
Added notes column to provide additional information on corresponding site and laterality combination.
2007
Equivalent Histologies Combinations updated – Highest histology (lower bound) adjusted.
Content added: Year of diagnosis (lower and upper bound) specified further
2007
Eligible CS Version 1st New table added. 2007
  • Additional updates have been made, however only the changes that require action on the part of the PTCRs have been included in this table.
  • Note that changes effective in the 2006 vreference year have also been included here.

0.5 Statistics Canada Contacts

PTCRs employees are encouraged to bring forward any questions by contacting one of the following:

For additional information regarding the processing of CCR data, please contact:
Colette Brassard
Section Chief
Operations and Integration Division
Statistics Canada
Tel: (613) 951-7282
Fax: (613) 951-0709
For any subject matter related questions/queries, please contact:
Kim Boyuk
Chief, Cancer Statistics
Health Statistics Division
Statistics Canada
Tel: (613) 951-2510
Fax: (613) 951-0792

Hollie Anderson
Manager, Canadian Cancer Registry
Health Statistics Division
Statistics Canada
Tel: (613) 951-0757
Fax: (613) 951-0792

Appendix A

Core reference tables

This section describes all core reference tables, namely:

  • Eligible province/territory or country codes prior to 1996;
  • Eligible province/territory or country codes in 1996 and after;
  • Eligible ICD-9 Cancer codes;
  • Eligible ICD-O-2 & 3 Topography codes;
  • Eligible ICD-O-2 Histology codes;
  • Eligible ICD-O-3 Histology codes;
  • Eligible ICD-9 Underlying Cause of Death Codes (UCOD);
  • Eligible ICD-10 Underlying Cause of Death Codes (UCOD) from 2000 to 2002;
  • Eligible ICD-10 Underlying Cause of Death Codes (UCOD) in 2003 and after;
  • Eligible Standard Geographic Classification (SGC) Codes from 1992 to 1995;
  • Eligible Standard Geographic Classification (SGC) Codes from 1996 to 2000;
  • Eligible Standard Geographic Classification (SGC) Codes from 2001 to 2005;
  • Eligible Standard Geographic Classification (SGC) Codes from 2006 to 2010;
  • Eligible Census Tracts from 1992 to 1995;
  • Eligible Census Tracts from 1996 to 2000;
  • Eligible Census Tracts from 2001 to 2005;
  • CCR core Scope;
  • ICD-9 to ICD-O-2/3 topography conversion table;
  • ICD-O-2 to ICD-O-3 conversion table;
  • Invalid Site and Histology combinations;
  • Invalid Histology and Behaviour combinations;
  • Valid Site and Laterality combinations;
  • Equivalent Topographies for overlapping and unspecified sites;
  • Equivalent Histologies;
  • Eligible CS Version 1st

These tables can be found in the spreadsheet named CCR reference tables 2009.xls.

Eligible province/territory or country codes prior to 1996

Content

This code set contains:

  • All valid country codes before 1996 based on ISO 3166-11 standard.
  • 14 codes in range [900 to 998] added by Statistics Canada and representing different Canadian provinces and territories.

Location

The official code set can be found in the document CCR reference tables 2009.xls under the tab country codes prior to 1996.

Code descriptions found in this document are given for indication purpose only. Please refer to the official ISO publication for exact code description.

Used by

Edit process: PVAL12 and PVAL15.

Revision
(Eligible province/territory or country codes prior to 1996)
Year Description
2004 Addition of codes:
On October 28, 2004, the director of the NWT Cancer Registry authorized the transfer of ownership of the 1992-1998 cancer patients on the Canadian Cancer Registry database whose addresses fall within the current geographic boundaries to the Nunavut Territories. In order to implement this change, Statistics Canada special code for Nunavut (962) has been added to the Eligible province/territory or country codes prior to 1996.

Eligible province/territory or country codes in 1996 and after

Content

This code set contains:

  • All valid country codes after 1996 based on ISO 3166-11.
  • 14 codes in range [900 to 998] added by Statistics Canada and representing different Canadian Provinces and Territories.
  • 2 codes in range [900 to 998] added by Statistics Canada and representing Former USSR (970) and Former Czechoslovakia (971).
  • 1 code added by Statistics Canada and representing the new ISO code for Ethiopia (231) as of 1997.

Location

The official code set can be found in the document CCR reference tables 2009.xls under the tab country codes in 1996 and after.

Code descriptions found in this document are given for indication purpose only. Please refer to the official ISO publication for exact code description.

Used by

Edit process: PVAL12 and PVAL15.

Revision
(Eligible province/territory or country codes in 1996 and after)
Year Description
1999 Addition of codes:
962 (Statistics Canada special code for Nunavut) has been added to reflect the creation of Nunavut territory.
1997 Addition of codes:
231 (ISO-1997 code for Ethiopia) has been added to reflect changes in ISO Country codes in 1997.
970 (Statistics Canada special code for Former USSR) and 971 (Statistics Canada special code for Former Czechoslovakia) have been added to comply with some Provincial Vital Statistics Offices.

Eligible ICD-9 Cancer codes

Content

This code set contains:

  • ICD-9 codes for malignant neoplasm (140 to 208);
  • ICD-9 codes for benign neoplasm of brain and other parts of nervous system (225);
  • ICD-9 codes for carcinoma in situ (230 to 234);
  • ICD-9 codes for neoplasm of uncertain behaviour (235 to 238);
  • ICD-9 codes for neoplasm of unspecified nature (239).
  • ICD-9 codes for disease that were not associated to neoplasm in ICD-9 but are now associated to neoplasm in more recent classifications such as ICD-O-2:
    • 2731: ICD-O-2 morphology 9765/1.
    • 2732: ICD-O-2 morphology 9763/3.
    • 2733: ICD-O-2 morphology 9761/3.
    • 2849: ICD-O-2 morphology 9980/1.
    • 2850: ICD-O-2 morphology 9982/1.
    • 2898: ICD-O-2 morphology 9932/3.
  • 1 CCR System specific code (0000) to maintain referential integrity.

Note: Although most codes are 4 digits long, some codes are 3 digits long (for example ICD-9 175 Malignant neoplasm of male breast).

Location

The official code set can be found in the document CCR reference tables 2009.xls under the tab ICD-9 Cancer codes.

Code descriptions are given for indication purpose only. Please refer to the official ICD-9 publication for exact code description.

Used by

Edit process: TVAL13.

Revision
(Eligible ICD-9 Cancer codes)
Year Description
2004 Deletion of code:
1759: Non-ICD-9 code for 'Malignant neoplasm of male breast'. This code has been introduced to CCR in 1992 by ICD-O-2 to ICD-9 conversion program. Corresponding tumours have been recoded to ICD-9 code '175'.

Eligible ICD-O-2 & 3 Topography codes

Content

This code set contains:

All ICD-O-2/3 topography codes (C00 to C80) including corrections from applicable errata.

Location

The official code set can be found in the document CCR reference tables 2009.xls under the tab ICD-O-2-3 Topography codes.

Code descriptions are given for indication purpose only. Please refer to the official ICD-O-3 publication for exact code description.

Used by

Edit process: TVAL15.

Revision
(Eligible ICD-O-2 & 3 Topography codes)
Year Description
2004 Deletion of codes:
  • 0000: CCR specific code for 'Not applicable (topography reported in Field T13, or Field T18)'. This code has been removed since ICD-O-2/3 Topography is required for all reported tumours (explicitly reported by PTCR or converted from previous classifications).
  • C141: Not an existing ICD-O-2/3 Topography code. 1995 errata approved by the WHO removing C14.1 laryngopharynx and including the term under C13.9. Production tables did not contain any reference to this code. Thus, recoding is not needed.

Eligible ICD-O-2 Histology codes

Content

This code set contains:

  • All ICD-O-2 histology codes (8000 to 9989) including corrections from applicable errata;
  • 12 North America specific codes (8148, 9688, 9708, 9710, 9715 to 9717, 9828, 9871 to 9874);
  • 1 CCR System specific code (0000) to maintain referential integrity.

Location

The official code set can be found in the document CCR reference tables 2009.xls under the tab ICD-O-2 histology codes.

Code descriptions are given for indication purpose only. Please refer to the official ICD-O-2 publication for exact code description.

Used by

Edit process: TVAL16.

Revision
(Eligible ICD-O-2 Histology codes)
Year Description
2004 Addition of code:
0000: 'Not reported (Histology reported in field T21)'. CCR Specific code added to maintain referential integrity.
1998 Addition of codes:
9828, 9871, 9872, 9873 and 9874: New codes used in North America only.
1997 Addition of codes:
9688, 9708, 9710, 9715, 9716 and 9717: New codes used in North America only.
1996 Addition of codes:
8148: New code used in North America only.

Eligible ICD-O-3 Histology codes

Content

This code set contains:

All ICD-O-3 Histology codes (8000 to 9989) including corrections from applicable errata.

Location

The official code set can be found in the document CCR reference tables 2009.xls under the tab ICD-O-3 histology codes.

Code descriptions are given for indication purpose only. Please refer to the official ICD-O-3 publication for exact code description.

Used by

Edit process: TVAL21.

Revision
(Eligible ICD-O-3 Histology codes)
Year Description
Not applicable Not applicable

Eligible ICD-9 Underlying Cause of Death Codes (UCOD)

Content

This code set contains:

  • All ICD-9 underlying cause of death codes except 7680 and 7681.
  • 2 CCR specific codes:
    • 0000: Patient not known to have died.
    • 0009: Unknown cause of death.

Note: Although most of the codes are 4 digits long, some are 3 digits long.

Location

The official code set can be found in the document CCR reference tables 2009.xls under the tab ICD-9 UCOD.

Code descriptions are given for indication purpose only. Please refer to the official ICD-9 publication for exact code description.

Used by

Edit process: PVAL17.

Revision
(Eligible ICD-9 Underlying Cause of Death Codes (UCOD))
Year Description
Not applicable Not applicable

Eligible ICD-10 Underlying Cause of Death Codes (UCOD) from 2000 to 2002

Content

This code set contains:

  • All ICD-10 underlying cause of death codes (version 2000).
  • 2 CCR specific codes:
    • 0000: Patient not known to have died.
    • 0009: Unknown cause of death.

Note: Although most of the codes are 4 characters long, some are 3 characters long.

Location

The official code set can be found in the document CCR reference tables 2009.xls under the tab ICD-10 UCOD from 2000 to 2002.

Code descriptions are given for indication purpose only. Please refer to the official ICD-10 publication for exact code description.

Used by

Edit process: PVAL17.

Revision
(Eligible ICD-10 Underlying Cause of Death Codes (UCOD) from 2000 to 2002)
Year Description
Not applicable Not applicable

Eligible ICD-10 Underlying Cause of Death Codes (UCOD) in 2003 and after

Content

This code set contains:

  • All ICD-10 underlying cause of death codes (version 2003).
  • 2 CCR specific codes:
    • 0000: Patient not known to have died.
    • 0009: Unknown cause of death.

Note: Although most of the codes are 4 characters long, some are 3 characters long.

Location

The official code set can be found in the document CCR reference tables 2009.xls under the tab ICD-10 UCOD in 2003 and after.

Code descriptions are given for indication purpose only. Please refer to the official ICD-10 publication for exact code description.

Used by

Edit process: PVAL17.

Revision
(Eligible ICD-10 Underlying Cause of Death Codes (UCOD) in 2003 and after)
Year Description
Not applicable Not applicable

Eligible Standard Geographic Classification (SGC) Codes from 1992 to 1995

Content

This code set contains:

  • All Census Sub-Division Unique Identifiers (CSDuid) from Standard Geographic Classification Codes – Version 1991. CSDuid use the format [PR][CD][CSD] where [PR] is a two-digit province/territory code, [CD] is a two-digit Census Division code and [CSD] is a three-digit Census Sub-Division code.
  • CCR Specific codes:
    • [PR][CD]999" where [PR] is a two-digit province/territory code and [CD] is a two-digit Census Division code. These codes represent an unknown CSD within a given province/territory and Census Division. There are as many codes as there are valid combinations of [PR] and [CD].
    • For example: "3501999" represents "Ontario – Census Division #1 – Unknown CSD".
    • "[PR]00999" where [PR] is a two-digit province/territory code. These codes represent an unknown CD and CSD within a given province/territory. There are as many codes as there are valid [PR] codes (13).
    • For example: "3500999" represents "Ontario – Unknown CD and CSD".

Location

The official code set can be found in the document CCR reference tables 2009.xls under the tab SGC codes from 1992 to 1995.

Code descriptions are given for indication purpose only. Please refer to the official Standard Geographic Classification – 1991 for exact code description.

Used by

Edit process: TVAL8.

Revision
(Eligible Standard Geographic Classification (SGC) Codes from 1992 to 1995)
Year Description
2004 Alteration of codes:
On October 28, 2004, the director of the NWT Cancer Registry authorized the transfer of ownership of the 1992-1998 cancer patients on the Canadian Cancer Registry database whose address fall within the current geographic boundaries to the Nunavut Territories. In order to implement this change, CD and CSD belonging to NWT but physically within the actual Nunavut boundaries have been migrated from NWT (61) to Nunavut (62). Thus, SGC codes starting with 6104, 6105 and 6108 (excluding 6208095- Holman) have been respectively updated to 6204, 6205 and 6208. Holman becomes 6107095.

Eligible Standard Geographic Classification (SGC) Codes from 1996 to 2000

Content

This code set contains:

  • All Census Sub-Division Unique Identifiers (CSDuid) from Standard Geographic Classification Codes – Version 1996. CSDuid use the format [PR][CD][CSD] where [PR] is a two-digit province/territory code, [CD] is a two-digit Census Division code and [CSD] is a three-digit Census Sub-Division code.
  • CCR Specific codes:
    • "[PR][CD]999" where [PR] is a two-digit province/territory code and [CD] is a two-digit Census Division code. These codes represent an unknown CSD within a given province/territory and Census Division. There are as many codes as there are valid combinations of [PR] and [CD].
    • For example: "3501999" represents "Ontario – Census Division #1 – Unknown CSD".
    • "[PR]00999" where [PR] is a two-digit province/territory code. These codes represent an unknown CD and CSD within a given province/territory. There are as many codes as there are valid [PR] codes (13).
    • For example: "3500999" represents "Ontario – Unknown CD and CSD".

Location

The official code set can be found in the document CCR reference tables 2009.xls under the tab SGC codes from 1996 to 2000.

Code descriptions are given for indication purpose only. Please refer to the official Standard geographic classification – 1996 for exact code description.

Used by

Edit process: TVAL8.

Revision
(Eligible Standard Geographic Classification (SGC) Codes from 1996 to 2000)
Year Description
2004 Alteration of codes:
On October 28, 2004, the director of the NWT Cancer Registry authorized the transfer of ownership of the 1992-1998 cancer patients on the Canadian Cancer Registry database whose address fall within the current geographic boundaries to the Nunavut Territories. In order to implement this change, duplicate CD and CSD related to NWT and Nunavut have been deleted: SGC codes starting with 6104, 6105 and 6108 (excluding 6208095– Holman which becomes 6107095).
1999 Addition of codes:
Due to Nunavut creation, new SGC codes have been added based on existing NWT SGC codes that fall within the geographic boundaries of the Nunavut Territories. SGC codes starting with 6204, 6205 and 6208 have been created based on their corresponding NWT SGC codes (SGC codes starting with 6104, 6105 and 6108 - excluding 6208095– Holman which becomes 6107095). Since corresponding SGC for NWT are still valid from 1996-1999, SGC codes starting with 6104, 6105 and 6108 have not been deleted.

Eligible Standard Geographic Classification (SGC) Codes from 2001 to 2005

Content

This code set contains:

  • All Census Sub-Division Unique Identifiers (CSDuid) from Standard Geographic Classification Codes – Version 2001. CSDuid use the format [PR][CD][CSD] where [PR] is a two-digit province/territory code, [CD] is a two-digit Census Division code and [CSD] is a three-digit Census Sub-Division code.
  • CCR Specific codes:
    • "[PR][CD]999" where [PR] is a two-digit province/territory code and [CD] is a two-digit Census Division code. These codes represent an unknown CSD within a given province/territory and Census Division. There are as many codes as there are valid combinations of [PR] and [CD].
    • For example: "3501999" represents "Ontario – Census Division #1 – Unknown CSD".
    • [PR]00999" where [PR] is a two-digit province/territory code. These codes represent an unknown CD and CSD within a given province/territory. There are as many codes as there are valid [PR] codes (13).
    • For example: "3500999" represents "Ontario – Unknown CD and CSD".

Location

The official code set can be found in the document CCR reference tables 2009.xls under the tab SGC codes from 2001 to 2005.

Code descriptions are given for indication purpose only. Please refer the to official Standard Geographic Classification – 2001 for exact code description.

Used by

Edit process: TVAL8.

Revision
(Eligible Standard Geographic Classification (SGC) Codes from 2001 to 2005)
Year Description
Not applicable Not applicable

Eligible Standard Geographic Classification (SGC) Codes from 2006 to 2010

Content

This code set contains:

  • All Census Sub-Division Unique Identifiers (CSDuid) from Standard Geographic Classification Codes – Version 2006. CSDuid is composed of [PR][CD][CSD] where [PR] is a two-digit province/territory code, [CD] is a two-digit Census Division code and [CSD] is a three-digit Census Sub-Division code.
  • CCR Specific codes:
    • "[PR][CD]999" where [PR] is a two-digit province/territory code and [CD] is a two-digit Census Division code. These codes represent an unknown CSD within a given province/territory and Census Division. There are as many codes as there are valid combinations of [PR] and [CD].
    • For example: "3501999" represents "Ontario – Census Division #1 – Unknown CSD".
    • "[PR]00999" where [PR] is a two-digit province/territory code. These codes represent an unknown CD and CSD within a given province/territory. There are as many codes as there are valid [PR] codes (13).
    • For example: "3500999" represents "Ontario – Unknown CD and CSD".

Location

The official code set can be found in the document CCR Reference Tables 2009.xls under the tab SGC codes from 2006 to 2010.

Code descriptions are given for indication purpose only. Please refer to the official Standard Geographic Classification – 2006 for exact code description.

Used by

Edit process: TVAL8.

Revision
(Eligible Standard Geographic Classification (SGC) Codes from 2006 to 2010)
Year Description
2006 New table

Eligible Census Tracts from 1992 to 1995

Content

This code set contains:
All Census Sub-Division Unique Identifiers (CSDuid) with their associated Census Tract Unique Identifiers (CTuid) from the Geographic Attribute File – 1991.

  • [CSDuid] is composed of [PR][CD][CSD] where [PR] is a two-digit province/territory code, [CD] is a two-digit Census Division code and [CSD] is a three-digit Census Sub-Division code.
  • [CTuid] is composed of [CMA][CTname] where [CMA] is a three-digit code for Census Metropolitan Area and [CTname] is the last six digits of the seven-digit Census Tract Name. The first digit, which is always zero, is dropped.

For implementation reasons, [CSDuid] not associated to any [CTuid] are associated with a CCR Specific [CTuid] of '000000.00' which represents a location outside of a Census Metropolitain Area.

CCR Specific codes:

  • [CTuid] = [CMA]999.99 where [CMA] is a three-digit code for Census Metropolitain Areas that have at least one Census Tract Name different than '0000.00'. These codes represent an unknown [CTname] with a given [CMA].
  • [CTuid] = '999999.99' represents an unknown [CMA] and [CTname].

For implementation reasons, all of the above codes are associated with a CCR specific [CSDuid] code of '0000000'. This [CSDuid] code has no meaning.

Location

The official code set can be found in the document CCR reference tables 2009.xls under the tab census tracts from 1992 to 1995.

Used by

Edit process: TVAL9 and TCOR3.

Revision
(Eligible Census Tracts from 1992 to 1995)
Year Description
Not applicable Not applicable

Eligible Census Tracts from 1996 to 2000

Content

This code set contains:
All Census Sub-Division Unique Identifiers (CSDuid) with their associated Census Tract Unique Identifiers (CTuid) from the Geographic Attribute File – 1996.

  • [CSDuid] is composed of [PR][CD][CSD] where [PR] is a two-digit province/territory code, [CD] is a two-digit Census Division code and [CSD] is a three-digit Census Sub-Division code.
  • [CTuid] is composed of [CMA][CTname] where [CMA] is a three-digit code for Census Metropolitan Area and [CTname] is the last six digits of the seven-digit Census Tract Name. The first digit, which is always zero, is dropped.

For implementation reasons, [CSDuid] not associated to any [CTuid] are associated with a CCR Specific [CTuid] of '000000.00' which represents a location outside of a Census Metropolitain Area.

CCR Specific codes:

  • [CTuid] = [CMA]999.99 where [CMA] is a three-digit code for Census Metropolitain Areas that have at least one Census Tract Name different than '0000.00'. These codes represent an unknown [CTname] with a given [CMA].
  • [CTuid] = '999999.99' represents an unknown [CMA] and [CTname].

For implementation reasons, all of the above codes are associated with a CCR specific [CSDuid] code of '0000000'. This [CSDuid] code has no meaning.

Location

The official code set can be found in the document CCR reference tables 2009.xls under the tab Census tracts from 1996 to 2000.

Used by

Edit process: TVAL9 and TCOR3.

Revision
(Eligible Census Tracts from 1996 to 2000)
Year Description
Not applicable Not applicable

Eligible Census Tracts from 2001 to 2005

Content

This code set contains:
All Census Sub-Division Unique Identifiers (CSDuid) with their associated Census Tract Unique Identifiers (CTuid) from the Geographic Attribute File – 2001.

  • [CSDuid] is composed of [PR][CD][CSD] where [PR] is a two-digit province/territory code, [CD] is a two-digit Census Division code and [CSD] is a three-digit Census Sub-Division code.
  • [CTuid] is composed of [CMA][CTname] where [CMA] is a three-digit code for Census Metropolitan Area and [CTname] is the last six digits of the seven-digit Census Tract Name. The first digit, which is always zero, is dropped.

For implementation reasons, [CSDuid] not associated to any [CTuid] are associated with a CCR Specific [CTuid] of '000000.00' which represents a location outside of a Census Metropolitain Area.

CCR Specific codes:

  • [CTuid] = [CMA]999.99 where [CMA] is a three-digit code for Census Metropolitain Areas that have at least one Census Tract Name different than '0000.00'. These codes represent an unknown [CTname] with a given [CMA].
  • [CTuid] = '999999.99' represents an unknown [CMA] and [CTname].

For implementation reasons, all of the above codes are associated with a CCR specific [CSDuid] code of '0000000'. This [CSDuid] code has no meaning.

Location

The official code set can be found in the document CCR reference tables 2009.xls under the tab census tracts from 2001 to 2005.

Used by

Edit process: TVAL9 and TCOR3.

Revision
(Eligible Census Tracts from 2001 to 2005)
Year Description
Not applicable Not applicable

CCR core scope

Description
This table contains the necessary information to assess whether a tumour is included within the CCR core scope or not. Since the scope of the CCR may change based on the date of diagnosis, a date range qualifies each topography, histology and behaviour combination. See Section 1.1.2.1 CCR core scope for more details.

Content

  • Year of diagnosis (Lower and Upper bound): Specifies the time frame where the ICD-O-2/3 topography, ICD-O-3 histology and ICD-O-3 behaviour combination is valid.
  • ICD-O-3 behaviour: Species the ICD-O-3 behaviour code accepted.
  • ICD-O-2/3 topography (Lower and Upper bound): Specifies the range of ICD-O-2/3 topography codes accepted.
  • ICD-O-3 histology (Lower and Upper bound): Specifies the range of ICD-O-3 histology codes accepted.

Usage

Tumour where the reported ICD-O-2/3 Topography, ICD-O-3 histology/behaviour and the year of date of diagnosis combination cannot be found within the corresponding ranges in the table is considered to be outside the CCR core scope.

Limitations

This table should not be used to validate ICD-O-2/3 topography nor the ICD-O-3 histology codes since corresponding ranges include invalid values.

Location

The table can be found in the document CCR reference tables 2009.xls under the tab CCR Core Scope.

Used by

Edit process: TCOR9.

Revision
(CCR core scope)
Year Description
2007 Update: Exclusion of topographies C53._ (cervix) and C61.9 (prostate) for all histologies, for ICD-O-3 behaviour code 2 in situ/intraepithelial/non-invasive.

Addition of pituitary, craniopharyngeal duct and pineal gland (topographies C75.1, C75.2, C75.3) with behaviour codes of 0.
2004 New table

ICD-9 to ICD-O-2 conversion table

Description
This table has been created by Statistics Canada in cooperation with the Ontario cancer treatment and research foundation and the Fichier des Tumeurs du Québec. It has been designed to convert an ICD-9 Cancer code to ICD-O-2/3 topography and morphology and assess the coherence between:

  • Reported ICD-9 Cancer code and ICD-O-2/3 topography values;
  • Reported ICD-9 Cancer code and ICD-O-2 histology values;
  • Reported ICD-9 Cancer code and ICD-O-2 behaviour values.

For both cases (conversion and coherence checking), strong limitations are applicable. See 'Limitations' below.

The ICD-9 to ICD-O-2 conversion is similar to the ICD-O-1 to ICD-O-2 conversion. The ICD-9 block of codes for primary malignant neoplasms is similar to the ICD-O-1 site codes and can be transformed into ICD-O-2 site codes. However, in this conversion, the ICD-9 non-malignant tumour codes are also converted. This conversion also provides a morphology code (which is more specific than the general "8000" code) for 104 of the 450 ICD-9 codes listed (Ex. ICD-9 code 200.0 converts to ICD-O-2/3 topography of C77.9 and ICD-O-2 Histology of 9593 and ICD-O-2 Behaviour of 3).

Content

This table contains converted ICD-O-2/3 topography, ICD-O-2 histology and behaviour for every CCR eligible ICD-9 cancer code.

This table contains the following fields:

  • ICD9: CCR eligible ICD-9 cancer code.
  • ICDO2/3T: Converted ICD-O-2/3 topography code.
  • ICDO2H:Converted ICD-O-2 histology code.
  • ICDO2B:Converted ICD-O-2 behaviour code.

Usage

  • Conversion from ICD-9 Cancer code to ICD-O-2/3 topography: ICD-O-2/3 topography is set to corresponding ICDO2/3T where reported ICD-9 Cancer code matches ICD9.
  • Edit between reported ICD-9 Cancer code and ICD-O-2/3 topography: reported ICD-O-2/3 topography must be equal to corresponding ICDO2/3T where reported ICD-9 Cancer code matches ICD9.
  • Edit between reported ICD-9 Cancer code and ICD-O-2 histology: If reported ICD-O-2 histology code equals "8000" and corresponding ICD-O-2 histology (based on reported ICD-9 cancer code) does not equal to "8000", a warning indicating that "A more specific histology code could have been provided based on reported ICD-9 cancer code." must be sent. If reported ICD-O-2 histology does not equal "8000", nothing further can be done.
  • Edit between reported ICD-9 Cancer code and ICD-O-2 behaviour: reported ICD-O-2 behaviour must be equal to corresponding ICD-O-2 behaviour where reported ICD-9 Cancer code matches ICD9.

Limitations

  • Table usage: this table has been created specifically for processing CCR data. It is not intended for other applications.
  • Converting non-malignant ICD-9 site codes: severe limitations exist in converting non-malignant ICD-9 site codes (225 and 230-239) to ICD-O-2 site codes due to broad site groupings which exist in ICD-9. Example: Single code 239.0, represents the entire digestive system. The comparable sites in ICD-O-2 are represented by 123 four-digit codes. For such cases, arbitrary equivalencies have been incorporated into the conversion. (This is the "Garbage In, Garbage Out" phenomenon - no detail is lost in the conversion process as there was no detail provided in the original code!)
  • Converted ICD-O-2 histology: In general, histological information is not represented in ICD-9 codes and, therefore, cannot always be transformed into precise ICD-O-2 histology codes. In addition, for codes that identify the histology of the tumour as well as the site, the histology code obtained through conversion will not be as specific as if directly coded with the ICD-O-2. Example: ICD-9 code 172._ represents "Malignant melanomas of the skin". It is therefore possible to convert code 172._ to the ICD-O-2 topography code for skin, which is C44._, and the ICD-O-2 histology code for "Melanoma, not otherwise specified", which is 8720. It should be noted that the histology code obtained through conversion is not as specific as if directly coded with the ICD-O-2 where a range of histology codes, 8720 to 8790, is available for different varieties of melanomas. This conversion provides a histology code (which is more specific than the general "8000" code) for only 104 of the 450 ICD-9 codes listed.
  • Extranodal lymphomas: It should be noted that all lymphomas, nodal and extranodal, are grouped together in the ICD-9 category of "Malignant neoplasms of lymphatic and haematopoietic tissue". It is not possible to identify extranodal lymphomas once they have been coded in ICD-9, therefore such information will not be available from converted data. This situation could result in differences in statistical tabulations. For example, lymphomas of stomach may be counted as lymphomas in ICD-9-based tabulations, as malignancies of stomach in ICD-O-2 site-based tabulations, or in the absence of explanatory notes to the contrary, they may be thought to be included with malignancies of stomach in converted ICD-O-2 site-based tabulations.

Location

The table can be found in the document CCR reference tables 2009.xls under the tab Conversion ICD-9 to ICD-O-2.

Used by

  • Pre-Edit process: ICD-O-2/3 topography calculation.
  • Edit process: TCOR6.
Revision
(ICD-9 to ICD-O-2 conversion table)
Year Description
2004 Update:
ICD-9 Cancer Code '232.8' is now associated to ICD-O-2/3 Topography code 'C44.8' instead of 'C44.9' (typo in old conversion table).
Addition:
ICD-9 Cancer Codes '2731', '2732', '2733', '2849', '2850' and '2898' have been added since the corresponding diseases are now considered to be related to neoplasm.

ICD-O-2 to ICD-O-3 conversion table

Description
This table is based on the "Conversion Of Neoplasms By Topography And Morphology From The International Classification Of Diseases For Oncology, Second Edition To International Classification Of Diseases For Oncology, Third Edition" (14/06/2001) produced by the Surveillance, Epidemiology and End Results Program (SEER) from National Cancer Institute (NCI). In some cases, SEER conversion has been modified to meet Canadian specific requirements. The exceptions are documented in the table.

Content

This table contains converted ICD-O-3 histology and ICD-O-3 behaviour for every unique CCR eligible ICD-O-2 histology and behaviour combination. It also contains duplicate ICD-O-2 histology/behaviour entries when conversion depends on ICD-O-2/3 topography.

For coherence checking between reported ICD-O-2 and ICD-O-3 values (when applicable), this table also contains alternative conversion options.

This table contains the following fields:

  • ICDO2H: CCR eligible ICD-O-2 histology code.
  • ICDO2B: CCR eligible ICD-O-2 behaviour code.
  • ICDO2T (Lower and Upper bound): Range of ICD-O-2/3 topography codes for which the conversion is to be used.
  • ICDO3H: Converted ICD-O-3 histology code.
  • ICDO3B: Converted ICD-O-3 behaviour code.
  • Review Flag: An indicator that indicated that the conversion must be hand reviewed. Possible values are:
    '0': No reviewed required.
    '1': Review required.
    '2': Review optional (for optimal coding).
  • Conversion flag: When multiple conversions are possible, this indicator tells which entry must be used for conversion purpose. Possible values are:
    '0': Alternative conversion.
    '1': Primary conversion.
  • CCR specific flag: An indicator that indicates that the conversion has been changed from SEER to meet Canadian specific requirements. Possible values are:
    '0': Compliant with SEER: ICD-O-3 histology/behaviour and review flag not changed.
    '1': Altered from SEER: ICD-O-3 histology/behaviour and/or review flag changed.

Usage

  • Conversion: Converted ICD-O-3 histology/behaviour are found in the table where reported ICD-O-2 histology matches ICDO2H, reported ICD-O-2 behaviour matches ICDO2B, reported ICD-O-2/3 topography is between ICDO2T_LB and ICDO2T_UB inclusively and conversion flag = 1. If review flag = 1, then a warning requesting for manual review of the conversion must be sent to the reporting jurisdiction.
  • Edit: Acceptable ICD-O-3 histology/behaviour values are found in the table where reported ICD-O-2 histology matches ICDO2H, reported ICD-O-2 behaviour matches ICDO2B, reported ICD-O-2/3 topography is between ICDO2T_LB and ICDO2T_UB inclusively. Other combinations are invalid. Conversion flag and review flag are ignored.

Limitations

  • This table should only be used for conversion from ICD-O-2 to ICD-O-3 (not the other way around) and coherence edits between ICD-O-2 and ICD-O-3 values.
  • This table must not be used to assess coherence among ICD-O-2 values nor ICD-O-3 values since it contains many possible histology and behaviour combinations from a subject-matter point of view.

Location

The table can be found in the document CCR reference tables 2009.xls under the tab conversion ICD-O-2 to ICD-O-3.

Used by

  • Pre-Edit process: ICD-O-3 histology and behaviour calculation.
  • Edit process: TCOR7.
Revision
(ICD-O-2 to ICD-O-3 conversion table)
Year Description
2004 Update
Table has been reconstructed based on SEER specification as of 14/06/2001.
CCR exceptions have been documented.
Addition
Table now incorporates conversion alternatives.

Invalid Site and Histology combinations

Description
This table contains invalid ICD-O-2/3 topography (site) and ICD-O-3 histology codes combinations.

Content

  • Site description: English description of the site.
  • ICD-O-2/3 topography (Lower and Upper bound): Specifies the range of ICD-O-2/3 topography codes.
  • ICD-O-3 histology (Lower and Upper bound): Specifies the range of ICD-O-3 histology codes.
  • Year of diagnosis (Lower and Upper bound): Specifies the time frame for which the corresponding site and histology combinations are invalid.
  • Histology description: English description of the histology.

Usage

Tumours where the ICD-O-2/3 topography and ICD-O-3 histology combination is found within the corresponding ranges are invalid. Others are valid.

Limitations

This table should not be used to validate ICD-O-2/3 topography nor the ICD-O-3 histology codes since corresponding ranges include invalid values.

Location

The table can be found in the document CCR reference tables 2009.xls under the tab invalid site and histology.

Used by

Edit process: TCOR10.

Revision
(Invalid Site and Histology combinations)
Year Description
2007

Content added:
Year of diagnosis (Lower and Upper Bound) is specified to indicate the time frame for when the corresponding site and histology combinations are invalid.

Combinations added:
Following the guidelines from NAACCR, these combinations of site and histology are considered invalid.

Peripheral nerves (ICD-O-2/3: C470-C479) – Melanomas (ICD-O-3: 8720-8790)
Connective tissue (ICD-O-2/3: C490-C499) – Melanomas (ICD-O-3: 8720-8790)
Brain (ICD-O-2/3: C710-C719) – Carcinomas (ICD-O-3: 8010-8671)
Brain (ICD-O-2/3: C710-C719) – Carcinomas (ICD-O-3: 8940-8941)
Other central nervous system (ICD-O-2/3: C720-C729) – Carcinomas (ICD-O-3: 8010-8671)
Other central nervous system (ICD-O-2/3: C720-C729) – Carcinomas (ICD-O-3: 8940-8941)
Ill-defined sites (ICD-O-2/3: C760-C768) – Melanomas (ICD-O-3: 8720-8790)
Ill-defined sites (ICD-O-2/3: C760-C768) – Sarcomas, except periosteal fibrosarcoma (ICD-O-3: 8800-8811)
Ill-defined sites (ICD-O-2/3: C760-C768) – Sarcomas, except periosteal fibrosarcoma (ICD-O-3: 8813-8830)
Ill-defined sites (ICD-O-2/3: C760-C768) – Sarcomas, except periosteal fibrosarcoma (ICD-O-3: 8840-8921)
Ill-defined sites (ICD-O-2/3: C760-C768) – Sarcomas, except periosteal fibrosarcoma (ICD-O-3: 9040-9044)
Ill-defined sites (ICD-O-2/3: C760-C768) – Dermatofibrosarcoma (ICD-O-3: 8990-8991)
Ill-defined sites (ICD-O-2/3: C760-C768) – Mesenchymoma (ICD-O-3: 8940-8941)
Ill-defined sites (ICD-O-2/3: C760-C768) – Mixed tumour, salivary gland type (ICD-O-3: 9120-9170)
Ill-defined sites (ICD-O-2/3: C760-C768) – Blood vessel tumour, Mesenchymal chondrosarcoma, and giant cell tumours (ICD-O-3: 9240-9252)
Ill-defined sites (ICD-O-2/3: C760-C768) – Nerve sheath tumour (ICD-O-3: 9540-9560)
Ill-defined sites (ICD-O-2/3: C760-C768) – Granular cell tumour and alveolar soft part sarcoma (ICD-O-3: 9580-9582)
Unknown Primary site (ICD-O-2/3: C809) – Melanomas (ICD-O-3: 8720-8790)

Combinations updated:
Following the guidelines from NAACCR, these combinations of site and histology have been updated.

Bone (ICD-O-2/3: C400-C419) – Carcinomas (except squamous cell) (ICD-O-3: 8010-8060)
Bone (ICD-O-2/3: C400-C419) – Carcinomas (except squamous cell) (ICD-O-3: 8075-8671)
Bone (ICD-O-2/3: C400-C419) – Carcinomas (except squamous cell) (ICD-O-3: 8940-8941)
Peripheral nerves (ICD-O-2/3: C470-C479) – Carcinomas (ICD-O-3: 8940-8941)
Meninges (ICD-O-2/3: C700-C709) – Carcinomas (ICD-O-3: 8940-8941)

2004

Combination removed:
Following the guidelines from NAACCR (NAACCR Record layout 10E version), these combinations of site and histology are no longer considered impossible anymore, therefore they should be accepted as valid for the CCR.

Lip (ICD-O-2/3: C000-C009) – Basal cell carcinoma (ICD-O-3: 8090-8098)
Rectosigmoid junction (ICD-O-2/3: C199) – Basal cell carcinoma (ICD-O-3: 8090-8098)
Rectum (ICD-O-2/3: C209) – Basal cell carcinoma (ICD-O-3: 8090-8098)
Anus and anal canal (ICD-O-2/3: C210-C218) – Basal cell carcinoma (ICD-O-3: 8090-8098)
Pleura and mediastinum (ICD-O-2/3: C381-C388) – Neuroendocrine carcinoma (ICD-O-3: 8246)

Invalid Histology and Behaviour combinations

Description
This table contains invalid ICD-O-3 histology and ICD-O-3 behaviour code combinations for every eligible ICD-O-3 histology code. For ease of reading, this table has not been normalized (ICD-O-3 behaviour column contains comma separated lists of invalid behaviour codes).

Contents

  • Histology description: English description of the ICD-O-3 histology codes range.
  • ICD-O-3 histology: ICD-O-3 histology code.
  • ICD-O-3 behaviour list: Comma separated list of all invalid ICD-O-3 behaviour codes for the corresponding ICD-O-3 histology. An empty list means that all ICD-O-3 behaviour codes are acceptable.
  • Year of diagnosis (Lower and Upper Bound): Time frame for which the corresponding histology and behaviour combinations are invalid.
  • Comments: Provides additional information on the corresponding histology and behaviour combination.

Usage

Tumours where the ICD-O-3 histology and ICD-O-3 behaviour codes combination is found within the table are invalid. Others are valid.

Location

The table can be found in the document CCR reference tables 2009.xls under the tab Invalid histology and behaviour.

Used by

Edit process: TCOR11.

Revision
(Invalid Histology and Behaviour combinations)
Year Description
2007 Addition of codes:
CCR synchronized with NAACCR Meta-files:
Neoplasm (8000/2)
Tumour cells (8001/2)
Malignant tumour, small cell type (8002/2)
Malignant tumour, giant cell type (8003/2)
Malignant tumour, spindle cell type (8004/2)
Clear cell tumour (8005/2)
Squamous intraepithelial neoplasia, grade III (8077/3)
Serous cystadenoma, borderline malignancy (C56.9) (8442/0,2,3)
Papillary cystadenoma, borderline malignancy (C56.9) (8451/0,2,3)
Serous papillary cystic tumour of borderline malignancy (C56.9) (8462/0,2,3)
Mucinous cystic tumour of borderline malignancy (C56.9) (8472/0,2,3)
Papillary mucinous cystadenoma, borderline malignancy (C56.9) (8473/0,2,3)
Pilocytic astrocytoma (C71._) (9421/0,1,2)
2004

Addition of codes:
The following Histology/Behaviour combinations were missing from previous version: 8842/2 and 8921/2.
The following Histology/Behaviour combinations have been added to keep CCR synchronized with NAACCR Meta-files (revision 2005): Mesothelial neoplasms (905) with in situ behaviour (2).

Valid Site and Laterality combinations

Description
This table contains valid ICD-O-2/3 topography site and laterality codes combinations for every eligible ICD-O-2/3 topography code. Since valid site and laterality combinations may change based on the date of diagnosis, a date range qualifies each combination. For ease of reading, this table has not been normalized (Laterality column contains comma separated lists of valid laterality codes).

Content

  • Site description: English description of the ICD-O-2/3 topography code.
  • ICD-O-2/3 topography: ICD-O-3 code representing the site.
  • Laterality list: Comma separated list of all valid laterality codes for the corresponding ICD-O-2/3 topography.
  • Year of diagnosis (Lower and Upper bound): Timeframe for which the corresponding site and laterality combination are valid.
  • Notes: Provides additional information for the ICD-O-2/3 topography such as exceptions to the laterality codes.

Usage

Tumours where the ICD-O-2/3 topography and laterality codes combination is found in the table for the appropriate year of diagnosis range are valid. Others are invalid.

Location

The table can be found in the document CCR reference tables 2009.xls under the tab valid site and laterality.

Used by

Edit process: TCOR12.

Revision
(Valid Site and Laterality combinations)
Year Description
2007

Laterality codes have a new CCR meaning. See T19 in the Data dictionary for additional information.

Laterality codes removed:
Laterality codes have been removed from several sites (ICD-O-2/3: C129, C313, C318, C319, C398, C408, C409, C418, C444, C448, C449, C638, C688, C715, C716, C718, C719, C728, C739, C764, C765, C809). Laterality code '0' is the only eligible code for these sites.

Laterality codes added:
Laterality codes '1', '2', '3', '4', and '9' have been added to several sites (ICD-O-2/3: C300, C340, C413, C414, and C570). Note that several exclusions are indicated for these sites. These exclusions should be coded to '0'.

Laterality code '3' has been added to several sites (ICD-O-2/3: C70.0, C71.0-C71.4, and C72.2-C72.5).

Laterality codes changed:
Laterality codes have changed in several sites (ICD-O-2/3: C07.9, C08.0, C08.1, C09.0, C09.1, C09.8, C09.9, C30.1, C31.0, C31.2, C34.1, C34.2*, C34.3, C34.8, C34.9, C38.4, C40.0, C40.1, C40.2, C40.3, C44.1, C44.2, C44.3, C44.5, C44.6, C44.7, C47.1, C47.2, C49.1, C49.2, C50.0, C50.1, C50.2, C50.3, C50.4, C50.5, C50.6, C50.8, C50.9, C56.9, C62.0, C62.1, C62.9, C63.0, C63.1, C64.9, C65.9, C66.9, C69.0, C69.1, C69.2, C69.3, C69.4, C69.5, C69.6, C69.8, C69.9, C71.0, C71.1, C71.2, C71.3, C71.4, C74.0, C74.1, C74.9). Most of the changes are due to the addition of code '3' and code '4'.

Content added:
A Notes column has been added to provide additional information on the corresponding site and laterality combination.

2004

Table structure: A time range has been added to support changes to valid site and laterality combination based on the Date of Diagnosis. (for example: ovary before and after 1999)

Laterality codes removed:

  • Laterality code '3' has been removed from the table since its an invalid CCRLaterality code.
  • Laterality codes '1', '2' and '4' have been removed for Unknown primary site (ICD-O-2/3: C80.9) since the laterality cannot be known if the site is not known in the first place.
  • Laterality code '4' has been removed for Overlapping lesion of urinary organs (ICD-O-2/3: C68.8) (Typographic error in the former table.).

Laterality codes added:
Laterality codes '1', '2', '4', and '9' have been added for five Central Nervous System sites (ICD-O-2/3: C70,0, C72.2-C72.5). Laterality codes '3' and '4' have also been added to other sites (ICD-O-2/3: C71.0-C71.4)

Equivalent topographies for overlapping and unspecified sites

Description
This table contains equivalent ICD-O-2/3 topography codes for overlapping and unspecified sites.

Content

  • Highest topography: ICD-O-2/3 topography code of the tumour having the highest ICD-O-2/3 topography code numerically. (For example: C728 > C700)
  • Lowest Topography (Lower and Upper bound): ICD-O-2/3 topography code range of the tumour having the lowest ICD-O-2/3 topography code numerically. (for example: C388 < C398)

Usage

  • Two tumours are considered to have mutually equivalent topographies if the higher ICD-O-2/3 topography code (numerically) is found in the highest topography column and the lower ICD-O-2/3 topography code (numerically) is found within the corresponding lowest topography code range columns.
  • If both ICD-O-2/3 topography codes are identical, tumours have indeed equivalent topographies and thus there is no need to use this table.
  • If the higher ICD-O-2/3 topography code cannot be found in highest topography column, then the corresponding topography has no equivalent topography other than itself.

Limitations

This table should not be used to validate ICD-O-2/3 topography since corresponding range includes invalid values.

Location

The table can be found in the document CCR reference tables 2009.xls under the tab equivalent topographies.

Used by

Edit process: DIM6.

Revision
(Equivalent topographies for overlapping and unspecified sites)
Year Description
2004 Table has been updated to better reflect table usage notes. No subject matter related impact.

Equivalent Histologies

Description
This table contains equivalent ICD-O-3 histology codes. This table is used for assessing multiple primary tumours for the CCR Tabulation Master File (TMF).

Content

  • Lowest histology (Lower and Upper bound): ICD-O-3 histology code of the tumour having the lowest ICD-O-3 histology code numerically. (for example: 8000 < 8010)
  • Highest histology (Lower and Upper bound): ICD-O-3 histology code of the tumour having the highest ICD-O-3 histology code numerically. (for example: 8046 > 8040)
  • Year of diagnosis (Lower and Upper bound): Time frame for which the corresponding equivalent histologies are valid.

Usage

  • Two tumours are considered to have mutually equivalent histologies if the lower ICD-O-3 Histology code (numerically) is found within the lowest histology code range column and the higher ICD-O-3 histology code (numerically) is found within the corresponding highest histology code range column.
  • If the two ICD-O-3 histology codes are identical, tumours have indeed equivalent histologies and thus there is no need to use this table.
  • If the lower ICD-O-3 histology code cannot be found within the lowest histology code range, then the corresponding histology has no equivalent histology other than itself.

Limitations

This table should not be used to validate ICD-O-3 Histology since corresponding ranges include invalid values.

Location

The table can be found in the document CCR reference tables 2009.xls under the tab equivalent histologies.

Used by

Edit process: DIM6.

Revision(Equivalent Histologies)
Year Description
2007 Combinations updated
Highest histology (lower bound) was adjusted for two equivalent histology code ranges. Change is highlighted in yellow within the table.
Content added:
Year of diagnosis (Lower and Upper Bound) is specified to indicate the time frame for when the corresponding equivalent histologies are valid.
2004 Table has been updated to better reflect table usage notes. No subject matter related impact.

Eligible CS Version 1st

Description
This table contains eligible version numbers that can be used to code Collaborative staging fields.

Content

  • CS version number: a list of acceptable version numbers used when coding Collaborative Staging (CS) fields
  • English Description: provides a description of the corresponding code in English
  • French Description: provides a description of the corresponding code in French

Usage

  • The version number used must be contained within this list. If the version number provided is not contained within this list, it is considered as an invalid version number.

Location

The table can be found in the document CCR reference tables 2009.xls under the tab CS version 1st.

Used by

Edit process: TVAL52.

Revision
(Eligible CS Version 1st)
Year Description
2007 New table

Note:

1International Standard ISO 3166-1, Codes for the representation of names of countries and their subdivisions—Part 1: Country codes, ISO 3166-1: 1997 (E/F), International Organization on Standardization (Geneva, 1997).

Bimonthly Diary for September, November, January, March, May and July

Confidential when completed

If necessary, please make address label corrections in the boxes below (please print).

  • Business Name
  • Address (number and street)
  • City
  • Province / Territory
  • Postal Code

Please Read Before Completing

Collected under the authority of the Statistics Act, Revised Statutes of Canada, 1985, Chapter S19. Completion of this questionnaire is a legal requirement under this Act.

Purpose of the Survey

This survey is being conducted every second month to collect the prices of prescribed drugs. The prices you report are essential to the production of the Consumer Price Index (CPI), an important indicator of how the Canadian economy is performing. This index, used by governments, businesses and private citizens, affects interest rates, taxes, wages, pensions and many other monetary transfers.

Confidentiality

Confidential when completed

Statistics Canada is prohibited by law from releasing any information it collects which could identify any person, business, or organization, unless consent has been given by the respondent or as permitted by the Statistics Act. The confidentiality provisions of the Statistics Act are not affected by either the Access to Information Act or any other legislation. Therefore, for example, the Canada Revenue Agency cannot access identifiable survey records from Statistics Canada.

Information from this survey will be used for statistical purposes only and will be published in aggregate form only.

Inquiries

If you require assistance in completing this questionnaire or if you have any questions or comments regarding this questionnaire, please call 1-800-263-1136 or by e-mail, cpd-info-dpc@statcan.gc.ca.

A Statistics Canada representative will pick up the completed questionnaire in 48 hours.

5-4100-10: 2011-06-23

Instructions

1 Brand Name drugs

a) For each brand name drug listed below, please provide the Name, the Drug Identification Number (DIN), the total price including the dispensing fee for the quantity and strength indicated and the associated drug dispensing fee (DDF), if available.

The price provided should be on a cash payment basis (uninsured) and should be provided for the current month only.

b) For all subsequent data collection months, price the same brand name drug that was reported for the previous period.

c) If that drug is no longer available for sale, provide the information (for the same strength and quantity) for another brand name drug, within the same therapeutic class.

d) Please use the comments section on page 7 to provide reasons for changes to reported data.

1.1
STC RP# Brand Name Drug DIN Strength Quantity
         

 

Table 1.1
Month Brand Name Drug DIN Strength Quantity Price (including DDF ) DDF
Sept. 2011            
Nov. 2011            
Jan. 2012            
Mar. 2012            
May 2012            
July 2012            

 

1.2
STC RP# Brand Name Drug DIN Strength Quantity
         

 

Table 1.2
Month Brand Name Drug DIN Strength Quantity Price (including DDF ) DDF
Sept. 2011            
Nov. 2011            
Jan. 2012            
Mar. 2012            
May 2012            
July 2012            

 

1.3
STC RP# Brand Name Drug DIN Strength Quantity
         

 

Table 1.4
Month Brand Name Drug DIN Strength Quantity Price (including DDF ) DDF
Sept. 2011            
Nov. 2011            
Jan. 2012            
Mar. 2012            
May 2012            
July 2012            

 

1.4
STC RP# Brand Name Drug DIN Strength Quantity
         

 

Table 1.4
Month Brand Name Drug DIN Strength Quantity Price (including DDF ) DDF
Sept. 2011            
Nov. 2011            
Jan. 2012            
Mar. 2012            
May 2012            
July 2012            

 

1.5
STC RP# Brand Name Drug DIN Strength Quantity
         

 

Table 1.5
Month Brand Name Drug DIN Strength Quantity Price (including DDF ) DDF
Sept. 2011            
Nov. 2011            
Jan. 2012            
Mar. 2012            
May 2012            
July 2012            

 

1.6
STC RP# Brand Name Drug DIN Strength Quantity
         

 

Table 1.6
Month Brand Name Drug DIN Strength Quantity Price (including DDF ) DDF
Sept. 2011            
Nov. 2011            
Jan. 2012            
Mar. 2012            
May 2012            
July 2012            

 

1.7
STC RP# Brand Name Drug DIN Strength Quantity
         

 

Table 1.7
Month Brand Name Drug DIN Strength Quantity Price (including DDF ) DDF
Sept. 2011            
Nov. 2011            
Jan. 2012            
Mar. 2012            
May 2012            
July 2012            

 

1.8
STC RP# Brand Name Drug DIN Strength Quantity
         

 

Table 1.8
Month Brand Name Drug DIN Strength Quantity Price (including DDF ) DDF
Sept. 2011            
Nov. 2011            
Jan. 2012            
Mar. 2012            
May 2012            
July 2012            

Instructions

2 Generic drugs

a) For each active ingredient listed below, please report, based on the number of prescriptions, your best selling generic drug along with the Drug Identification Number (DIN), the total price including the dispensing fee for the quantity and strength indicated and the associated drug dispensing fee (DDF) if available.

The price should be based on a cash payment basis (uninsured) for the current month.

b) For all subsequent data collection months, price the same generic drug that was reported for the previous period.

c) If a generic drug selected in the previous period is no longer available for sale, substitute with the generic drug currently available with the same active ingredient for the same strength and quantity.

d) Please use the comments section on page 7 to provide reasons for changes to reported data.

2.1
STC RP# Active Ingredient Strength Quantity
       

 

Table 2.1
Month Generic Drug Name DIN Strength Quantity Price (including DDF ) DDF
Sept. 2011            
Nov. 2011            
Jan. 2012            
Mar. 2012            
May 2012            
July 2012            

 

2.2
STC RP# Active Ingredient Strength Quantity
       

 

Table 2.2
Month Generic Drug Name DIN Strength Quantity Price (including DDF ) DDF
Sept. 2011            
Nov. 2011            
Jan. 2012            
Mar. 2012            
May 2012            
July 2012            

 

2.3
STC RP# Active Ingredient Strength Quantity
       

 

Table 2.3
Month Generic Drug Name DIN Strength Quantity Price (including DDF ) DDF
Sept. 2011            
Nov. 2011            
Jan. 2012            
Mar. 2012            
May 2012            
July 2012            

 

2.4
STC RP# Active Ingredient Strength Quantity
       

 

Table 2.4
Month Generic Drug Name DIN Strength Quantity Price (including DDF ) DDF
Sept. 2011            
Nov. 2011            
Jan. 2012            
Mar. 2012            
May 2012            
July 2012            

 

2.5
STC RP# Active Ingredient Strength Quantity
       

 

Table 2.5
Month Generic Drug Name DIN Strength Quantity Price (including DDF ) DDF
Sept. 2011            
Nov. 2011            
Jan. 2012            
Mar. 2012            
May 2012            
July 2012            

 

Comments

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Thank you for your cooperation

Statistics Canada use only

  • RF
  • UC- Specify
  • OOB- Specify
  • CO- Specify
  • NP
  • BR- Specify
  • TC- Specify
  • UL- Specify
  • OT- Specify

 

Bimonthly Diary for October, December, February, April, June and August

Confidential when completed

If necessary, please make address label corrections in the boxes below (please print).

  • Business Name
  • Address (number and street)
  • City
  • Province / Territory
  • Postal Code

Please Read Before Completing

Collected under the authority of the Statistics Act, Revised Statutes of Canada, 1985, Chapter S19. Completion of this questionnaire is a legal requirement under this Act.

Purpose of the Survey

This survey is being conducted every second month to collect the prices of prescribed drugs. The prices you report are essential to the production of the Consumer Price Index (CPI), an important indicator of how the Canadian economy is performing. This index, used by governments, businesses and private citizens, affects interest rates, taxes, wages, pensions and many other monetary transfers.

Confidentiality

Confidential when completed

Statistics Canada is prohibited by law from releasing any information it collects which could identify any person, business, or organization, unless consent has been given by the respondent or as permitted by the Statistics Act. The confidentiality provisions of the Statistics Act are not affected by either the Access to Information Act or any other legislation. Therefore, for example, the Canada Revenue Agency cannot access identifiable survey records from Statistics Canada.

Information from this survey will be used for statistical purposes only and will be published in aggregate form only.

Inquiries

If you require assistance in completing this questionnaire or if you have any questions or comments regarding this questionnaire, please call 1-800-263-1136 or by e-mail, cpd-info-dpc@statcan.gc.ca.

A Statistics Canada representative will pick up the completed questionnaire in 48 hours.

5-4100-10: 2011-06-23

Instructions

1 Brand Name drugs

a) For each brand name drug listed below, please provide the Name, the Drug Identification Number (DIN), the total price including the dispensing fee for the quantity and strength indicated and the associated drug dispensing fee (DDF), if available.

The price provided should be on a cash payment basis (uninsured) and should be provided for the current month only.

b) For all subsequent data collection months, price the same brand name drug that was reported for the previous period.

c) If that drug is no longer available for sale, provide the information (for the same strength and quantity) for another brand name drug, within the same therapeutic class.

d) Please use the comments section on page 7 to provide reasons for changes to reported data.

1.1
STC RP# Brand Name Drug DIN Strength Quantity
         

 

Table 1.1
Month Brand Name Drug DIN Strength Quantity Price (including DDF ) DDF
Oct. 2011            
Dec. 2011            
Feb. 2012            
Apr. 2012            
June 2012            
Aug. 2012            

 

1.2
STC RP# Brand Name Drug DIN Strength Quantity
         

 

Table 1.2
Month Brand Name Drug DIN Strength Quantity Price (including DDF ) DDF
Oct. 2011            
Dec. 2011            
Feb. 2012            
Apr. 2012            
June 2012            
Aug. 2012            

 

1.3
STC RP# Brand Name Drug DIN Strength Quantity
         

 

Table 1.4
Month Brand Name Drug DIN Strength Quantity Price (including DDF ) DDF
Oct. 2011            
Dec. 2011            
Feb. 2012            
Apr. 2012            
June 2012            
Aug. 2012            

 

1.4
STC RP# Brand Name Drug DIN Strength Quantity
         

 

Table 1.4
Month Brand Name Drug DIN Strength Quantity Price (including DDF ) DDF
Oct. 2011            
Dec. 2011            
Feb. 2012            
Apr. 2012            
June 2012            
Aug. 2012            

 

1.5
STC RP# Brand Name Drug DIN Strength Quantity
         

 

Table 1.5
Month Brand Name Drug DIN Strength Quantity Price (including DDF ) DDF
Oct. 2011            
Dec. 2011            
Feb. 2012            
Apr. 2012            
June 2012            
Aug. 2012            

Instructions

2 Generic drugs

a) For each active ingredient listed below, please report, based on the number of prescriptions, your best selling generic drug along with the Drug Identification Number (DIN), the total price including the dispensing fee for the quantity and strength indicated and the associated drug dispensing fee (DDF) if available.

The price should be based on a cash payment basis (uninsured) for the current month.

b) For all subsequent data collection months, price the same generic drug that was reported for the previous period.

c) If a generic drug selected in the previous period is no longer available for sale, substitute with the generic drug currently available with the same active ingredient for the same strength and quantity.

d) Please use the comments section on page 7 to provide reasons for changes to reported data.

2.1
STC RP# Active Ingredient Strength Quantity
       

 

Table 2.1
Month Generic Drug Name DIN Strength Quantity Price (including DDF ) DDF
Oct. 2011            
Dec. 2011            
Feb. 2012            
Apr. 2012            
June 2012            
Aug. 2012            

 

2.2
STC RP# Active Ingredient Strength Quantity
       

 

Table 2.2
Month Generic Drug Name DIN Strength Quantity Price (including DDF ) DDF
Oct. 2011            
Dec. 2011            
Feb. 2012            
Apr. 2012            
June 2012            
Aug. 2012            

 

2.3
STC RP# Active Ingredient Strength Quantity
       

 

Table 2.3
Month Generic Drug Name DIN Strength Quantity Price (including DDF ) DDF
Oct. 2011            
Dec. 2011            
Feb. 2012            
Apr. 2012            
June 2012            
Aug. 2012            

 

2.4
STC RP# Active Ingredient Strength Quantity
       

 

Table 2.4
Month Generic Drug Name DIN Strength Quantity Price (including DDF ) DDF
Oct. 2011            
Dec. 2011            
Feb. 2012            
Apr. 2012            
June 2012            
Aug. 2012            

 

2.5
STC RP# Active Ingredient Strength Quantity
       

 

Table 2.5
Month Generic Drug Name DIN Strength Quantity Price (including DDF ) DDF
Oct. 2011            
Dec. 2011            
Feb. 2012            
Apr. 2012            
June 2012            
Aug. 2012            

 

2.6
STC RP# Active Ingredient Strength Quantity
       

 

Table 2.6
Month Generic Drug Name DIN Strength Quantity Price (including DDF ) DDF
Oct. 2011            
Dec. 2011            
Feb. 2012            
Apr. 2012            
June 2012            
Aug. 2012            

 

2.7
STC RP# Active Ingredient Strength Quantity
       

 

Table 2.7
Month Generic Drug Name DIN Strength Quantity Price (including DDF ) DDF
Oct. 2011            
Dec. 2011            
Feb. 2012            
Apr. 2012            
June 2012            
Aug. 2012            

Comments

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Month:
DIN number:
Comments :

Thank you for your cooperation

Statistics Canada use only

  • RF
  • UC- Specify
  • OOB- Specify
  • CO- Specify
  • NP
  • BR- Specify
  • TC- Specify
  • UL- Specify
  • OT- Specify

 

The Monthly Survey of Large Retailers

Legal Name Operating Name
The Food Retailers
Canada Safeway Limited Canada Safeway Retail Division, Canada Safeway Liquor Stores
Overwaitea Food Group Limited Overwaitea Foods Division, Overwaitea Foods Gas
Buy-Low Foods Ltd Buy Low Foods
Loblaw Companies Limited Loblaws Supermarket Division, Zehrmart Division, At the Pumps(Ontario Gas Bar stores), Supermarches/Banniere Provigo, Supermarches/Banniere Maxi, Supermarches/Banniere Maxi & CIE, Loblaws Quebec, Quebec Gas Bars, The Real Canadian Superstore, Extra Foods, Atlantic Dominions, Real Atlantic Superstore, Superstore Ontario Division, Western Gas Bars, Atlantic Gas Bars,
The Real Canadian Liquor Store Ltd Real Canadian Liquor Store
Metro Ontario Inc Metro Ontario, Food Basics, Drug Marts
Métro-Richelieu Inc Division Super C
Sobeys Group Inc TRA Maritimes, Needs Convenience Stores, Price Chopper, Sobeys, Ontario Corporate Stores, Quebec Corporate Stores, Sobeys West Corporate Stores, Sobeys Atlantic Corporate Stores, Sobeys Western Cellars, IGA, Foodland
The Great Atlantic & Pacific Company of Canada, Limited A & P Drug Mart, Food Basic$
The Department Stores (including concessions)
Hudson's Bay Company The Bay/La Baie, Fields Stores, Home Outfitters, Zellers
Sears Canada Inc Sears Canada Full Line Stores, Sears Whole Home Furniture Stores, Sears Off-Mall Dealers, Sears Clearance Centres
Wal-Mart Canada Corp. Wal-Mart Canada
The Other Non-Food Retailers
668824 Alberta Ltd Visions Electronics
American Eagle Outfitters Canada Corporation American Eagle Outfitters
Best Buy Canada Ltd Best Buy, Future Shop
Boutique Jacob Inc Boutique Jacob
Boutique Marie Claire Inc Boutique Marie Claire
Boutiques Tristan & Iseut Inc. Boutiques L'Officiel, Boutiques West Coast
Canadian Tire Corporation Limited Canadian Tire Gas Bar, Partsource, Canadian Tire Corporation
Club Monaco Corp Club Monaco
Comark Inc Bootlegger, Cleo Division,Ricki's Division
Costco Wholesale Canada Ltd Costco Canada Warehouses Stores, Costco Canada Liquor Stores
Cotton Ginny Inc. Cotton Ginny
Eddie Bauer of Canada Corporation Eddie Bauer
Fairweather Ltd Fairweather
Foot Locker Canada Corporation Champs Sports Division, Foot Locker Division
Gap (Canada) Inc Old Navy Clothing Co., Banana Republic, Gap, GapKids
Old Navy (Canada) Inc Old Navy
Grafton-Fraser Inc Grafton Fraser
Groupe Bikini Village Inc. Bikini Village, Océan Bikini Village
Groupe BMTC Inc Ameublements Tanguay, Brault et Martineau
Harry Rosen Inc Harry Rosen
Holt Renfrew & Co Ltd Holt Renfrew
Ikea Canada Limited Partnership Ikea Canada
International Clothiers Inc International Clothiers
The Source (Bell) Electronics Inc. / La Source (Bell) Electronique Inc. La Source
Pharma Plus Drugmarts Ltd. Pharma Plus Drugmarts
La Senza Corporation La Senza
Le Chateau Inc Le Chateau
Leon's Furniture Limited Leon's Furniture Retail Division
Boutique Laura Canada Ltée Laura's Shoppe Canada Ltd.
Magasin Laura (P.V.) Inc. Magasin Laura (P.V.)
Moores The Suit People Inc Moores Clothing For Men
Northern Reflections Ltd Northern Reflections
Nygard International Partnership Nygard International - Retail Division
Pantorama Industries Inc Pantorama
Reitmans (Canada) Limitée Reitmans
Roots Canada Ltd Roots Canada
Sony of Canada Ltd Sony of Canada - Retail Division
Suzy's Inc Suzy Shier
Tabi International Corporation Tabi International
Talbots Canada Corporation Talbots Canada
The Bargain! Shop Holdings Inc The Bargain! Shop
The Brick Warehouse LP The Brick - Retail Operations
The Children's Place (Canada) LP The Children's Place
Sport-Chek International 2000 LTD Sport Mart Division, National Sports, Atmosphere, Sport Chek Division, Nevada Bob's Golf, Athlete's World Retail Division, Econosport
Thrifty's Inc (2005) Bluenotes
Winners Merchants International LP Homesense, Winners
YM Inc (Sales) YM (SALES)
MARK'S WORK WEARHOUSE LTD. Mark's Work Wearhouse

 

Census Metropolitan Area Methodology1

For the reporting of crime statistics and police personnel, official Statistics Canada census metropolitan area (CMA) populations have been adjusted to follow policing boundaries. Police service boundaries often do not correspond directly with CMA boundaries, particularly in the case of rural detachments. In an effort to match as closely as possible, the following guidelines are used:

  • If more than half of a detachment's population falls within CMA boundaries, then all of that detachment's crime is included and the portion of its population falling outside the CMA is added to the official CMA population.

  • Conversely, if less than half of a detachment's population falls within CMA boundaries, then all of that detachment's crime is excluded and the portion of its population falling within the CMA is subtracted from the official CMA population.

CMA Abbotsford-Mission

  • The following areas within the CMA have been excluded: Fraser Valley H (5909064), Upper Sumas 6 (5909877).

CMA Barrie

  • The following areas outside the CMA have been included: Bradford West Gwillimbury (3543014).

  • The following areas within the CMA have been excluded: Springwater (3543009).

CMA Brantford

  • The following areas outside the CMA have been included: Six Nations (Part) 40 (3528037).

CMA Calgary

  • The following areas outside of CMA have been included: Ghost Lake (4815027), Waiparous (4815030), Stoney 142, 143, 144 (4815802),  8% of Kananaskis (4815013), 36% of Bighorn No.8 (4815015), 27% of Kneehill County (4805041), Acme (4805044), Linden (4805046), 4% of Wheatland County (4805012), 2% of Mountain View County (4806028).

  • The following areas within the CMA have been excluded: 10% of Rocky View No. 44 (4806014).

CMA Edmonton

  • The following areas outside of CMA have been included: Nakamun Park (4813003), Val Quentin (4813005), West Cove (4813006), Yellowstone (4813007), Ross Haven (48 13 008), Castle Island (4813009), Sunset Point (4813011), Alberta Beach (4813012), Onoway (4813014), 4% of Alexis 133 (4813811), 8% of Wetaskiwin County No.10 (4811001), Argentina Beach (4811003), Silver Beach (4811009), 57% of Lac Ste. Anne County (4813001), Westlock County (4813028), 96% of Thorhild County No. 7 (4813036), Thorhild (4813042), Sandy Beach (4813016), Sunrise Beach (4813017).

  • The following areas within the CMA have been excluded: 11% of Parkland County (4811034), Seba Beach (4811038), Betula Beach (4811039), Point Alison (4811041), 10% of Leduc County (4811012), 2% of Golden Days (4811023), 6% of Sturgeon County (4811059).

CMA Greater Sudbury

  • The following areas within the CMA have been excluded: Wahnapitei 11 (3553040), Whitefish Lake 6 (3552051).

CMA Guelph

  • The following areas within the CMA have been excluded: Guelph/Eramosa (3523009).

CMA Halifax

  • Perfect match.

CMA Hamilton

  • The following areas within the CMA have been excluded: 63% of Burlington (3524002), Grimsby (3526065).

  • The following areas outside the CMA have been included: 37% of Oakville (3524001), 37% of Milton (3524009), 37% of Halton Hills (3524015).

CMA Kelowna

  • Perfect match.

CMA Kingston

  • The following areas within the CMA have been excluded: Frontenac Islands (3510005).

CMA Kitchener

  • The following areas outside of CMA have been included: Wellesley (3530027), Wilmot (3530020).

CMA London

  • The following areas outside of CMA have been included: Newbury (3539002), Southwest Middlesex (3539005), Chippewas of the Thames First Nation 42 (3539017), Munsee-Delaware Nation 1 (3539018), Oneida 41 (3539021), North Middlesex (3539041), Lucan Biddulph (3539060).

  • The following areas within the CMA have been excluded: Southwold (3534024), Central Elgin (3534020).

CMA Moncton

  • The following areas outside of CMA have been included: 40% of Brunswick (1304016), 10% of Cardwell (1305026), 50% of Havelock (1305028), Hopewell (1306001), Riverside-Albert (1306003), Harvey (1306004), Alma (1306006), Alma (1306007), Salisbury (1307024), Petitcodiac (1307029).

  • The following areas within the CMA have been excluded: Saint-Paul (1308008), Dorchester (1307011), Dorchester (1307012), Memramcook (1307013), Fort Folly 1 (1307014).

CMA Montréal

  • The following areas outside of CMA have been included: Rivière-Beaudette (2471005), Saint-Télesphore (2471015), Saint-Polycarpe (2471020), Saint-Clet (2471045), Pointe-Fortune (2471140), Rigaud (2471133), Très-Saint-Rédempteur, (2471125), Sainte-Marthe, (2471110), Sainte-Justine-de-Newton, (2471115), Sainte-Jean-Baptiste (2457033), Calixa-Lavallée (2459030), Contrecoeur (2459035).

  • The following areas within the CMA have been excluded: Lavaltrie (2452007), Gore (2476025), L’Épiphanie (2460035), L’Épiphanie (2460040).

CMA Oshawa

  • Not currently used due to the fact that data would have to be based on estimates from Durham Regional Police.

  • The following areas outside of CMA have been included: 64% of Pickering (3518001), 64% of Ajax (3518005), 64% of Scugog (3518020), 64% of Mississaugas of Scugog Island (3518022), 64% of Uxbridge (3518029), 64% of Brock (3518039).

  • The following areas within the CMA have been excluded: 36% of Whitby (3518009), 36% of Oshawa (3518013), 36% of Clarington (3518017).

CMA Ottawa-Gatineau (Ontario Portion)

  • The following areas outside of CMA have been included: 62% of The Nation / La Nation (3502025).

CMA Ottawa-Gatineau (Quebec Portion)

  • The following areas outside of CMA have been included: Notre-Dame-de-la-Salette (2482010).

  • The following areas within the CMA have been excluded: Denholm (2483005).

CMA Peterborough

  • Perfect match.

CMA Québec

  • The following areas outside of CMA have been included: Sainte-Anne-de-Beaupré (2421030), Beaupré (2421025), Saint-Joachim (2421020), Saint-Tite-des-Caps (2421005), Saint-Ferréol-les-Neiges (2421010), Lac-Croche (2422902).

  • The following areas within the CMA have been excluded: Saint-Lambert-de-Lauzon (2426070), Beaumont (2419105), Saint-Henri (2419068).

CMA Regina

  • The following areas outside of CMA have been included: Findlater (4706062), Bethune (4706061), Dufferin No.190, (4706059), Silton (4706077), Kannata Valley (4706075), Craven (4706078), South Qu'Appelle No. 157 (4706034), Lajord No. 128 (4706011).

  • The following areas within the CMA have been excluded: Pense No. 160 (4706021), Pense (4706023), Belle Plaine (4706022).

CMA Saguenay

  • The following areas within the CMA have been excluded: Saint-Honoré (2494060), Saint-Fulgence (2494035).

CMA Saint John

  • The following areas within the CMA have been excluded: Saint Martins (1301001), St. Martins (1301002), Simonds (1301004), Petersville (1304001), Upham (1305004), Hampton (1305006), Westfield (1305011), Kingston (1305014), Grand Bay-Westfield (1305015), Greenwich (1305038), Musquash (1301016), Lepreau (1302008).

CMA Saskatoon

  • The following areas outside of CMA have been included: Ruddell (4716003), Maymont (4716004), Mayfield No. 406 (4716005), Great Bend No. 405 (4716008), Radisson (4716009), Borden (4716011), Rosedale No. 283 (4711031), Hanley (4711032), Lost River No. 313 (4711059), Kenaston (4711036), McCraney No. 282 (4711034), Bladworth (4711038), Viscount (4711092), Plunkett (4711094), Viscount No. 341 (4711091), Wolverine No. 340 (4711096). Bayne No. 371 (4715011), Bruno (4715012), Grant No. 372 (4715014), Prud’Homme (4715016), Vonda (4715017), Aberdeen No. 373 (4715018), Aberdeen (4715019).

CMA Sherbrooke

  • The following areas outside of CMA have been included: Sainte-Catherine-de-Hatley (2445060), Austin (2445085), Orford (2445115).

  • The following areas within the CMA have been excluded: North Hatley (2445050), Hatley (2445055), Ascot Corner (2441055), Saint-Denis-de-Brompton (2442025), Stoke (2442005), Compton (2444071), Waterville (2444080).

CMA St. Catharines-Niagara

  • The following areas outside of CMA have been included: Grimsby (3526065), West Lincoln (3526021).

CMA St. John’s

  • The following areas within the CMA have been excluded: Bay Bulls (1001557), Witless Bay (1001559).

CMA Thunder Bay

  • The following areas within the CMA have been excluded: Neebing (3558001), Gillies (3558012), O’Connor (3558016), Conmee (3558019), Fort William 52 (3558003).

CMA Toronto

  • The following areas outside of CMA have been included: 30% of Whitby (3518009), 30% of Oshawa (3518013), 30% of Clarington (3518017), 30% of Scugog (3518020), 30% of Mississaugas of Scugog Island (3518022), 30% of Brock (3518039), Adjala Tosorontio (3543003), 78% of Essa (3543021), 63% of Burlington (3524002).

  • The following areas within the CMA have been excluded: 70% of Pickering (3518001), 70% of Ajax (3518005), 70% of Uxbridge (3518029), Bradford West Gwillimbury (3543014), 37% of Oakville (3524001), 37% of Milton (3524009), 37% of Halton Hills (3524015).

CMA Trois-Rivières

  • The following areas outside of CMA have been included: Deschaillons-sur-Saint-Laurent (2438070), Saint-Pierre-les-Becquets (2438065), Sainte-Cécile-de-Lévrard (2438060), Parisville (2438055), Fortierville (2438047), Sainte-Sophie-de-Lévrard (2438040), Sainte-Françoise (2438035), Manseau (2438028), Sainte-Marie-de-Blandford (2438015), Lemieux (2438020), Saint-Sylvère (2438005).

  • The following areas within the CMA have been excluded: Wôlinak (2438802), Saint-Maurice (2437230), Champlain (2437220).

CMA Vancouver

  • The following areas outside of CMA have been included: 69% of Squamish-Lillooet D (5931021), Cheakamus 11 (5931801).

CMA Victoria

  • The following areas outside of CMA have been included: Capital H (Part 2) (5917056), Gordon River 2 (5917815), 3% of Capital G (5917029).

CMA Windsor

  • Perfect match.

CMA Winnipeg

  • The following areas outside of CMA have been included: Brokenhead (4612054), Cartier (4610043), Niverville (4602046), St-Pierre-Jolys (4602037), 10% of Hanover (4602041), De Salaberry (46 02 032), St. Andrews (4613043), Dunnottar (4613049).

  • The following areas within the CMA have been excluded: 50% of Rosser (4614015).

Notes

  1. Source: Statistics Canada, Demography Division and Canadian Centre for Justice Statistics

Legislative Influences - 2012

Changes in legislation and the resulting change in the offence classification creates discontinuity in the historical record of particular criminal offences. Legislative changes to assault, sexual assault, theft, arson, mischief, prostitution and youth crime must be considered when making comparisons over time. Some of the more significant changes are as follows:

Sexual Assault: Bill C-127 (1983):

Bill C-127 abolished the offences of rape, attempted rape and indecent assault and introduced a three-tiered structure for sexual assault offences. The Bill also eased the circumstances under which police could lay charges in incidents of sexual and non-sexual assault.

Young Offenders Act (1984):

With the proclamation of the YOA in April 1984, 12 years became the minimum age for which criminal charges could be laid. However, the maximum age continued to vary until April 1985, when the maximum age of 17 (up to the 18th birthday) was established in all provinces and territories. Youths, as defined in this publication, refer to those aged 12 to 17 (inclusive). This definition applies to the target group who fall under the delegation of the Young Offenders Act (YOA).

Traffic Offences: Bill C-18 (1985):

Bill C-18 (1985): In December 1985, Bill C18 made major legislative changes with respect to certain traffic offences (all 700 series offences). It imposed more stringent sentences for dangerous driving and drinking and driving. It also facilitated the enforcement of impaired driving laws by authorizing police to take blood and/or breath samples under certain circumstances. As a result, data previous to 1985 for traffic offences are not comparable and have not been presented.

Property value limits: Bill C-18 (1985) and Bill C-42 (1995):

Bill C-18 (1985) and Bill C-42 (1995): In 1985, Bill C-18 altered the property value limits from under and over $200 to under and over $1,000. This applies to offences such as theft, possession of stolen goods, mischief and fraud. As of February 1995, Bill C-42 revised the property value limits to under and over $5,000.

Alternative measures: Bill C-41 (1996):

Bill C-41 was proclaimed into law September 3, 1996. One of its highlights was the introduction of “alternative measures” for adults, which provided ways of dealing with disputes and minor offences outside the formal court proceedings.

Firearms: Bill C-68 (1997):

Bill C-68, proclaimed on January 1, 1997, requires that all firearm owners must obtain a Firearms License by January, 2001. This license replaces the Firearms Acquisition Certificate in use since 1977. Commencing October 1, 1998, each weapon must be registered within five years and a Registration Certificate will be issued. Bill C-68 also provides for tougher penalties for using a firearm while committing a crime.

Controlled Drugs and Substances Act: Bill C-8 (1997):

This new legislation came into force on May 14, 1997. The Controlled Drugs and Substances Act (CDSA) repealed and replaced the Narcotic Control Act (NCA) and parts of the Food and Drugs Act (FDA) in 1996. With this change in legislation, offences related to the possession, trafficking and importation of certain controlled or restricted drugs not identified in the earlier statutes are now (since 1997) included in other drugs category. Hence, comparisons with years prior to 1997 should be made with caution.

Dangerous Operation Evading Police:  Bill C-202 (2000):

Law C-202 came into effect March 30th, 2000.  This legislation modifies section 249 of the Criminal Code, thus creating new offences of dangerous operation of a motor vehicle when used for evading police.

Youth Criminal Justice Act: Bill C-7 (2003):

The extrajudicial measures encouraged by the Youth Criminal Justice Act, proclaimed on April 1, 2003, include taking no further action, informal police warnings, referrals to community programs, formal police cautions, Crown cautions, and extrajudicial sanctions programs. It is presumed that extrajudicial measures are adequate to hold accountable non-violent offenders who have not previously been found guilty in court.

Street Racing: Bill C-19 (2006):

Bill C-19, proclaimed on December 14, 2006, addresses the street-racing problem by making four amendments to the Criminal Code: “Street-racing” has been defined, five new street-racing offences have been added, for three of the new offences, it provides maximum prison terms longer than those currently provided for dangerous operation or criminal negligence in the operation of a motor vehicle, and it introduces mandatory driving prohibition orders for a minimum period of time, with the length of the prohibition increasing gradually for repeat offences.

Unauthorized Recording of a Movie: Bill C-59 (2007):

Bill C-59, proclaimed on June 22, 2007, addresses the illegal recording of movies in theatres by creating two offences in the criminal code: recording for personal use of a movie shown in a theatre – liable to imprisonment for not more than two years, and recording for commercial purposes of a movie shown in a theatre – liable to imprisonment for not more than five years.

Tackling Violent Crime: Bill C-2 (2008)

As a result of Bill C-2, which was proclaimed on February 28, 2008, the age of consent was raised from 14 to 16 for the following Criminal Code offences: sexual interference, invitation to sexual touching, sexual exploitation, bestiality and exposure to person under 14. For sexual assault levels 1 to 3, the age changes for complainant (formerly 14) to under the age of 16.

Impaired operation and failure to provide blood sample now includes the separation between alcohol and drugs (or combination of drugs). Fail/refuse to provide breath sample and failure to comply or refusal (drugs) will now have a maximum penalty of 25 years. 

New firearm offences will separate offences of breaking and entering by robbery to steal a firearm and to steal a firearm, which carry a maximum penalty of 25 years.

Tackling Violent Crime: Bill C-2 (2009)

As a result of Bill C-2, which was proclaimed on February 28, 2008, the UCR has also created a new code for sexual exploitation of a person with a disability. As well, two new Firearm violations have been added: Robbery to steal a firearm, and Break and Enter to steal a firearm.

Act to amend the Criminal Code (organized crime and protection of justice system participants) Bill C-14 (2009)

Bill C-14 officially came into effect on October 2, 2009. As a result, two new violation codes have been created: Assaulting with a weapon or causing bodily harm to a peace officer, and aggravated assault to a peace officer.

In 2002, legislative changes were made to include the use of the Internet for the purpose of committing child pornography offences. As such, the percent change in this offence is calculated from 2003 to 2009.

Codifying Identity Theft: Bill S4 (2010)

Bill S-4 officially came into effect on January 8, 2010. As a result, two new violation codes were created: Identity Theft and Identity Fraud.

Trafficking in Person’s under the age of 18: Bill C-268 (2010)

Bill C-268 officially came into effect on June 29, 2010. As a result, a new section was added to the Criminal Code; Section 279.011(1).  This section will be coded into the existing UCR code of Trafficking in Persons.

Comparing UCR Data with Courts and Corrections Data

It is difficult to make comparisons between data reported by police and data from other sectors of the criminal justice system (i.e., courts and corrections). There is no single unit of count (i.e., incidents, offences, charges, cases or persons) which is defined consistently across the major sectors of the justice system. As well, charges actually laid can be different from the most serious offence by which incidents are categorized. In addition, the number and type of charges laid by police may change at the pre-court stage or during the court process. Time lags between the various stages of the justice process also make comparisons difficult.

Data Elements and Violation Coding Structure for the Uniform Crime Reporting Survey

The Uniform Crime Reporting (UCR) Survey was designed to measure the incidence of crime in Canadian society and its characteristics. Presented are the data elements that are captured by the survey, and the violation codes that are used in data collection.

Data Elements

Aboriginal Indicator

Apparent Age

Attempted/Completed Violation

Charges Laid Or Recommended

Clearance Date

Counter Frauds And Motor Vehicles – UCR 2.1

Counter Frauds And Motor Vehicles – UCR 2.2

CSC Status (Charged/Suspect - Chargeable)

Cyber Crime

Date Charges Laid Or Recommended Or Processed By Other Means

Date Of Birth

FPS Number

Fraud Type

Geocode Information

Hate Crime

Incident Clearance Status

Incident Date/Time (From and To [Date and Time])

Incident File Number

Level Of Injury

Location Of Incident

Most Serious Violation / Violations

Most Serious Violation Against The Victim (VAV)

Most Serious Weapon Present

Motor Vehicle Recovery

Organized Crime / Street Gang

Peace – Public Officer Status

Property Stolen

Relationship of CSC, (Charged/Suspect – Chargeable), To The Victim

Report Date

Respondent Code

Sex

Shoplifting Flag

Soundex Code – UCR 2.1

Soundex Code – UCR 2.2

Special Survey Feature

Target Vehicle

Update Status

Vehicle Type

Weapon Causing Injury

Violation Structure for the Uniform Crime Reporting Survey

Crimes Against The Person

Violations Causing Death

  • Murder 1st Degree
  • Murder 2nd Degree
  • Manslaughter
  • Infanticide
  • Criminal Negligence Causing Death
  • Other Related Offences Causing Death

Attempting The Commission Of A Capital Crime

  • Attempted Murder
  • Conspire To Commit Murder

Sexual Violations

  • Aggravated Sexual Assault
  • Sexual Assault With A Weapon
  • Sexual Assault
  • Other Sexual Crimes (expired 2008-03-31)
  • Sexual Interference (effective 2008-04-01)
  • Invitation To Sexual Touching (effective 2008-04-01)
  • Sexual Exploitation (effective 2008-04-01)
  • Sexual Exploitation Of A Person With A Disability (effective 2008-05-01)
  • Incest (effective 2008-04-01)
  • Corrupting Children (effective 2008-04-01)
  • Luring A Child Via A Computer (effective 2008-04-01)
  • Anal Intercourse (effective 2008-04-01)
  • Bestiality - Commit / Compel / Incite A Person (effective 2008-04-01)
  • Voyeurism (effective 2008-04-01)

Assaults

  • Aggravated Assault Level 3
  • Assault With Weapon or Causing Bodily Harm Level 2
  • Assault Level 1
  • Unlawfully Causing Bodily Harm
  • Discharge Firearm With Intent
  • Using Firearm/Imitation Of Firearm In Commission Of Offence (effective 2008-04-01)
  • Pointing A Firearm (effective 2008-04-01)
  • Assault Against Peace Public Officer
  • Assault Against Peace Officer With A Weapon Or Causing Bodily Harm (effective 2009-10-02)
  • Aggravated Assault Against Peace Officer (effective 2009-10-02)
  • Criminal Negligence Causing Bodily Harm
  • Trap Likely To Or Causing Bodily Harm (effective 2008-04-01)
  • Other Assaults

Violations Resulting In The Deprivation Of Freedom

  • Kidnapping / Forcible Confinement (expired 2010-01-08) 
  • Kidnapping (effective 2010-01-08)
  • Forcible Confinement (effective 2010-01-08)
  • Hostage Taking
  • Trafficking In Persons (effective 2005-11-01)
  • Abduction Under 14, Not Parent/Guardian
  • Abduction Under 16
  • Removal Of Children From Canada (effective 1998-01-01)
  • Abduction Under 14 Contravening A Custody Order
  • Abduction Under 14, By Parent/Guardian

Other Violations Involving Violence Or The Threat of Violence

  • Robbery
  • Robbery To Steal Firearm (effective 2008-05-01)
  • Extortion
  • Intimidation Of A Justice System Participant Or A Journalist (effective 2008-04-01)
  • Intimidation Of A Non-Justice System Participant (effective 2008-04-01)
  • Criminal Harassment (effective 1994-01-01)
  • Indecent/Harassing Telephone Calls (effective 2008-04-01)
  • Utter Threats To Person (effective 1998-01-01)
  • Explosives Causing Death/Bodily Harm (effective 1998-01-01)
  • Arson – Disregard For Human Life (effective 1999-05-01)
  • Other Violations Against The Person

Crimes Against Property

  • Arson
  • Break And Enter
  • Break And Enter To Steal Firearm (effective 2008-05-01)
  • Break And Enter A Motor Vehicle (Firearm) (effective 2008-05-01)
  • Theft Over $5,000
  • Theft Of A Motor Vehicle Over $5,000 (effective 2004-01-01)
  • Theft Over $5,000 From A Motor Vehicle (effective 2004-01-01)
  • Shoplifting Over $5,000 (effective 2008-04-01)
  • Theft $5,000 Or Under
  • Theft Of A Motor Vehicle $5,000 And Under (effective 2004-01-01)
  • Theft $5,000 Or Under From A Motor Vehicle (effective 2004-01-01)
  • Shoplifting $5,000 Or Under (effective 2008-04-01)
  • Have Stolen Goods
  • Fraud
  • Identity Theft (effective 2010-01-08) 
  • Identity Fraud (effective 2010-01-08) 
  • Mischief
  • Mischief Over $5,000 (expired 2008-03-31)
  • Mischief $5,000 Or Under (expired 2008-03-31)
  • Mischief To Religious Property Motivated By Hate (effective 2008-04-01)

Other Criminal Code Violations

Prostitution

  • Bawdy House
  • Living Off The Avails Of Prostitution Of A Person Under 18 (effective 1998-01-01)
  • Procuring
  • Obtains/Communicates With A Person Under 18 For Purpose Of Sex (effective 1998-01-01)
  • Other Prostitution

Gaming And Betting

  • Betting House
  • Gaming House
  • Other Gaming And Betting

Offensive Weapons

  • Explosives
  • Prohibited (expired 1998-12-01)  
  • Restricted (expired 1998-12-01)
  • Firearm Transfers/Serial Numbers (expired 1998-12-01)
  • Other Offensive Weapons (expired 1998-12-01)
  • Using Firearms/Imitation (expired 2008-03-31)
  • Weapons Trafficking (effective 1998-12-01)
  • Weapons Possession Contrary To Order (effective 1998-12-01)
  • Possession Of Weapons (effective 1998-12-01)
  • Unauthorized Importing/Exporting Of Weapons (effective 1998-12-01)
  • Pointing a Firearm (expired 2008-03-31)
  • Firearms Documentation/Administration (effective 1998-12-01)
  • Unsafe Storage Of Firearms (effective 1998-12-01)

Other Criminal Code

  • Failure To Comply With Conditions
  • Counterfeiting Currency
  • Disturb The Peace
  • Escape Custody
  • Indecent Acts
  • Production/Distribution Of Child Pornography (effective 1998-01-01)
  • Voyeurism (expired 2008-03-31)
  • Public Morals
  • Luring A Child Via A Computer (expired 2008-03-31)
  • Obstruct Public Peace Officer  
  • Prisoner Unlawfully At Large   
  • Trespass At Night
  • Failure To Attend Court
  • Breach Of Probation
  • Threatening/Harassing Phone Calls (expired 2008-03-31)
  • Utter Threats Against Property Or Animals (effective 2008-04-01)
  • Advocating Genocide (effective 2008-04-01)
  • Public Incitement Of Hatred (effective 2008-04-01)
  • Unauthorized Recording Of A Movie / Purpose Of Sale, Rental, Commercial Distribution (2007-06-22)
  • Offences Against Public Order (Part II CC)
  • Property Or Services For Terrorist Activity (effective 2002-01-01)
  • Freezing Of Property, Disclosure, Audit (effective 2002-01-01)
  • Participate In Activity Of Terrorist Group (effective 2002-01-01)
  • Facilitate Terrorist Activity (effective 2002-01-01)
  • Instruction/Commission Of Act Of Terrorism (effective 2002-01-01)
  • Harbour Or Conceal Terrorist (effective 2002-01-01)
  • Hoax – Terrorism (effective 2005-01-01)
  • Firearms And Other Offensive Weapons (Part III CC)
  • Offences Against The Administration Of Law And Justice (Part IV CC)
  • Sexual Offences, Public Morals And Disorderly Conduct (Part V CC)
  • Invasion Of Privacy (Part VI CC)
  • Disorderly Houses, Gaming And Betting (Part VII CC) (expired 2008-03-31)
  • Offences Against The Person And Reputation (Part VIII CC)
  • Offences Against The Rights Of Property (Part IX CC)
  • Fraudulent Transactions Relating To Contracts And Trade (Part X CC)
  • Intimidation Of Justice System Participant (expired 2008-03-31)
  • Wilful And Forbidden Acts In Respect Of Certain Property (Part XI CC)
  • Offences Related To Currency (Part XII CC)
  • Proceeds Of Crime (Part XII.2 CC) (effective 1998-01-01)
  • Attempts, Conspiracies, Accessories (Part XIII CC)
  • Instruct Offence For Criminal Organization (effective 2002-01-01)
  • Commit Offence For Criminal Organization (effective 2002-01-01)
  • Participate In Activities Of Criminal Organization (effective 2002-01-01)
  • All Other Criminal Code (includes Part XII.1 CC)

Controlled Drugs And Substances Act (Effective 1997-06-01)

Possession

  • Heroin
  • Cocaine
  • Other Controlled Drugs And Substances Act
  • Cannabis
  • Methamphetamine (Crystal Meth) (effective 2008-04-01)
  • Methylenedioxyamphetamine (Ecstasy) (effective 2008-04-01)

Trafficking

  • Heroin
  • Cocaine
  • Other Controlled Drugs And Substances Act
  • Cannabis
  • Methamphetamine (Crystal Meth) (effective 2008-04-01)
  • Methylenedioxyamphetamine (Ecstasy) (effective 2008-04-01)

Importation And Exportation

  • Heroin
  • Cocaine
  • Other Controlled Drugs And Substances Act
  • Cannabis
  • Methamphetamine (Crystal Meth) (effective 2008-04-01)
  • Methylenedioxyamphetamine (Ecstasy) (effective 2008-04-01)

Production

  • Heroin (effective 2008-04-01)
  • Cocaine (effective 2008-04-01)
  • Other Controlled Drugs And Substances Act (effective 2008-04-01)
  • Cannabis
  • Methamphetamine (Crystal Meth) (effective 2008-04-01)
  • Methylenedioxyamphetamine (Ecstasy) (effective 2008-04-01)

Other Federal Statute Violations

Bankruptcy Act

Income Tax Act

Canada Shipping Act

Canada Health Act

Customs Act

Competition Act

Excise Act

Young Offenders Act (expired 2003-03-31)

Youth Criminal Justice Act (effective 2003-04-01)

Immigration And Refugee Protection Act

Firearms Act (effective 1998-12-01)

National Defence Act (effective 2002-01-01)

Other Federal Statutes

Traffic Violations

Dangerous Operation

  • Causing Death
  • Causing Bodily Harm
  • Operation Of Motor Vehicle, Vessel Or Aircraft

Flight From Peace Officer (effective 2000-07-01)

  • Causing Death
  • Causing Bodily-Harm
  • Flight From Peace Officer

Impaired Operation/Related Violations

  • Causing Death (Alcohol)
  • Causing Death (Drugs)
  • Causing Bodily Harm (Alcohol)
  • Causing Bodily Harm (Drugs)
  • Operation Of Motor Vehicle, Vessel Or Aircraft Or Over 80 Mg. (Alcohol)
  • Operation Of Motor Vehicle, Vessel Or Aircraft Or Over 80 Mg. (Drugs)
  • Failure To Comply Or Refusal (Alcohol)
  • Failure To Comply Or Refusal (Drugs)
  • Failure To Provide Blood Sample (Alcohol)
  • Failure To Provide Blood Sample (Drugs)

Other Criminal Code Traffic Violations

  • Failure To Stop Or Remain
  • Driving While Prohibited
  • Other Criminal Code

Street Racing

  • Causing Death By Criminal Negligence While Street Racing (effective 2006-12-14)
  • Causing Bodily Harm By Criminal Negligence While Street Racing (effective 2006-12-14)
  • Dangerous Operation Causing Death While Street Racing (effective 2006-12-14)
  • Dangerous Operation Causing Bodily Harm While Street Racing (effective 2006-12-14)
  • Dangerous Operation Of Motor Vehicle While Street Racing (effective 2006-12-14)

For more information, contact Information and Client Services (toll-free 1-800-387-2231; 613-951-9023), Canadian Centre for Justice Statistics.

Vital Statistics: Marriage Database Data Accuracy (2005 to 2008)

Same-sex marriages

Following provincial court rulings in 2003, vital statistics registries in Ontario and British Columbia started registering marriages of same-sex couples. In 2004, subsequent rulings by courts in five provinces (Quebec, Manitoba, Nova Scotia, Saskatchewan, and Newfoundland and Labrador) and one territory (Yukon) expanded the number of jurisdictions registering same-sex marriages. A court ruling in New Brunswick allowed same–sex marriages, a month before federal legislation legalized same–sex marriages across Canada, on July 20th, 2005. Canada became the third country in the world, after the Netherlands and Belgium, to legalize same sex marriages across its territory.

Due to this legislative change, the information identifying the sex of each spouse was partially recorded in some provinces or territories and it is not available for Ontario (2003 to 2008) and Saskatchewan (2007 and 2008).

Response rates

Item response

For 2005 to 2008, the response rates varied from 99% to 100% for most of the demographic variables on the marriage database (age, previous marital status). The response rates for birthplace of the groom and bride varied from 84% (2008) to 97% (2005). The response rates for the sex variable varied from 55% (2008) to 58% (2005).

Annual Store Retail Survey Data Accuracy for 2009

Table 1
Geography RF (TOR) % CV(TOR)
Canada 95.8 0.4
Newfoundland and Labrador 90.9 1.0
Prince Edward Island 95.0 0.4
Nova Scotia 96.1 0.9
New Brunswick 94.9 0.9
Quebec 96.6 0.9
Ontario 95.1 0.8
Manitoba 95.7 0.8
Saskatchewan 97.1 0.8
Alberta 96.0 0.8
British Columbia 96.7 0.9
Yukon 88.9 0.3
Northwest Territories 96.5 0.0
Nunavut 91.7 0.0
Table 2
NAICS RF (TOR) % CV(TOR)
Total 95.8 0.4
New Car Dealers 97.9 1.3
Used and Recreational Motor Vehicle and Parts Dealers 95.0 2.0
Gasoline Stations 94.5 1.0
Furniture Stores 97.0 1.3
Home Furnishings Stores 95.9 2.0
Computer and Software Stores 89.2 3.3
Home Electronics and Appliance Stores 96.1 1.1
Home Centres and Hardware Stores 97.5 1.6
Specialized Building Materials and Garden Stores 90.5 2.3
Supermarkets 98.8 1.1
Convenience and Specialty Food Stores 92.5 1.5
Beer, Wine and Liquor Stores 80.7 0.4
Pharmacies and Personal Care Stores 95.0 1.7
Clothing Stores 93.1 0.7
Shoe, Clothing Accessories and Jewellery Stores 89.5 1.2
General Merchandise Stores 99.1 0.8
Sporting Goods, Hobby, Music and Book Stores 94.0 1.5
Miscellaneous Store Retailers 92.7 1.5